```{=html}
<!-- <!-1- Nuova geometria per avere la copertina centrata -1->-->
```
```{=html}
<!-- \newgeometry{top=4cm, bottom=4cm, left=4cm, right=4cm}-->
```
```{=html}
<!-- \title{Malattie cardiovascolari e dell'apparato respiratorio (C.I.)}-->
```
```{=html}
<!-- \author{Emanuele Vicinelli}-->
```
```{=html}
<!-- \date{a.a. 2019/2020}-->
```
```{=html}
<!-- \maketitle-->
```
```{=html}
<!-- * * * *-->
```
```{=html}
<!-- \begin{figure}[H]-->
```
```{=html}
<!-- \vspace{2cm}-->
```
```{=html}
<!-- \centering-->
```
```{=html}
<!-- \includegraphics[width=8cm]{../head.pdf}-->
```
```{=html}
<!-- \end{figure}-->
```
```{=html}
<!-- <!-1- Data in cui il pdf è stato compilato-1->-->
```
```{=html}
<!-- \thispagestyle{fancy}-->
```
```{=html}
<!-- \fancyhead{}-->
```
```{=html}
<!-- \fancyfoot{}-->
```
```{=html}
<!-- \renewcommand{\headrulewidth}{0pt}-->
```
```{=html}
<!-- \rfoot{\today}-->
```
```{=html}
<!-- \restoregeometry-->
```
```{=html}
<!-- \newpage-->
```
```{=html}
<!-- \tableofcontents-->
```
```{=html}
<!-- \newpage-->
```
```{=html}
<!-- \listoffigures-->
```
```{=html}
<!-- \newpage-->
```

------------------------------------------------------------------------

```{=html}
<!-- mar 16 mar 2021, 16:11:26, CET -->
```
# Valvulopatie

```{=html}
<!-- Piovaccari -->
```
  -----------------------------------------------------------------------------
                    Ventricolo sx  Ventricolo dx  Aorta          Arteria
                                                                 polmonare
  ----------------- -------------- -------------- -------------- --------------
  Sistolica         90--140        25--35         90--140        25--35

  Protodiastolica   -2[^1] -- 5                                  

  Telediastolica    8-12           4-8                           

  Diastolica                       -2--0          60--90         5--15

  Media             90                            90             20
  -----------------------------------------------------------------------------

-   Valvulopatia --- patologia delle valvole cardiache (stenosi e/o
    rigurgito)
    -   Valvulopatia provoca alterazioni dei parametri emodinamici nei
        dintorni della valvola stessa. Studiando l'emodinamica
        circostante + EO + clinica si giunge a dx

> **Soffi cardiaci**
>
> ![](img/soffi.jpg)\
> - Usare intensità nella scala di Levine per descriverli - Descrivere
> sempre posizione (non limitarsi ai focolai classici, ma valutare
> irradiazione e direzione) - Valutarli in funzione del momento del
> ciclo cardiaco

-   Per fare diagnosi di valvulopatia
    -   Quadro clinico (ottima anamnesi *olistica*)
    -   EO toracico e cardiovascolare per SeS orientativi di disfunzioni
        di circolo/congestione
    -   ECG: ci sono aritmie?
    -   ECO
        -   TT per studiare normale funzione
        -   TE se necessario
        -   In casi selezionati: ecostress (`dobutamina`) per
            smascherare sintomi. Attenzione alla sicurezza, prima
            stratificare il rischio
    -   Imaging coronarico

## Epidemiologia delle valvulopatie

-   incidenza ↑ con ↑ età per degenerazione vlvolare
-   Anni '50: picco in età giovanile per malattia reumatica
-   Frequenza
    1.  Valvulopatia mitralica da rigurgito
    2.  Valvulopatia aortica
    3.  Valvulopatia valvola polmonare
    4.  Valvulopatia da endocardite
    5.  Stenosi mitralica

> **Malattia reumatica post streptococica**
>
> -   Fisiopatologia: vegetazione streptococcica su lembi valvolari
>     porta a danneggiamento → riparazione → stenosi → incompetenza
>     valvolare
> -   Tipica in under 15aa in zone povere con alti tassi d'infezione per
>     Streptococco
>     -   Africa
>     -   Asia meridionale
> -   Mortalità in calo (per abx -- sulfamidici e penicillina), ma
>     grandi differenze (1/$propto$ con ricchezza)
> -   Possibile grave complicanza: ictus per tromboemboli secondari
> -   Non sottovalutare incidenza in migranti

## Valvulopatia mitralica

-   Apparato valvolare mitralico con 3 elementi (tutti e 3, se
    ostacolati, danno valvulopatia)
    1.  2 lembi valvolari (anteromediale e posterolaterale)
    2.  2 sistemi di corde tendinee
    3.  2 muscoli papillari
-   3 entità di valvulopatie
    -   Stenosi
        -   Reumatica (99%)
        -   Congenita (corde tendinee fanno capo ad un unico m papillare
            -- "valvola a paracadute")
    -   Da rigurgito (anche "***insufficienza mitrale***")
        -   Acuta → forme infettive, ischemia dei mm papillari, prolasso
            dei lembi valvolari, rottura delle corde tendinee (es da
            trauma toracico)
        -   Cronica → ischemia, prolasso dei lembi, endocardite
            infettiva, febbre reumatica, calcificazioni, cardiomiopatie
            (squilibri pressori)

### Stenosi mitralica (SM)

-   ***Stenosi mitralica*** --- riduzione dell'orifizio mitralico quando
    la valvola è aperta

-   **Area fisiologica dell'orifizio mitralico: 4--6 cm^2^**

      -----------------------------------------------------------------------
      Grado di SM             Area orifizio mitralico Intensità HF
                                                      tipicamente associata
      ----------------------- ----------------------- -----------------------
      SM lieve                1,5--2 cm^2^            NYHA 1

      SM moderata             1--1,5 cm^2^            NYHA 2--3

      SM grave                \< 1 cm^2^              NYHA 4
      -----------------------------------------------------------------------

-   Mitrale è valvola atrioventricolare che funge da sbarramento *di
    fatto* nel ritorno del sangue dai polmoni: SM ⇒ ↓ flusso a valle e
    stasi a monte ⇒ ↑ pressione nel circolo polmonare

    -   Ipertensione polmonare (dapprima reversibile, poi permanente
        nonostante valvuloplastica risolva)
    -   **Atrio**[^2] sinistro si ipertrofizza (ipertrofia concentrica)
        e/o si dilata per accomodare aumentati volumi (ipertrofia
        eccentrica)

-   Corteo patologico associato

    -   Ipertensione polmonare
    -   CHF di grado variabile (edema polmonare, congestione epatica,
        edemi declivi, faticabilità)
    -   Tendenzialmente AFib (per dilatazione e distensione parete
        atriale) ± RVR (che peggiora low-output per ↓ tempo di diastole)
    -   Tromboemboli (per disturbo del flusso)

-   Obiettività

    -   **Auscultazione dei toni**
        -   S1 aumenta di intensità
        -   S2 normale (se non ipertensione polmonare)
        -   Rullio diastolico con rinforzo presistolico[^3]
        -   Schiocco di apertura della valvola[^4]
    -   ECG
        -   P polmonari se RS
        -   Tachicardia
        -   AFib
    -   Rx torace
        -   Si visualizza bene auricola sinistra
        -   Si visualizzano bene arterie polmonari (dx/sx)
        -   Segni di congestione polmonare (circolo polmonare congesto,
            [linee di Kerley
            A\|B\|C](https://it.wikipedia.org/wiki/Linea_di_Kerley)...)
        -   In proiezione lat si visualizza dilatazione atriale (a volte
            talmente marcata da spostare esofago, ma visibile sse si fa
            pasto bariato)
    -   **Eco**
        -   Si vede benissimo il comportamento valvolare (ispessimento
            dei lembi, apertura, area, gradiente di flusso al
            Doppler...) nell'eco TE, visto che si arriva
            fondamentalmente all'atrio
        -   Possibile metodica per stimare area mitrale (in funzione di
            tempo di diastole, tempo di sistole, gradiente pressorio
            veno--arterioso dei capillari polmonari)
        -   Consente di capire se insufficienza si accompagna a stenosi
        -   Consente di stimare LVEF, importante per capire gravità
            della situazione

-   Terapia

    -   Chirurgia risolutiva (se beneficio \> rischio, tipicamente sì se
        stenosi moderata/*severa*)
        -   Valvuloplastica percutanea con palloncino[^5]
        -   Valvuloplastica a cielo aperto
        -   Sostituzione valvolare (insufficienza resistente a
            trattamento, calcificazioni gravi, anatomia sfavorevole)
    -   Di mantenimento
        -   `βb`/`digossina` per rate control
        -   `diuretici` per decongestionare
        -   `warfarin` (NAO controindicati[^6]) per evitare
            tromboembolismo (INR 2÷3)

### Insufficienza mitralica (IM)

-   ***Insufficienza mitralica*** (IM) --- incontinenza dell'apparato
    valvolare mitralico che provoca flusso retrogrado
-   A seconda dell'eziologia e della presentazione
    -   Presentazione clinica
        -   Acuta
        -   Cronica
    -   Eziologia
        -   Degenerativa
        -   Reumatica
        -   Secondaria a patologie congenite
-   Fisiopatogenesi
    0.  Mitrale incontinente ⇒ 2 vie di uscita (aorta e atrio)
    1.  Pressione atriale \< pressione aortica ⇒ via atriale è
        preferenziale
    2.  Dilatazione eccentrica + ↓ contrattilità atriale ⇒ stasi a monte
        ⇒
        -   ↓ gittata cardiaca
        -   ipertensione polmonare
        -   ipertrofia atriale
        -   ↑↑ insorgenza di aritmie per stiramento delle vie di
            conduzione
    3.  Quando la mitrale si apre la massa ematica scende in ventricolo
        ⇒ ipertrofia *anche* ventricolare ("*cor bovinum*", dilatazione
        del cuore sx)
-   Obiettività
    -   Auscultazione cardiaca
    -   Eco
-   Trattamento: variabile in funzione di entità sintomi
    -   Valutare opportunità (r/b) di riparazione con valvuloplastica
        (ci sono varie tecniche)

#### IM acuta

-   Condizione in cui l'IM si instaura in modo acuto o subitaneo
    -   Perforazione/rottura di un lembo valvolare
    -   Rottura delle corde tendinee
    -   Disfunzione/rottura dei mm papillari (tipicamente da infarto)
    -   Disfunzione protesica
-   Obiettività
    -   Eco/ventricolografia: ventricolo si contrae bene (è insorgenza
        acuta, riesce ancora a fare fronte ad aumentato carico)
    -   Nelle curve pressorie: c'è "onda V", corrispondente a flusso
        retrogrado del sangue in atrio durante la sistole

#### Prolasso della mitrale

-   IM dovuta a prolasso di almeno uno dei lembi valvolari; poiché i
    lembi non collabiscono porta ad insufficienza valvolare
    -   f:m = 2:1
    -   Anziani forme frequentemente gravi
    -   Turbolenza del flusso e stasi ⇒ ↑↑ rischio di endocardite
        batterica
    -   Decorso tendenzialmente benigno, ma correlato con \> incidenza
        di morte cardiaca imprvvisa
-   Quadro sintomatico varia in funzione di entità e velocità
    d'insorgenza del rigurgito
    -   Eco: ventricolo dilatato, anulus allargato, flapping della
        valvola
    -   Ses di IM (possibilmente acuta) ± dolore toracico
    -   Obiettività auscultatoria: click valvolari
        (proto/meso/telediastolico) per flapping + soffio
        (tendenzialmente telesistolico). L'obiettività auscultatoria
        cambia tra clino/ortostatismo/squatting (per cambiamento assetto
        emodinamico intracardiaco

## Valvulopatia aortica

-   Anatomia: 3 porzioni semilunari (2 cuspidi coronariche + 1 non
    coronarica)
    -   Valvola bicuspide in 1--1.5%
    -   Malformazioni rare: Valvola monocuspide, quadricuspide
-   **Area fisiologica anulus = 4 cm^2^**

### Stenosi aortica (SA)

-   Valvulopatia più frequente in EU e USA (21--26% popolazione \>65aa)
-   3 sottotipi
    -   SA sopravalvolare (congenita)
    -   SA valvolare (congenita o acquisita)
        -   Degenerativa calcifica (senile)
        -   Congenita (non 3 cuspidi, bicuspidismo è alterazione più
            diffusa)
        -   Postreumatica (poco diffusa)
        -   Protesica (in aumento, vita normale protesi valvolari
            biologiche è 10--15 (teorica), ma 7--10 nella pratica)
    -   SA sottovalvolare (congenita, entra in ddx con cardiopat
        ipertrofica ostruttiva)
-   Patogenesi
    0.  Valvola normale
    1.  Sclerosi valvolare con meccanismo analogo ad aterosclerosi (LDL,
        insudazione, macrofagi schiumosi, ossidazione delle LDL,
        organizzazione della placca)
    2.  Stenosi valvolare per sclerosi dei lembi che diventano rigidi e
        ipomobili
    3.  Produzione di un **gradiente pressorio** tra ventricolo sx ed
        aorta ⇒ ristagno in ventricolo sinistro (LVPO, Left Ventricole
        Pressure Overload)
        -   Ipertrofia concentrica ⇒ ↓ densità di distribuzione
            dell'ossigeno ⇒ ↑ sofferenza del miocardio
        -   LV noncompliante e rigido
        -   Se fail LV (aritmia, ↑ domanda, decadimento funzionale)⇒
            AHF/CHF
    4.  Possibile dilatazione atriale secondaria a insufficienza LV
        -   SE si perde il kick atriale E il ventricolo sx è già
            affaticato/rigido/ipertrofico si possono determinare stati
            di bassa portata molto pericolosi (EP, ipotensione)
-   SeS
    -   Dispnea (ingravescente col progredire)
    -   Angina da sforzo (indistinguibile per SeS da SCA)
    -   Sincope da sforzo (segno di inadeguata portata)
-   Obiettività cardiovascolare
    -   SeS orientativi di HF sx (torace umido, polso alternante)
    -   Polso parvo e tardo (scarsa ampiezza, picco ritardato e discesa
        lenta)
    -   Soffio nel focolaio aortico
        -   S1 ok o ridotto
        -   S2 potenzialmente coperto da soffio (più è coperto, più
            stenosi è grave)
        -   Soffio (meso)sistolico "a diamante"
        -   Possibile irradiazione
        -   Possibile S4 (presistolico) da contrazione atriale vigorosa
            per vincere ipertrofia ventricolare
        -   Possibile click dopo S1 che indica apertura improvvisa della
            valvola
    -   Ecg: segni di ipertrofia ventricolare (Sv2+Rv5 \> 35mm) ±
        possibili T invertite (anomalie della ripolarizzazione
        secondarie ad ipertrofia). Possibili segni di interessamento
        atriale in patologia che progredisce
    -   RX torace: segni di ipertrofia ventricolare ± segni di
        calcificazione dell'anello aortico
    -   ⭐️ Eco
        -   Stima dell'anulus valvolare[^7]

              Severità SA   Area
              ------------- ----------------
              Non SA        3.5--4 cm^2^
              Severa        \< 1 cm^2^
              Critica       0.5--0.7 cm^2^

        -   Ispessimento delle cuspidi

        -   Ipocinesia valvolare

        -   Ipertrofia ventricolare

        -   Eventuali concomitanti insufficienza mitralica dovuta a
            variazione dell'anatomia che l'ipertrofia concentrica del
            vent sx impone sull'anulus mitralico

        -   Misurazione del gradiente pressorio ventricolo--aorta (max e
            media): grave \> 40 mmHg (SA moderata se \> 30 mmHg)

        -   Se eco sforzo (attenzione, solo pz. selezionati!) possibile
            slatentizzare forme solo precedentemente sospettate oppure
            valutare effettiva severità di SA in situazioni
            precedentemente dubbie/mal valutabili
-   Terapia
    -   Gestione dei sintomi e ottimizzare la gestione dello scompenso
    -   Per risolvere realmente[^8]: valvuloplastica (attenta
        valutazione *olistica* r/b)
        -   Valvuloplastica con palloncino (soluzione temporanea, dopo
            1--3aa valvola ritorna a chiudersi). Ripetibile qb
        -   TAVI --- Trans-catheter Aortic Valvular Implant
            (protesica/biologica)
        -   Sostituzione valvolare a cielo aperto con valvola
            (protesica/biologica)

### Insufficienza aortica (IA)

-   ***IA*** --- non completa chiusura dell'apparato valvolare aortico
    -   Anomalia nelle cuspidi (retrazione, perforazione, trauma,
        prolasso)
    -   Anomalie nell'aorta (aortite, sifilide, Marfan, dilatazione,
        dissezione)
-   Acuta o cronica
    -   Acuta è quadro drammatico: se ventricolo non si adatta a
        sovraccarico si determina EPA in zero secondi
-   Fisiopatologia
    0.  Valvola aortica normale
    1.  Valcola aortica incontinente
    2.  Rigurgito in ventricolo, con sovraccarico di volume
    3.  Dilatazione del VNs → ipertrofia eccentrica ⇒ ↓ contrattilità ⇒
        ↓ FE, HF sx
-   SeS
    -   Angina pectoris (difficile irrorazione da parte delle coronarie)
    -   Dispnea (HF)
    -   Sincope (bassa portata)
-   Obiettività cardiovascolare
    -   ↑ PA differenziale (per ↓↓ PAD a causa del rigurgito, fino a PAD
        di 40 mmHg)
    -   Tipicamente polso ampio, celere, scoccante
    -   Tipicamente "danza delle arterie": movimento delle arterie
        omerali o delle carotidi (riscontro anche nel giovane per tono
        adrenergico)
    -   Segno di de Musset: scosse ritmiche del capo sincrone con polso
    -   Segno di Quincke: pulsazioni evidenti nel letto ungueale a
        seguito di piccola compressione
    -   Soffio diastolico decrescendo--crescendo
        -   S2 meno intenso (le semilunari non si toccano)
        -   Soffio ad alta frequenza (meglio con diaframma ben adeso)
        -   Soffio copre diastole ⇔ insufficienza *non* severissima (non
            si hanno ancora altre pressioni diastoliche ventricolari a
            causa del rigurgito)
-   Terapia
    -   Chirurgia
        -   Sostituzione valvolare meccanica
        -   TAVI ha meno possibilità, non si ha valvola stenosata che
            trattiene l'impianto. Possibile considerarla su valvola
            biologica quando questa arriva a fine vita (metodica *valve
            in valve*)
    -   Gestione
        -   βb **non** indicati, bradi aumenta tempo di diastole e
            peggiora rigurgito

> ***Sindrome di Marfan***\
> Disordine ereditario del connettivo, a causa di mutazione (autosomica
> dominante) del gene della fibrillina-1, componente del connettivo.
>
> Segni: pollice mano che passa oltre il polso, petto escavato,
> dislocazione del cristallino, possibilità di circondare ampiamente il
> proprio polso con pollice e medio
>
> Conseguneze: msk, cardiovascolari, visive, sistema nervoso, apparato
> respiratorio, altro.
>
> Notevole in questo ambito: insufficienza aortica progressiva per
> dilatazione dell'anulus, ↑ rischio di dissezione aortica, ↑
> probabilità aneurisma

## Valvulopatia della tricuspide

### Stenosi della tricuspide

### Insufficienza della tricuspide

-   Fisiopatologia
    1.  Tricuspide insufficiente
    2.  Dilatazione dell'atrio
    3.  Scompenso (congestizio) dx -- prima atrio poi ventricolo
-   Eziologia prevalente: endocardite infettiva (batterica o fungina)
    -   Clinica
        -   Febbre
        -   Noduli di Osler (aggregati di immunocomplessi che
            embolizzano nel microcircolo)
        -   Emorragie sottoungueali
        -   Petecchie congiuntivali
        -   diffusione (e colonizzazione potenziale) in ogni distretto
            vascolarizzato
    -   Terapia: lunga, aggressiva e difficile in pz. con valvola
        protesica
        -   Antibiotici aggressivi, ev continua, per lungo tempo.
            Obiettivo: altissime concentrazioni ematiche, perché devices
            protesici non sono vascolarizzati e bisogna distruggere il
            biofilm
        -   Rimozione chirurgica di vegetazioni se \> 15 mm per rischio
            embolico
            -   Vegetazione visibile ad Eco TT (SPIN 70%) ma ancora
                meglio a Eco TE

## Valvulopatie della polmonare

-   Congenite, molto rare
-   Trattate con valvuloplastica/palloncino anche in bambini appena nati
-   Molto rare

# Aritmie

-   **Aritmia** --- ritmo cardiaco anomalo in (1) frequenza, (2)
    regolarità o (3) modalità di genesi o conduzione dell'impulso

  ---------------------------------------------------------------------------
          Eziologia          Aritmia
  ------- ------------------ ------------------------------------------------
  Bradi   ↓ automaticità SA  Bradicardia sinusale

          Alterata           Sindrome braditachiaritmica
          automaticità SA    

          Blocco di          BAV
          conduzione         

  Tachi   ↑ automaticità SA  Tachicarrida sinusale

          Trigger            BES e BEV

          Trigger (EAD)      Tachicardie ventricolari polimorfiche a QT lungo
                             (TdP)

          Trigger (DAD)      Tachicardie ventricolari monomorfe a QT normale
                             (multifocali o focali) (\*)

          Circuito di        TV e FV (\*)
          rientro/Trigger    

          Circuito di        Flutter atriale
          rientro            

          Circuiti di        Fibrillazione atriale
          rientro            

                             Tachicardia intranodale

          Circuito di        Tachicardia parossistica sopraventricolare
          rientro            (ANVRT/AVRT)
  ---------------------------------------------------------------------------

## Bradiaritmie

-   Aritmie con FC ≤ 60 bpm
-   I meccanismi di genesi sono 2: ridotta automaticità e blocchi di
    conduzione

1.  ↓ automaticità[^9] - Da ↑ tono parasimpatico (*rest & digest*,
    ipertrofia cardiaca di atleti, IM inferiore[^10]) - Da rallentamento
    della conduzione attraverso il nodo AV (principalmente per farmaci
    (βb, ca-ant, digossina) - Sbilanciamenti elettrolitici
    (**iperkaliemia**) - Da ↓ attività metabolica dei cardiomiociti
    (ipotermia, ipotiroidismo marcato) - ↑ ICP
    2.  Blocchi di conduzione del nodo AV
        -   Iperkaliemia
        -   Infarto che interessa il nodo AV (solitamente infarti
            inferiori)
        -   `βb`, `ca-inibitori`, `digossina`
        -   Infiltrazioni del nodo AV (***amiloidosi***,
            ***sarcoidosi***)
        -   Endocardite da ***malattia di Lyme***
        -   Fibrosi idiopatica (età)

### Bradicardia sinusale

-   Non trattata se pz. asintomatica
-   Se sintomatica
    1.  valutare origine
    2.  `atropina` in situazioni estreme se emodinamica preoccupant

### Blocco del SA

-   Vedi elettivo

### Sindrome braditachiaritmica

-   Disritmia del SA in cui si alternano periodi di tachi a peiodi di
    bradi
-   Tipico: nonnino con tessuto SA fibrotico o atri fibrotici ⇒ si
    instaurano circuiti a random e producono tachi, quando si
    interrompono sopravanza il seno -- il quale è malato e fa bradi

### Blocco Atrio--Ventricolare

-   Per dettagli vedi elettivo
-   Dividiamo i BAV in 3 gradi
    1.  BAV di 1/o grado
    2.  BAV di 2/o grado
    3.  BAV di 3/o grado
-   L'eziologia della BAV è variabile:
    -   Cause intrinseche
        -   Esiti ischemici
        -   Anomalie cardiache congenite
        -   Difetti valvolari (calcificazioni dell'ostio valvolare
            possono danneggiare il sistema di conduzione)
    -   Cause estrinseche
        -   Disturbi elettrolitici (es: iperkaliemia)

#### BAV di primo grado

-   Allungamento del PR \> 200ms
-   Tendenzialmente asintomatico

#### BAV di secondo grado

-   **Ogni tanto una P viene bloccata** ⇒ una P non sequita da QRS e T
-   Si individuano 2 forme, che rispecchiano la sede del blocco
    1.  BAV Mobitz 1 (di Luciani-Wenckebach)
        -   Generalmente blocco "alto", nella parte craniale del nodo AV
            ⇒ il ritmo di scappamento che emerge ha frequenza alta
    2.  BAV Mobitz 2
        -   Generalmente blocco "basso", nella parte bassa del nodo AV o
            nel fascio di HIS ⇒ il ritmo di scappamento che emerge ha
            frequenza bassa ⇒ ↑↑ rischio di insorgenza di bradicardie
            importanti/BAV completo
            -   Trattamento con PM non glielo leva nessuno

#### BAV di terzo grado

-   Dissociazione atrioventricolare completa
-   **Le onde P e i QRS sono dissociate** per un blocco *completo* del
    nodo AV
    -   All'ECG: medesime distanze $\bar{PP}$, $\bar{RR}$, ma le
        distanze $\bar{PR}$ non sono assolutamente costanti
-   L'attivazione ventricolare è sempre, quindi, per scappamento
    -   Se va bene il ritmo di scappamento è alto, con una frequenza
        ancora accettabile\
        ![](img/bav3-alto.png)
    -   Se va male il ritmo di scappamento è basso (anche ventricolare)
        ⇒ frequenza bassa e morfologia dei QRS tipica)

#### Trattamento

1.  Valutare se pz. è stabile o no
2.  Valutare se è opportuno intervenire (se basso grado ha senso
    aspettare)
3.  Se causa reversibile: trattare la causa
4.  Trattare i sintomi acuti
    -   Bradicardia ⇒ `atropina`[^11]
        -   Se blocco è basso atropina potrebbe paradossalmente
            aumentare il grado del blocco per riduzione del filtro della
            parte alta AV
        -   Evitare se glaucoma
    -   Se blocco è basso o non rispondente ad atropina: inotropi
        (cautela, possibile proaritmia)
    -   Se non risposta: terapia elettrica + monitoraggio continuo
        -   Pacing trans--cutaneo[^12]
        -   Pacemaker temporaneo (con inserimento percutaneo [secondo
            Seldinger](https://en.wikipedia.org/wiki/Seldinger_technique))
5.  Valutare terapia cronica (pacemaker)

> **Pacemaker** - Condizioni che vanno trattate con pacemaker - BAV 3 -
> BAV 2 Mobitz II sintomatico - Malattia del nodo del seno sintomatica -
> Sindrome da iperattivazione del seno carotideo che impatta gravemente
> QoL - Bradiaritmie importanti - Condizioni che possono essere trattate
> con pacemaker - BAV congenito - BAV 2 Mobitz 1 - BAV 2 Mobitz 2
> asintomatico (meh... PM indicato) - Malattia del nodo del seno con
> sintomi minori

> Ogni pacemaker viene categorizzato con una sequenza di 3 o 4 lettere a
> seconda delle funzionalità (tendenzialmente si usano pacemaker `DDD`)
>
> ![](img/tipi-pacemaker.png)
>
> Per quanto riguarda oggetti che producono campi elettromagnetici
> tendenzialmente la regola è
>
> -   I dispositivi industriali/elettromedicali possono dare problemi
> -   Il cellulare va tenuto a debita distanza (\> 15 cm)
> -   Gli elettrodomestici quotidiani (o l'antitaccheggio) non danno
>     problemi
> -   I magneti su pacemaker attivano il cosiddetto *red-switch* del
>     pacemaker, facendo in modo che stimolino a frequenza fissa (\~
>     80--100 bpm). Molta attenzione se esiste un ritmo sottostante: se
>     il pacemaker stimola al momento sbagliato possono insorgere
>     aritmie ventricolari

## Blocchi di branca

-   Blocchi di conduzione a livello di una delle due branche
    -   Blocco di branca destra (BBDx)
    -   Blocco di branca sinistra (BBSx)

### BBdx

-   All'ECG
    -   QRS \> 120 ms
    -   Comparsa di R' in derivazioni che guardano a destra
    -   Onda S specularmente in laterali che guardano vent sx

### BBsx

-   Fisiologia
-   All'ECG
    -   QRS \> 120 ms
    -   Q assente in V5 e V6
    -   QRS con incisura in V5,6, avL
-   BBsx ha maggiore probabilità di essere patologico
    -   Se nuova insorgenza può essere espressione di IMA (anche se meno
        specifico di ST-elevation, perché bbsx può svilupparsi in
        numerose condizioni parafisiologiche/patologiche)

### Emiblocchi

-   Blocchi dei fascicoli (tendenzialmente a sx)
-   All'ECG
    -   Scarsa crescita della R nelle precordiali
    -   Deviazione d'asse

### Aberranze di conduzione

-   BB che si sviluppa solo sopra (o raramente, sotto) a certe frequenze
    -   In caso di tachiaritmie sopraventricolari
    -   In caso di sforze
    -   Raramente se bradiacardie

## Tachiaritmie

-   Le tachiaritmie vengono divise a seconda della durata dei sintomi
    -   Parossistiche --- va e viene a cazzo
    -   Persistente --- c'è, e te la tieni fino al trattamento
    -   Permanente --- c'è, e te la tieni nonostante il trattamento
-   La distinzione principale da fare in ambito di tachicardie è
    rispetto alla sede d'origine (atriali -- o sopraventricolari -- vs
    ventricolari)
    -   Tachicardie sopraventricolari
    -   Tachicardie ventricolari
-   I meccanismi di genesi sono 3: aumentata automaticità, trigger e
    circuiti di rientro
    1.  Da aumentata automaticità del nodo SA[^13]
        -   Da ↑ tono ortosimpatico (*fight or fly*, ipovolemia,
            ipossia[^14], dolore, stati ansiosi importanti...)
        -   simpaticomimetici (`adrenalina`, `noradrenalina`,
            `dopamina`, cocaina, metanfetamina)
        -   Da ↑ attività metabolica (ipertermia, febbre,
            ipertiroidismo...)
        -   Sbilanci elettrolitici (**↓ K^+^**)
    2.  Da trigger (da presenza di zone trigger *ectopiche* \[= non da
        cellule pacemaker, ma da fluttuazioni del potenziale di membrana
        di generici cardiomiociti\], dalle quali *parte* un impulso
        accessorio che non segue la normale via di conduzione del
        cuore)^\[![](img/Delayed-DAD-and-early-afterdepolarization-EAD-can-evoke-single-or-sustained-trains-of.png)\]^\[[EAD
        vs DAD](img/ead-dad.png)\]
        -   EADs (Early AfterDepolarization) --- impulso ectopico che
            parte prematuramente, interrompendo la normale fase di
            depolarizzazione dei cardiomiociti[^15]
            -   **Da ↓ K^+^**, ↓ Ca^++^, ↓ Mg^++^
            -   Da anti-Aritmici (A)
            -   Da anti-Biotici (B)
            -   Da anti-psiCotici (C)
            -   Da anti-Depressivi (D)
            -   Da anti-Emetici (E)
        -   DADs (Delayed AfterDepolarization) --- impulso ectopico che
            parte a depolarizzazione dei cardiomiociti completata[^16]
            -   ↑ tono simpatico
            -   Da ischemia
            -   Da ipossia
            -   Da infiammazione del miocardio
            -   Da stiramento dei miocaridociti (cardiomiopatia
                dilatativa, rigurgiti valvolari)
            -   Da `digossina≠`
    3.  Da rientro (da circuiti che si instaurano lungo il normale
        sistema di conduzione quando questo presenta un ostacolo non
        conduttivo. Perché si crei il rientro i circuiti devono condurre
        l'impulso a velocità differente)\
        ![](img/circuiti-di-rientro.png)
        -   Per tessuto cicatriziale non conduttivo
        -   Per fibrosi idiopatica (età)

### Battiti ectopici (BES e BEV)

-   Individuiamo 3 tipi di battiti ectopici
    1.  Battiti ectopici sopraventricolari (BES)
    2.  Batti ectopici giunzionali
    3.  Battiti ectopici ventricolari (BEV)
-   Non hanno ruolo prognostico negativo (il trattamento non aumenta la
    sopravvivenza) a meno che non siano così tanti da avere
    cardiomiopatie dilatative

### Tachicardia sinusale

-   Solitamente \< 150 bpm (raro che superino questa frequenza)
-   Diagnosi: FC \> 100 e ritmo sinusale
    -   Ogni QRS ha la sua P
    -   Ogni QRS ha la sua T
    -   P ↑ in 2 e avF

### Flutter atriale

-   **Attivazione *regolare* dell'atrio ad una frequenza elevata
    (200-300 cicli pm)** seguite, ogni *tot* da un complesso QRS
    -   Ogni quanto compare il QRS dipende dalla refrattarietà del nodo
        (frequenza fissa vs variabile)
-   All'ECG
    -   Aspetto "a dente di sega" (onde P vengono chiamate onde F in
        questo caso specifico)
-   ↑ ritmo tromboembolico (per movimento turbolento della parete
    atriale che non garantisce un flusso ordinato e continuo)

### Fibrillazione atriale

-   Tipica di sg. anziani
-   ↑ ritmo tromboembolico (per movimento disorganizzato della parete
    atriale che non garantisce un flusso ordinato e continuo)
-   Insorgono come parossistiche ⇒ difficile diagnosi a meno di Holter o
    simili
    -   Specialmente all'inizio: nel 50% dei sg. regrediscono \< 8h
    -   Le linee guida dicono di monitorare i pz. a rischio, ma non è
        semplice
    -   Il paziente a rischio è
        -   Rischio di stroke/tromboembolismo(calcolare score
            CHADS-VASc)
        -   Sintomi da aritmia
        -   Comorbidità
-   All'ECG
    -   Linea basale finemente o grossolanamente irregolare
    -   Ritmo irregolarmente irregolare è patognomonico (ci sono
        talmente tante p che una ad un certo punto viene condotta)

#### Gestione del pz. con fibrillazione atriale

1.  Prevenzione del rischio tromboembolico: valutare anticoagulazione
    (tp. OAC o VKA[^17] in pz. con valvola protesica) con score
    **CHA~2~DS~2~--VAS~2~C**
    -   CHADS-VASC = 0 (M) o 1 (F) → Non necessario trattamento
        antitrombotico
    -   CHADS-VASC \> → considerare (=1 (M) o 2 (F)) o impostare (≥
        2 (M) o ≥ 3 (F)) OAC
        -   Stratificare i pz. in funzione del rischio di sanguinamento
            (score HAS-BLED)
        -   Alto rischio di sanguinamento da LG non è ragione per non
            fare anticoagulanti, solo per fare followup più aggressivo
2.  Terapia dei sintomi
    -   **Rate control** (↑ filtro AV)
        -   `βb`, `Ca-ant`, `digitale`
    -   **Rythm control**[^18]
        -   Antiaritmici
        -   Cardioversione elettrica
            -   Non indicata se pz. non è scoagulato da \> 3 settimane
                (arresto brusco della parete atriale può portare a
                distacco dei trombi)
                -   Ok se fibrillazione insorta certamente \< 12h
                    (rischio \~ 0.3%)[^19]
                -   Ok se pz. correttamente scoagulato (INR in range
                    terapeutico)
                -   Ok se eco TE esclude trombi
        -   Ablazione transcatetere
3.  Valutare tp. anticoagulante a lungo termine
    -   Valutare CHADS-VASC

          ------------------------------------------------------------------------
          Score             Risk              Anticoagulation   Considerations
                                              Therapy           
          ----------------- ----------------- ----------------- ------------------
          0 (male) or 1     Low               No anticoagulant  No anticoagulant
          (female)                            therapy           therapy

          1 (male)          Moderate          Oral              Oral
                                              anticoagulant     anticoagulant,
                                              should be         with well
                                              considered        controlled vitamin
                                                                K antagonist (VKA,
                                                                e.g. warfarin with
                                                                time in
                                                                therapeutic range
                                                                \>70%), or a
                                                                direct oral
                                                                anticoagulant
                                                                (DOAC,
                                                                e.g. dabigatran,
                                                                rivaroxaban,
                                                                edoxaban or
                                                                apixaban)

          2 or greater      High              Oral              Oral
                                              anticoagulant is  anticoagulant,
                                              recommended       with well
                                                                controlled vitamin
                                                                K antagonist (VKA,
                                                                e.g. warfarin with
                                                                time in
                                                                therapeutic range
                                                                \>70%), or a
                                                                direct oral
                                                                anticoagulant
                                                                (DOAC,
                                                                e.g. dabigatran,
                                                                rivaroxaban,
                                                                edoxaban or
                                                                apixaban)
          ------------------------------------------------------------------------

    -   Punteggio CHADS-VASC correla con rischio di stroke ad 1aa

    -   Stratificare rispetto a rischio di sanguinamento (score
        HAS-BLED) per correggere fattori che predispongono a diatesi
        emorragica
4.  Gestire i fattori d rischio
    -   HTN
    -   Inattività
    -   OSAS
    -   Alcool
    -   Assetto lipidico
    -   BMI
    -   Fumo
    -   Glicemia e diabete

> **Score per il rischio di tromboembolismo in pz. con FA non valvolare
> (CHA~2~DS~2~-VASc)**
>
>   -----------------------------------------------------------------------
>                           Condition               Points
>   ----------------------- ----------------------- -----------------------
>   C                       Congestive heart        1
>                           failure (or Left        
>                           ventricular systolic    
>                           dysfunction)            
>
>   H                       Hypertension: blood     1
>                           pressure consistently   
>                           above 140/90 mmHg (or   
>                           treated hypertension on 
>                           medication)             
>
>   A2                      Age ≥75 years           2
>
>   D                       Diabetes Mellitus       1
>
>   S2                      Prior Stroke or TIA or  2
>                           thromboembolism         
>
>   V                       Vascular disease        1
>                           (e.g. peripheral artery 
>                           disease, myocardial     
>                           infarction, aortic      
>                           plaque)                 
>
>   A                       Age 65--74 years        1
>
>   Sc                      Sex category            F → +1
>   -----------------------------------------------------------------------
>
> **Score per stratificare il rischio di sanguinamento (HAS-BLED)**
>
>   ---------------------------------------------------------------------------------------
>       Condition                                                         Points
>   --- ----------------------------------------------------------------- -----------------
>   H   Hypertension: (uncontrolled, \>160 mmHg systolic)                 1
>
>   A   Abnormal renal function: Dialysis, transplant, Cr \>2.26 mg/dL or 1`<br>`{=html}1
>       \>200 µmol/L`<br>`{=html}Abnormal liver function: Cirrhosis or    
>       Bilirubin \>2x Normal or AST/ALT/AP \>3x Normal                   
>
>   S   Stroke: Prior history of stroke                                   1
>
>   B   Bleeding: Prior Major Bleeding or Predisposition to Bleeding      1
>
>   L   Labile INR: (Unstable/high INR), Time in Therapeutic Range \< 60% 1
>
>   E   Elderly: Age \> 65 years                                          1
>
>   D   Prior Alcohol or Drug Usage History (≥ 8                          1`<br>`{=html}1
>       drinks/week)`<br>`{=html}Medication Usage Predisposing to         
>       Bleeding: (Antiplatelet agents, NSAIDs)                           
>   ---------------------------------------------------------------------------------------

### Tachicardia atriale focale

### Tachicardia intranodale

### Tachicardie sopraventricolari da rientro

-   2 tipi, a seconda di dove si instaura il rientro: AVRT vs AVNRT
    -   AVRT: tachicardia da rientro passante per via anomala che si
        chiude in atrio. Esempio tipico: WPW (il fascio prende il nome
        di "via di Kent")
        -   Ortodromica: segue il flusso di conduzione normale (SA → AV
            → His → branche → Purkinje → Kent → AV)
            -   A QRS stretto (la polarizzazione dei ventricoli è tutto
                sommato normale)
        -   Antidromica: anticipa e oppone il flusso di conduzione (SA →
            Kent → Purkinje → branche → His → AV → Kent)
            -   A QRS largo (la polarizzazione dei ventricoli non è
                corretta)
            -   Statisticamente più rara
    -   AVNRT: tachicardia da rientro in cui il circuito di rientro è
        intranodale

#### Trattamento e gestione

-   Manovre vagali (diminuiscono automatismo del nodo AV e aumentano la
    sua funzione di filtro)
    -   Massaggio del seno carotideo
    -   Diving reflex
    -   Manovra di valsalva (anche modificata)
    -   Compressione dei bulbi oculari (pericolosa, danno ai bulbi)
    -   Induzione del riflesso del vomito, eruttazioni
-   Farmaci
    -   Che agiscono sul nodo AV
        -   `adenosina` (può portare broncocostrizione, va fatta in bolo
            *+ flush*!)
        -   `verapamil`
        -   `diltiazem`
    -   Che agiscono su nodo AV e su via anomala
        -   `propafenone`
        -   `flecainide`
        -   `amiodarone` (molta attenzione ad effetti collaterali,
            principalmente ↑ QT)
-   Cardioversione elettrica
-   Trattamento definitivo: ablazione transcatetere a radiofrequenza
    della via di rientro

### Tachicardie ventricolari

-   Run di \> 3 battiti di origine ventricolare con frequenza \> 120 bpm
    -   Non sostenuta se \< 30''
        -   Non prognosi negativa in sg. sano (se cardiopatia
            sottostante la prognosi dipende dalla cardiopatia)
    -   Sostenuta se \> 30'' ⇒ da interrompere speedy, o alto rischio
        compromissione emodinamica (sincope, bassa portata (fino a pVT),
        degenerazione in FV)

### Fibrillazione ventricolare

### Torsione di punta

-   VTach polimorfa (QRS vedo che sono sia larghi che stretti)
-   Eziologia
    -   Bradi (B di HISDEBS)
    -   Ipokaliemia
    -   Uso di farmaci che allargano il QT (allungano la
        ripolarizzazione) ⇐ R su T
    -   QT lungo congenito

```{=html}
<!-- ven 16 apr 2021, 16:48:27, CEST -->
```
# T-LOC[^20] di pertinenza cardiologica

## Sincope

-   ***Sincope*** --- perdita **transitoria** dello stato di coscienza
    caratterizzata da **rapida insorgenza** , **breve durata** e
    **recupero spontaneo** senza sequele. La causa è una **ipoperfusione
    cerebrale transitoria** globale

    -   Sintomo, non dx
    -   Prodromi *talvolta* (50--70% pz.) presenti
    -   Ha grande impatto sulla QOL (sopratutto in pz.
        anziano/comorbido)
    -   Andamento bimodale nella popolazione: picco a 15-20aa, poi
        aumento progressivo da 60aa in poi
    -   40% ez indeterminate

-   Attenzione: ci sono cause non sincopali che producono un quadro che
    mima la sincope

    -   LOC per causa neurogena (es: epilessia)
    -   Fenomeni psichiatrici
    -   Disordini metabolici (iperventilazione \[⇒ ipocapnia\],
        ipoglicemia)
    -   Ischemia vertebrobasilare

-   Attenzione: ci sono cause non cardiologiche che producono un quadro
    che mima la presincope

    -   Cataplessia[^21]
    -   Drop attacks (ischemie del circolo posteriore ⇒ altearzione di
        equilibrio e propriocezione)
    -   Cadute
    -   narcolessia
    -   Ischemie carotidee

-   Patofisiologia (ez prevalenza calante)

    ![](img/sincope-patofisio.png)

    -   Neuromediata
        -   Riflessi autonomici inappropriati in risposta a stimoli
            (stress, clima ambientale, ortostatismo) ⇒ alterazione
            dell'enmodinamica per una collaborazione di 2 aspetti
            (continuum)
            -   Prevale la vasodilatazione → sincope vasodepressiva
            -   Prevale la bradicardizzazione → sincope cardioinibitoria
        -   Tipici esempi
            -   Vasovagale (da stimolazione del vago)
            -   Situazionale (attivazione del riflesso di valsalva o del
                diving reflex)
    -   Ortostatica
        -   Da alterazione del SNA (patologie primitive o
            secondarie[^22] del SNA portano a disriflessia autonomica
            che non consente di gestire bene i necessari cambiamenti nel
            passaggio tra clino→ortostatismo)
        -   Da agenti esterni: farmaci con azione ipotensiva o attivi
            sul SNA potenziano disriflessia autonomica o situazioni di
            deplezione di volume
    -   Cardiogena
        -   Da aritmia (bradi/tachi/BAV). Sopratutto nei momenti di
            passaggio da o verso RS
        -   Da riduzione della gittata (problemi di precarico,
            postcarico, riduzione della contrattilità)
            -   IMA (particolarmente se molto estesi si ha grande ↓
                contrattilità. Se IMA dx invece si può avere attivazione
                vagale riflessa e ipotensione)
                -   Sincope durante primissimo periodo postinfarto
                    (30gg) *devono* preoccupare e far pensare ad eventi
                    maggiori
            -   Stati ipotensivi
            -   EP, sopratutto se massivi, per drastica riduzione del
                precarido sinistro
            -   Valvulopatie (particolarmente stenosi valvolare).
                Sincope in pz. con valvulopatia è evento prognostico
                importante, *deve* produrre accertamenti diagnostici e
                gestionali perché è indice di situazione in
                peggioramento *acuto* che può essere preambolo di morte
                improvvisa -- questo perché è spia di inadeguatezza ad
                adattare la perfusione alle richieste momentanee
            -   Da cardiopatia ipertrofica (se sincope in cardiopatia
                pensare ad aritmia grave, auspicabilmente risolta se il
                pz. arriva da noi cosciente)
    -   Cerebrovascolare

-   Prognosi in funzione dell'eziologia che sottende la sincope e dal
    rischio di trauma che porta la sincope

    -   Se prodromi il pz. è più tutelato dal rischio di trauma
    -   Comorbidità (tra cui età, rischio c/v, BMI, farmaci) possono
        aggravare prognosi
        -   Anziano ha prognosi peggiore rispetto al giovane
    -   Situazioni di rischio (es: lavoro in setting pericoloso, tipo
        autista, lavoratore edile, ecc) *devono* imporre maggiore
        cautela gestionale
    -   Rischio di mortalità è doppio se l'eziologia della sincope è
        cardiaca, mortalità non cambia se eziologia è neuromediata

-   Importante è fare corretta diagnosi del meccanismo patofisiologico
    sottostante (EO + anamnesi hanno buona resa diagnostica in \> 50%
    sg.)

    -   Anamnesi
        -   Circostanze in cui si trovava sg. prima dell'evento
            (posizione,cosa stava facendo, situazione, ambiente)
        -   Approfondire eventuali prodromi
        -   Approfondire SeS dell'evento
            -   Cute: colore, sudorazione
            -   sintomi autonomici
            -   Dolore
            -   Cardiopalmo?
            -   perdita degli sfinteri?
            -   Clonie/tonie? (molto rari in sincope vera, poi avvengono
                tardivamente secondariamente a ipoperfusione cerebrale
                prolungata)
        -   Approfondire come si è concluso l'evento
        -   APP/APR neurologica, cardiovascolare
    -   EO
        -   Cardiovascolare
        -   Valutare opportunità[^23] di fare il massaggio del seno
            carotideo durante EO (clino e ortostatismo) durante ECG
        -   Si possono fare test (tilt test/con `isoprotenololo`/con
            `nitrati`) per tentare di provocare la sincope
    -   ECG 24h (ECG12 standard o studio elettrofisiologico subito post
        sincope non hanno più rilevanza che fatti in un momento
        qualsiasi)
    -   Metodiche di terzo livello: apparecchi loop e/o event recorder
        -   Event recorder: ECG che pz. attiva quando si sente male (non
            utile in sincope ma per indagare cardiopalmo)
        -   Loop recorder: apparecchio che acquisisce continuamente
            tracciato e analizza la forma d'onda, memorizzandola sse
            identifica alterazioni

> **Sincope vs epilessia**
>
>   -----------------------------------------------------------------------
>   Sincope                             Epilessia
>   ----------------------------------- -----------------------------------
>   Non movimenti tonico-clonici, se    Movimenti tonico-clonici spesso
>   presenti sono finalistici e         stereotipati
>   semi-organizzati                    
>
>   Ripresa rapida, al netto            Stato postcritico
>   dell'astenia                        
>   -----------------------------------------------------------------------

-   Trattamento: prevenzione del rischio ± farmacologico (riflettere su
    r/b)
    -   Prevenzione
        -   informare pz. su fattori di rischio e su patologia
        -   Corretto apporto idrico
        -   Evitare fattori predisponenti
        -   Spiegare manovre per evocare contro-riflessi ipertensori
            quando si sentono prodromi
            -   Hand grip → chiudere pugno contro resistenza
            -   Arm tensing → si prendono le mani, si stringono, e si
                tirano prima da un lato e poi dall'altro
            -   Leg crossing → sdraiarsi, Trendelemburg a gambe
                incrociate
    -   Farmacologico (idealmente segue da visita cardiologica, meglio
        in centri che si occupano di sincopi)
        -   `α-stimolanti` → inibiscono il riflesso vagale (ha effetti
            avversi notevoli se patologia cardiovascolare sottostante,
            va prescritto solo in determinate eziologie e contesti
            selezionati -- spesso iperspecialistici). Eg: `gutron`, che
            ↑ postcarico (potente vasocostrittore)
        -   `βb` → ok solo in determinate eziologie di sincopi, perché
            altre invece le favorisce. Idem per dosaggi
        -   `SSRI` → non si capisce perché funzionano, ma dati empirici
            ne sostengono l'uso

# Coronaropatie

-   ***Coronaropatia*** --- è una definizione ad ombrello che racchiude
    le patologie delle coronarie, ad insorgenza acuta o cronica
    -   ***SCC*** (Sindromi Coronariche Croniche)
        -   Angina stabile (anche Cardiopatia Ischemica Cronica, o CAD
            --- Coronary Artery Disease)
    -   ***SCA*** (Sindromi Coronariche Acute; anche **ACS**, Acute
        Coronary Syndrome)
        -   Angina instabile
        -   Cardiopatia ischemica
            -   IMA STEMI
            -   IMA NSTEMI
        -   Morte cardiaca improvvisa
-   Fattori di rischio
    -   DM
    -   HTN
    -   Ipercolesterolemia/alterazioni dell'assetto lipidico
    -   Fumo
    -   Familiarità
    -   Età
    -   ↑ BMI
-   Tutte le tipologie di sindromi coronariche condividono, per la
    stragrande maggioranza (\> 90%), lo stesso substrato patologico: la
    lesione da placca aterosclerotica
    -   Le caratteristiche della placca aterosclerotica sono il
        principale discriminante della manifestazione patologica
        (stabile/fissa nelle SCC, instabile/dinamica nelle SCA)
        -   Placca aterosclerotica delle SCC: cappuccio fibroso integro,
            spesso e stabile, piccolo core lipidico, scarsa
            rappresentazione delle cellule infiammatorie ⇒ si ha
            **stenosi fissa**
        -   Placca aterosclerotica delle SCA: cappuccio fibroso sottile
            e prono a rottura, grande core lipidico, grande
            rappresentazione delle cellule infiammatorie (le quali,
            ossidandola, predispongono la placca alla rottura). La
            placca aterosclerotica, poi, porta a trombi rossi (ha vasa
            vasorum, si può ulcerare, il danno endoteliale altera la
            coagulabilità, la placca produce flusso turbolento...) ⇒ si
            ha una **stenosi dinamica**
    -   La placca aterosclerotica incide sul lume vasale in due modi:
        con un rimodellamento del lume *positivo* o *negativo*[^24]
        -   **Rimodellamento positivo** del lume arterioso → la placca
            cresce *senza* restringere il lume (o restringendolo
            relativamente poco) ⇒ flusso a valle preservato a vario
            grado (prevalente in presentaizoni **instabili** di
            coronaropatia)
        -   **Rimodellamento negativo** del lume arterioso → la placca
            cresce *restringendo* il lume ⇒ ↓ flusso a valle (prevalente
            in presentazioni **stabili** di coronaropatia)

> SCA è coronaropatia *d'esordio* in 60% M e 50% F!!

## Angina

-   Angina può essere stabile (è SCC) o instabile (è SCA)

    -   Stabile → La placca aterosclerotica è piccola e stabile.
        Insorgenza dei sintomi è tipica dopo medesima intensità di
        sforzo fisico. Attentamente monitorata per evoluzione
    -   Instabile → La placca aterosclerotica è grande, l'ostruzione
        coronarica è notevole. Insorgenza imprevedibile, non relata allo
        sforzo o anche a riposo. SCA con altissimo grado di
        imprevedibilità evolutiva ⇒ rischio

-   Quadro tipico

    -   Toracoalgia come IM ma durata ridotta
    -   Responsiva ai nitrati (se non risponde sono cazzi, molto prob
        IMA)
    -   **no ↑ cTn**[^25]
    -   Cambiamenti ECG tipo NSTEMI *possono* essere possibili, ma
        -   Sse concomita dolore (stato di ostruzione coronarica) quando
            facciamo ECG
        -   Sono temporanei, poi regrediscono

-   Per differenziare la gravità dell'angina, così come la sua
    (in)stabilità si usa la classificazione della Canadian Cardiovasc
    Society

      -----------------------------------------------------------------------
      Classe                              Descrizione
      ----------------------------------- -----------------------------------
      1                                   Sostanzialmente non limitazione --
                                          Quantità ordinaria/intensa di
                                          attività fisica senza sviluppare
                                          angina

      2                                   Leggera limitazione --- Ok
                                          percorrere 160 m senza angina

      3                                   Marcata limitazione --- Angina per
                                          attività \< 160m a piedi (o
                                          equivalente)

      4                                   Inabilità ad attività fisica,
                                          possibili sintomi a riposo (nei
                                          fatti è angina instabile)
      -----------------------------------------------------------------------

-   Per evidenziare cambiamenti ECG (che devono essere transitori,
    altrimenti non è SCC, ma è SCA, perché testimonierebbero una
    sofferenza permanente da occlusione delle coronarie) ci vuole ECG da
    sforzo, anche detto "provocativo" (stress appropriato in funzione
    della classe di angina)

    -   ECG è alto SPIN, basso SNOUT in SC *croniche*[^26]
    -   ECG sotto sforzo dev'essere *fatto bene*
        -   Bisogna raggiungere la frequenza massimale (F~max~ = 220 --
            anni pz.) oppure negatività non dirimente
        -   Non devono esserci impedimenti msk funzionali per consentire
            adeguato movimento
    -   Possibile scintigrafia miocardica (sempre provocativa) per
        vedere stato della perfusione del miocardio con tracciante
        radioattivo
        -   Stress può essere anche farmacologico (`adenosina`, che
            blocca temporaneamente nodo AV e impone ↓ CO), non solo
            fisico
        -   Si usa tracciante radiopaco captato da cardiomiociti sani
            (vivi e ben funzionali) ⇒ si evidenzia sia distribuzione
            ematica che zone sofferenti/necrotiche/fibrotiche
            (impossibile dirimere in prima battuta, per fare questo si
            ripete un secondo test, pochi gg dopo per vedere se le zone
            non captanti sono rimaste le stesse \[allora erano
            fibrotiche\] o non ci sono più \[angina stabile\] o sono le
            stesse ma regredite \[pregresso infarto in risoluzine\])

-   Nella CCS si individuano 3 scenari clinici

    1.  Pz. con sospetta CAD
        -   Presenza di sintomi da sforzo
        -   Recente comparsa di HF
    2.  Pz. con diagnosi di CAD (1aa come cutoff perché rischio di morte
        cala col tempo)
        -   Diagnosi \> 1aa
        -   ACS con rivascolarizzazione \< 1aa
    3.  Imaging coronarico contrastante con sintomi
        -   AngioTC neg, ma angina[^27]
        -   AngioTC pos, ma non angina

-   La terapia per l'angina stabile si basa su una terapia di
    prevenzione del peggioramento (prevenzione secondaria) + terapia per
    gestire il dolore anginoso al bisogno

    -   Prevenzione secondaria degli eventi avversi maggiori (di fatto
        identica a tp. post SCA)
        -   `statine` (correzione fattori di rischio modificabili)
        -   `ACE-ini` (correzione fattori di rischio modificabili)
        -   `βb` (ridurre domanda miocardica)
        -   `ca-ant` (preferibili se eziologia dell'angina è vasospasmo
            coronarico)
        -   ± `aspirina` secondo necessità clinica, particolarmente se
            si sospetta alto rischio di progressione verso instabilità o
            IMA (prevenire che il pz. trombi!)
    -   Gestione della toracoalgia anginosa
        -   `nitrati` (sl) per vasodilatare (vasodilatano anche la
            periferia, attenzione a PA)

## Cardopatia ischemica

-   ***IMA*** --- condizione di **necrosi** del miocardio conseguente a
    prolungata (\> 10--15 minuti) **ischemia**
    -   Se alterazioni flusso \< 10--15 min ⇒ non danno ischemico →
        ***angina pectoris***
        -   Stabile → insorgenza dopo sforzo di entità fissa
        -   Instabile → insorgenza non prevedibile (grande
            imprevedibilità, può facilmente evolvere in IM)
-   Cardiopatia ischemica è 1/a causa di morte in paesi industrializzati
    e non (Ita CI provoca 10% dei decessi)
    -   Picco di mortalità: 60--65 M, 70F (mortalità max \< 30gg da
        evento, poi progressivamente in calo)
    -   Prevalenza in ↑, per ↑ età media; questo nonostante interventi
        di prevenzione primaria
    -   Prognosi acuta migliora se trattamento è appropriato E rapido E
        definitivo
-   Principio generale nella gestione dell'IMA: time is muscle![^28]

### Classificazione dell'infarto miocardico

-   Classificazione a seconda dell'eziologia
    1.  **Tipo 1 → da placca ateromasica che ostruisce/occlude ramo
        terminale**
        -   Causa: placca ateromasica
        -   Diagnosi
            -   Clinica compatibile
            -   ECG de novo compatibile
            -   ↑ cTn-HS sopra 99mo percentile per \> 1 misurazione
            -   Evidenza imaging di alterata motilità di parete
                riferibile a eziologia ischemica
            -   Evidenza di trombosi all'angiografia coronarica
    2.  **Tipo 2 → da mismatch di ossigeno: domanda miocardio \<
        offerta**
        -   Causa: aritmie, anemia severa, squilibri pressori,
            vasospasmo, dissezione coronarica. Con o senza placca
            ateromasica.
        -   Diagnosi
            -   Clinica compatibile
            -   ↑ cTn-HS sopra 99mo percentile per \> 1 misurazione
            -   Nuova alterazione ECG grafiche (vedi tipo 1)
            -   Evidenze imaging di necrosi miocardica (es ipocinesia
                delle pareti)
    3.  **Tipo 3 → con morte improvvisa**
        -   Causa: ehm... potenzialmente tutte quelle di tipo 1 e 2
        -   Diagnosi
            -   Il pz. muore prima che sia fatto iter diagnostico
            -   Riscontro autoptico di IM
    4.  **Tipo 4 → complica rivascolarizzazione percutanea**
        -   Tipo 4a → immediatamente conseguente a rivascolarizzazione
            -   Clinica compatibile
            -   ↑ cTn-HS
                -   se ctn pre-procedurali ok ⇒ ↑ ctn \> x5 baseline
                -   se ctn pre-procedurali cronicamente elevate ⇒ ↑ ctn
                    \> 20% baseline
            -   Nuove alterazioni ECG
            -   Imaging compatibile (spesso angiografica) con
                complicanze procedurali (es: dissezione, no-reflow[^29],
                chiusura ramo collaterale, embolizzazione distale)
            -   imaging mostra perdita di miocardio (ipocinesi
                segmentaria del ventricolo)
        -   Tipo 4b → conseguente a trombosi intra-stent
        -   Tipo 4c → re-stenosi dopo mesi da POBA
    5.  **Tipo 5 → perioperatorio che complica cardiochirurgia
        riperfusiva**[^30]
        -   ↑ cTn
            -   se ctn pre-procedurali ok ⇒ ↑ ctn \> x10 baseline
            -   se ctn pre-procedurali cronicamente elevate ⇒ ↑ ctn \>
                20% baseline
        -   Q patologiche
        -   Riscontro imaging ipocinesia di parete
        -   Riscontro angiografico di trombo
    6.  **Tipo bonus: infarti strani**
        -   MINOCA (Myocardial Infarction with Non Obstructed Coronary
            Arteries)
            -   Dissezione delle coronarie
            -   Grave vasospasmo coronarico
            -   Disfunzione del microcircolo
        -   Sindrome di Takotsubo (anche *apical balooning syndrome*,
            *sindrome del cuore infranto*, *cardiomiopatia da stress*)
            --- cambiamenti morfologici del miocardio (balooning
            apicale) + clinca consistente con infarto conseguente a
            forte stress emotivo

> **cTn-HS**
>
> Marker di danno, in quanto sono enzimi cellulari che non si dovrebbero
> dosare in circolo.\
> Fare curva a T~0~, T~3h~, T~6h~ + T~12\|15h~ se dubbio Tipica curva:
>
> ![](img/ctn.png){width="50%"}
>
> Ricordarsi che tanti fattori ↑ cTn (sono indice specifico e sensibile
> quando sono molto elevate, ma quando sono poco elevate la questione è
> più sfumata)
>
> -   Sforzi intensi
> -   Sepsi
> -   Insufficienza respiraotira acuta
> -   **Insufficienza renale** (↓ escrezione! Valutare *sempre* GFR)

### Alterazioni ECG suggestive per IM

-   2 principali tipologie di IM in base alle alterazioni ECG
    -   **STEMI** --- IM con STE. **Si ha occlusione completa del ramo
        coronarico**
        -   **STJ ≥[^31] 0.1 mV in almeno 2 derivazioni contigue**;
            oppure
            -   In V2 e V3 STE deve \> 1.5 mV donne e \> 2 uomo (\>
                2.5mm uomo under 40aa)
            -   ATTENZIONE: *Deve esserci anche ST sotto speculare!*
        -   **Nuovo BBsx** (ma considerare criteri di Sgarbossa)
        -   **Onde Q patologiche** (\> 0.04ms x 1/4 R[^32]
        -   Manifestazioni STEMI precoci (T iperacute → T invertite →
            STE → Q pato)
            -   T iperacute
            -   T invertite rispetto a QRS
    -   **NSTEMI** --- IM in cui non si ha STE. **Si ha subocclusione
        del ramo coronarico, oppure ostruzioni in rami terminali che
        servono piccoli territori di miocardio**
        -   ST \< TP dal punto J (tipicamente: STD ha il primo tratto
            orizzontale e discendente). Meglio in 2 derivazioni contigue
        -   Inversione delle T
        -   ECG normale/non nuove modifiche
    -   In STE di fatto cTn è sempre positiva[^33]
-   La coronaria ostruita si può stimare in base alla localizzazione
    delle alterazioni ECG
    -   Anteriori → aa coronaria discendente anteriore
    -   Laterali → aa circonflessa sinistra
    -   Inferiori → aa coronaria dx
-   ⚠️ **Attenzione!!** ⚠️
    -   Se in dubbio, ECG seriati!
    -   T iperacute possono essere manifestazione precocissima di
        infarto: è opportunità d'oro, se notata, di evitare di mandare
        gente al camposanto
    -   STD nelle anteriori potrebbe essere il sottoslivellamento
        opposto ad un infarto posteriore: FAI V7 E V8!
    -   Non esitare a fare V4R se si sospetta infarto Dx, che si vede
        male nella configurazione usuale (STE in V1, OPPURE STE nelle
        inferiori con segni di AHF *solo dx* + ipotensione OPPURE STD
        nelle anteriori)
-   Mortalità
    -   Mortalità acuta STEMI \> mortalità acuta NSTEMI, ma la mortalità
        a 1aa è equivalente
    -   Più le lesioni sono diffuse ⇒ infarto + esteso (la coronaria è
        tappata a monte) ⇒ ↑ rischio

> **STE vs STD**\
> STE[^34] è indice di **danno ischemico transmurale**[^35]; STD[^36] è
> indice di **danno ischemico subendocardico** NB: quello che
> differenzia STEMI vs NSTEMI è soltanto l'ECG. In entrambi si ha ↑ cTn
> e SeS tipici di IMA
>
> STEMI:NSTEMI = 1:4
>
> In realtà STE la si ha per brevissima durata (2--6min) anche
> nell'angina di Prinzmetal

### Clinica

#### S/s

-   Il sintomo cardine che *deve* far venire sospetto diagnostico è la
    toracoalgia angionsa

    -   Dolore toracico di tipo anginoso ("*angor*")

        ![Toracoalgia anginosa con sedi tipiche e ddx da
        considerare](img/toracoalgia-sedi-tipiche.png)

        -   Oppressivo, costrittivo, a morsa
        -   Intensità *estremamente* variabile (da fastidio non meglio
            definito a "crushing chest pain")
        -   Localizzazione tipicamente retrosternale, ma con grande
            variabilità[^37]
            -   Frequentemente: retrosternale, epigastrico, irradiato a
                braccio sx
            -   Meno frequente: collo, mandibole, irradiato a braccio
                dx, dorso
        -   Viscerale, mal localizzabile (indicato a mano aperta o a
            pugno)
        -   Non si modifica con respiro o con palpazione
        -   Non si allevia, nemmeno con nitrati
        -   Dura \> 10--15 minuti (se meno è tipico di angina, non IMA)

    -   Accompagnato da dispnea

    -   Accompagnato da sintomi aspecifici viscerali: nausea, vomito,
        eruttazioni, sudorazione algida, astenia, *angor animi*

    -   Spesso all'anamnesi riscontrabili episodi di angina instabile
        spontaneamente regrediti nelle 48h precedenti

-   In base a 3 criteri si distingue il dolore toracico tipico da quello
    atipico

    1.  Tipologia di dolore (Sede, Caratteristica, Durata)
    2.  Insorgenza in relazione allo sforzo
    3.  Sollievo con nitrati o riposo

      Angina       Criteri
      ------------ ---------------------
      Tipica       3 criteri su 3
      Atipica      2 criteri su 3
      Non angina   Nessun criterio o 1

-   Attenzione! Una buona fetta di IM (\~20%) producono un quadro
    atipico! (per localizzazione o intensità del dolore)

    -   Attenzione a: donne, diabetici, anziani (possibile infarto
        analgesico)
    -   Attenzione a "cattiva digestione" non spiegata
    -   Attenzione se familiarità
    -   Attenzione se fattori di rischio
        -   BMI alto
        -   Ipertensione
        -   Diabete e ipercolesterolemia
        -   Familiarità
        -   Fumo e alcool

-   Correlare bene con anamnesi (anamnesi metà diagnosi) e fattori di
    rischio per ↑ probabilità pretest

-   IM può portare a AHF, i cui SeS orientativi vanno cercati

      -----------------------------------------------------------------------
      Classe                              Gravità dello scompenso in base
                                          alla compromissione emodinamica
                                          nell'IM
      ----------------------------------- -----------------------------------
      Killip I                            No scompenso

      Killip II                           Segni franchi di scompenso

      Killip III                          Scompenso grave, fino ad EPA con
                                          rantoli in tutti i campi

      Killip IV                           Shock cardiogeno
      -----------------------------------------------------------------------

-   Eseguire sempre un EO CV completo per valutare insorgenza di SeS
    orientativi di patologie secondarie ad IMA o che si accompagnano

#### Ddx

-   Patologie CV
    -   **Dissezione aortica** (big miss, big fuck 😵; qui se
        anticoaguliamo il pz. lo uccidiamo)
    -   Pericardite a varia eziologia (acuta, virale, batterica...)
    -   Ponte miocardico[^38]
    -   CHF/AHF
    -   Varie cardiomiopatie, tra cui ipertrofia ventricolare
    -   Valvulopatie
    -   **Aritmie**
    -   Iperventilazione (↓ CO~2~ ⇒ vasocostrizione ⇒ spasmo)
-   Patologie polmonari
    -   **Embolia polmonare**
    -   **Pneumotorace**
    -   Polmonite
    -   Pleurite
-   Patologie gi
-   Patologie della parete toracica
    -   Costocondrite
    -   Altro msk
-   Altro
    -   Zoster
    -   Psicogeno
-   Iatrogene
    -   Esiti di ablazione
    -   Esiti di cardioversione
    -   Esiti di chirurgia cardiotoracica

### Diagnosi

-   *Time is muscle!* Essenziale buona *rete territoriale* con percorsi
    dedicati [@delucagiuseppeTimeDelayTreatment2004]

![](data:image/png;base64,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)

### Terapia

> **Controindicazioni per fibrinolisi/riperfusione/anticoagulazione**
>
> -   Gravidanza
> -   IR grave/issima
> -   Ictus ischemico recente (\< 2w)
> -   Recente intervento chirurgico (\< 3w)
> -   Allergie a farmaci (principalemnte aspirina)

1.  MANO
    -   `fentanyl` EV (↓ dolore e ↓ risposta simpatica che aumenterebbe
        richiesta che miocardio non soddisfa)
    -   `ASA` (PO 325mg o EV) → antiaggregazione
    -   Nitrati (sl) → dilatazione delle coronarie (controindicati in
        infarto dx perché già si ha ↓ contrattilità e ristagno in
        periferia, se si vasodilata si abbatte l'output e si ammazza il
        pz.. Anzi, a volte infarti dx beneficiano fluidi)
    -   O~2~ → migliorare la delivery dell'O~2~, ma titolare a SpO2 ≤
        96% per evitare stress ossidativo
2.  Eparina
    -   Prepara per angioplastica
3.  Trombolisi (anche "fibrinolisi") se tp. riperfusione non indicata
    -   tPA
    -   `streptochinasi` o `urochinasi` o `alteplase` o `tenecteplase`
4.  Riperfusione (rivascolarizzazione percutanea + angioplastica
    coronarica)
    -   Cateterizzazione della coronaria ostruita
    -   Balooning della coronaria per ripefondere (POBA, Plain Old
        Baloon Angioplasty)
    -   Stent metallico per mantenere apertura (gold standard è stent
        medicato[^39] con citostatici per controllare epitelizzazione
        dello stent e re-occlusioni)
5.  Terapia di mantenimento a lungo termine per prevenire eventi
    cardiovascolari successivi e perdita della funzione cardiaca
    -   Tp anti**aggregante** cronica
        -   `ASA`
        -   Eventuale doppia antiaggregazione se stent per almeno 12
            mesi (`clopidogrel`/`prasugrel`/`ticagrelor`)
    -   Tp. per gestire rischio in funzione della clinica
        -   `statine`
        -   `ACE-ini`
        -   `βb`
        -   `Ca-ant`
        -   Diuretici

### Complicanze

-   Non cardiologiche
    -   Infezioni (respiratorie, urinarie, cutanee)
    -   Ictus
    -   Complicanze da farmaci/trattamento
    -   Perdita del compenso in altri quadri patologici concomitanti
        (es: diabete, IR...)
-   Cardiologiche
    -   **Aritmie** (con possibile ACR)
        -   TV/FV
        -   BAV (fino al 3/o grado)
    -   **AHF**
        -   → shock cardiogeno in 5% degli IM (specialmente in quelli
            non trattati o trattati tardivamente)
        -   Edema polmonare
    -   Embolia polmonare
    -   Insufficienza valvolare acuta
    -   Re-infarto
    -   Pericardite
    -   Complicanze meccaniche
        -   Precoci
            -   Rottura del setto interventricolare
                -   Complica 1--2% IMA (5% morti precoci)
                -   Insorgenza: ore -- settimane
                -   M:F = 3:2
                -   Patogenesi: danno infartuale ⇒ ↓ resistenza del
                    setto interventricolare ⇒ ↑ rischio di rottura
                    -   Shunt dx--sx di grado variabile ⇒ scompenso
                        cardiaco a bassa portata
                    -   Compromissione emodinamica di grado variabile
                -   Tp. è riparazione esclusivamente chirurgica, ma
                    difficile:
                    -   Procedura in emergenza su un cuore infartuato
                    -   Non è detto che ci sia modo di suturare
                        efficacemente la rottura o la parte circostante
                        per danneggiamento della parete
            -   Rottura della parete libera
                -   Rottura ⇒ tamponamento cardiaco ⇒ shock ostruttivo
                -   Drammaticamente mortale
                -   Frequentemente azniani con diabete
            -   Insufficienze valvolari acute, solitamente mitralica (⇐
                infarto dei mm papillari)
        -   Tardive (ora molto rare per disponibilità precoce di cure
            intensive)
            -   Danno ischemico permanente
                -   Danno del miocardio permanente → CHF
                -   Ischemia papillare cronica → valvulopatia →
                    insufficienza valvolare (spesso mitralica)
            -   Aneurisma cardiaco (⇐ dilatazione sacciforme del
                ventricolo ⇐ sostituzione del tessuto miocardico con
                tessuto fibroso non contrattile ⇐ danno ischemico)[^40]
            -   Pseudoaneurisma[^41] cardiaco (⇐ piccola rottura di
                parete secondaria a danno ischemico)
            -   Trombosi endoventricolare (⇐ per stasi dovuta a ↓
                contrattilità di parete conseguente al danno ischemico)
                -   Complicanze distrettuali per dipartita dei trombi

### Score prognostici per stratificazione del rischio post-**NSTE-ACS**

1.  Timi Risk Score (0--7 punti, \>6 ⇔ evento avverso[^42] a 14gg 41%)
    -   Età ≥ 65aa
    -   ≥ 3 fattori di rischio per CAD
    -   Stenosi ≥ 50% nota
    -   Uso di `ASA` negli ultimi 7 gg
    -   Recente (\< 24h) angina severa
    -   ↑ cTn
    -   STD ≥ 0.5mm
2.  Grace Risk Score (correla con prognosi immediata E a 6mesi)
3.  CUSADE Bleeding Score (valutazione del rischio emorragico, utile
    sopratutto quando doppia antiaggregazione per DES)

### Cardiopatia ischemica senza malattia coronarica

-   Flusso di sangue nei vasi epicardici non è garanzia di reale
    irrorazione del miocardio
-   Ad oggi si individuano 2 quadri patologici di cardiopatia ischemica
    non dovuto ad ostruzione delle coronarie:
    -   MINOCA: Myocardial Infarction with Non Obstructive Coronary
        Arteries
    -   INOCA: Ischemia with Non Obstructive Coronary Arteries

#### MINOCA

#### INOCA

-   Non immediato rischio di vita, ma abbassano notevolmente QoL
-   Medesimo trattamento di pz. con stenosi coronarica
    -   ACE-ini
    -   Statine
    -   βB
    -   Ca^++^-antagonisti se evidenze di vasospasmo coronarico
-   Valutare, con score appropriati (TMI) la stratificazione del rischio
    del pz. per capire se è necessario follow-up e quanto aggressivi
    essere

## Dissezione coronarica spontanea

-   **Dissezione coronarica non traumatica e non relata a processo
    arterosclerotico**
    -   Eziologia INSIDE-OUT → Slaminamento della coronaria con flap
        intimale
    -   Eziologia OUTSIDE-IN → ematoma de novo della media da rottura
        dei vasa vasorum
-   F\>M
-   Rischio
    -   Gravidanza/puerperio
    -   Ipertensione
    -   Intenso stress emotivo/fisico
    -   Ormoni sessuali

### Terapia

-   **Più conservativa possibile** (angioplastica come ultima risorsa,
    potrebbe peggiorare la dissezione)
    -   Tp. antipertensiva
    -   βb
    -   CardioASA

## Cardiomiopatia da stress (Takotsubo, apical balooning, sindrome del cuore infranto)

-   Non è infarto (non ho necrosi)
-   F:M = 9:1
-   Presentazione clinica identica a STEMI (con cui condivide parte
    delle complicanze \[insufficienza valvolare acuta, trombosi
    endocardiaca apicale, C\|AHF, aritmie\])
-   Diagnosi
    -   Coronarografia: le coronarie devono essere normali
    -   Tipica morfologia cardiaca a "vaso"[^43] con apice immobile[^44]

# Patologie del pericardio

```{=html}
<!-- Manfrini -->
```
-   Patologie del pericardio sono essenzialmente 2
    -   Pericarditi (anche miopericarditi se interessano anche
        miocardio)
        1.  Acuta → di nuova insorgenza
        2.  Incessanta → \> 1mese, \< 3 mesi (pericardite non incessante
            si risolve \~ 4settimane)
        3.  Cronica → \> 3 mesi
            -   Essudativa
            -   Costrittiva
        4.  Ricorrente → pericardite acuta seguita da intervallo libero
            da sintomi che, però, recidiva
    -   Tamponamento cardiaco/pericardico
-   Epidemiologia
    -   5% accessi a DEA per toracoalgia
    -   1% pz. con pericardite acuta ha decesso intraH
-   Eziologie
    1.  infettive (principalmente virale in paesi ind, TBC paesi in via
        di sviluppo)
    2.  chimiche
    3.  fisiche
    4.  autoimmuni (LES, artrite reumatoide, vasculiti, sarcoidosi,
        MICI, postinfarto[^45])
    5.  neoplastiche, tipicamente secondarismi (linfomi, k mammario, k
        polmonare)
    6.  traumi
    7.  altre patologie che determinano infiammazione o trasudazione
        (uremia, amiloidosi, CHF e stati congestivi)
    8.  come complicanza IMA transmurale
    9.  iatrogene da manipolazione del cuore/pericardio

## Pericardite acuta

-   SeS: principalmente cardiocircolatori e ostruttivi
    -   Dolore toracico "cardiaco" oppressivo (ma caratteristicamente è
        potenzialmente: sensibile ad atti respiratori; alleviato in
        posizione seduta con tronco inclinato in avanti; a volte in
        precordio e non retrosternale)
    -   Dispnea da sforzo/→ ortopnea
    -   Sintomi dovuti a compressione locale (occasionali): nausea,
        disfagia, raucedine, singhiozzo
    -   Sintomi aspecifici
        -   Febbre
        -   Astenia
        -   palpitazioni
    -   All'EO cv: sfregamenti pericardici[^46], polso paradosso[^47]
    -   All'ECO: ispessimento dei foglietti pericardici o versamento
        franco
    -   All'ECG: possibili alterazioni STE
-   Data potenziale somiglianza con IMA-STEMI, la ddx può essere
    difficile se presentazione dubbia, quindi iter dev'essere
    -   Anamnesi (metà diagnosi!)

    -   ECG

          -----------------------------------------------------------------------
          Pericardite                         IMA
          ----------------------------------- -----------------------------------
          ST sopra in **tutte le derivazioni  ST sopra **localizzato al
          tranne V1 e aVR**                   territorio coronarico** colpito

          ST sopra concavo verso l'alto ("a   ST sopra convesso
          cucchiaio")                         

          **Segmento PR depresso              Segmento PR pari
          *down-slope***[^48]                 

          Non compare onda Q                  Può comparire onda Q

          Quando si normalizza l'ST l'onda T  Quando si normalizza l'ST l'onda T
          si inverte successivamente          si inverte contemporaneamente
          -----------------------------------------------------------------------

    -   ECO, Eco, Eco ed ancora Eco

    -   RX torace per valutare eventuale allargamento ombra cardiaca

    -   Esami ematici

        -   Marker di danno miocardico (devono essere assenti)
        -   PCR mossa
-   Terapia
    -   Se agente eziologico determinato: diretta alla causa (50% casi
        idiopatico)
    -   Se idiopatico: `FANS` + `colchicina`.
        -   `corticosteroide` in seconda scelta (correlato con recidive)

## Pericardite incessante

Non trattata

## Pericardite cronica

### Pericardite cronica costrittiva

-   3 mesi

-   Progressiva obliterazione di spazio pericardico per formazione di
    aderenze fibrose tra miocardio e pericardio ⇒ manca la distensione
    in diastole ⇒ ↓ riempimento ventricolare

-   SeS
    -   Astenia
    -   Dispnea da sforzo o dispnea
    -   Segni di congestione sistemica (↑PVJ, epatomegalia, versamento
        pleurico, reflusso epatogiugulare)
    -   EO cardio
        -   Itto diminuito (versamento impedisce la palpazione)
        -   Polso paradosso in 33% dei casi
        -   Rumore di *pericardial knock* all'auscultazione (ricorda un
            3/o tono)

-   Diagnosi
    -   Buon EO (e buona APR, ricerca di fattori di rischio per
        pericardite)
    -   CXR
    -   Eco

-   Terapia
    -   Poco margine per tp. medica
    -   Tp. definitiva chirurgica: pericardiectomia

## Pericardite ricorrente

-   Medesimo iter e gestione di pericardite acuta
-   Chi recidiva
    -   1/5 dei pz. con pericardite virale recidiva
    -   Fino a 50% dei pz. con pericardite virale trattata con
        cortcosteroide!!

## Tamponamento cardiaco

-   Versamento cardiaco → ↑ pressione intrapericardica ⇒ ↓ portata
    cardiaca → shock ostruttivo/cardiogeno
-   La chiave fisiopatologica è doppia: quantità e velocità di accumulo
    -   50cc accumulati rapidamente possono portare a versamento
        sintomatico
    -   1000cc accumulati lentamente possono non dare grandi sintomi
-   Iter e gestione deve essere rapido, perché ho un concreto rischio di
    destabilizzazione emodinamica per shock ostruttivo
-   Diagnosi
    -   ECG con complessi QRS a ridotto voltaggio (I + III + III \<
        15mm) ± alternanza elettrica
    -   Toni parafonici
    -   Possibile polso paradosso
    -   Buona idea Rx torace, se ho tempo
    -   Eco, eco, eco, eco, **ECO**! TC o RMN in alternativa (imaging
        non invasivo
-   Trattamento: LG ESC
    -   Elezione: gestione medica se non situazione critica
    -   Urgenza/emergenza: pericardiocentesi con guida ecografica[^49]

# Embolia polmonare acuta

-   ***Acute Pulmonary Embolism*** (anche EPA)--- condizione clinica
    causata da ostruzione acuta di una porzione di estensione variabile
    del letto arterioso polmonare a seguito di (trombo)emboli -- i quali
    sono solitamente originati in vene profonde degli arti inferiori
    (***TVP***)
-   È problema clinico estremamente rilevante: di difficile diagnosi e
    alta mortalità
    -   ⚠️ Sintomi non specifici, e molto eterogenei ⇒ **mantenere
        un'alta soglia di sospetto** e correlare [SeS](#epses) con
        [fattori di rischio](#epfattrischio)
    -   Frequente (particolarmente in pz. ospedalizzati)
    -   Alta mortalità se non diagnosticata
    -   Fattori di rischio frequentemente ritrovabili in popolazione,
        sopratutto ospedalizzata
-   Approccio stratificato secondo rischio.
    1.  **Rischio grave** (3--5% pz.): pathway clinico rapido, ho poco
        tempo per evitare morte
    2.  **Rischio basso--moderato** (95--97 % pz.): iter diagnostico più
        lento, ma sensibile e specifico

      Stratificazione del rischio   Mortalità   Prevalenza
      ----------------------------- ----------- ------------
      Alto                          14--30%     3
      Intermedio--alto              7.7         15
      Intermedio--basso             6.0         50
      Basso                         0.5         30

## Epidemiologia

-   115--269 casi/100K abitanti all'anno
    -   5% dei casi quadro severo
    -   90% dei casi quadro lieve
-   Mortalità tendenzialmente costante (\~ 8% dei casi)

## Presentazione clinica

-   **Eterogenea**. La gravità dipende
    -   Da dimensioni dei trombi (più sono grandi, più tappano una zona
        estesa, più sono gravi)
    -   Dalla tempistica: più trombi contemporaneamente è peggio che un
        trombo solo
    -   Da localizzazione terminale

### Fattori di rischio {#epfattrischio}

-   Forti
    -   Fratture aaii
    -   Precedente tromboembolismo venoso (50% TEV → EP, di queste solo
        10% porta a sintomi)
    -   Ospedalizzazione da \< 3 mesi per HF, AFib, AFlutter
    -   IMA \< 3 mesi
    -   Immobilismo (⇐ danni al midollo)
    -   Traumi maggiori
    -   Protesi/sostituzioni di anca e ginocchio
-   Moderati
    -   Artroscopia
    -   Patologie autoimmuni
    -   Trasfusioni
    -   Cateteri venosi (centrali \> periferici)
    -   Chemioterapia
    -   CHF, Insufficienza respiratoria
    -   Uso di agenti eritropoietenici
-   Minori
    -   Tp. ormonale sostitutiva, contraccettivi orali, tp per
        fecondazione in vitro
    -   Procedure per fertilizzazione in vitro/contraccettivi orali
    -   Periodo post--parto (↑ coagulazione)
    -   Infezioni (polmonite, IVU, HIV, Covid-19...)
    -   IBD
    -   Neoplasie (particolarmente se metastatiche)
    -   Ictus con paralisi
    -   TV superficiale
    -   Trombofilie congenite
-   Deboli
    -   Immobilità a letto \> 3gg
    -   Diabete
    -   Ipertensione
    -   Immobilità da seduta prolungata[^50]
    -   Età
    -   Chirurgia laparoscopica
    -   Obesità
    -   Gravidanza
    -   Vene varicose

> **Wells' Score**\
> Score che correla fattori di rischio con probabilità di PE
>
> -   Symptoms of DVT (+3 points)
> -   No alternative diagnosis better explains the illness (+3 points)
> -   Tachycardia with pulse \> 100 (+1.5 points)
> -   Immobilization (\>= 3 days) or surgery in the previous four weeks
>     (+1.5 points)
> -   Prior history of DVT or pulmonary embolism (+1.5 points)
> -   Presence of hemoptysis (+1 point)
> -   Presence of malignancy (+1 point)
>
>   Score   Probabilità di PE
>   ------- -------------------
>   \> 6    Alta
>   2-6     Intermedia
>   \< 2    Bassa

### Diagnosi {#epses}

1.  Sospetto diagnostico se (mantenere bassa soglia di sospetto!)
    -   Fattori di rischio (Wells' score per correlarli con probabilità)
    -   Sintomi
        -   Dispnea
            -   Solitamente a insorgenza improvvisa
            -   A volte solo dispnea da sforzo[^51]
            -   Possibile platipnea in stati di cuore polmonare[^52],
                più tipica in grandi EP
        -   Dolore toracico (pleuritico o substernale)
        -   Tosse
        -   Emottisi
        -   ± Sincope
    -   Segni
        -   Tachipnea (FR ≥ 20)[^53]
        -   Tachicardia (FC ≥ 100)
        -   Segni di TVP: edemi declivi, differenze aa (temperatura,
            dolorabilità \[specialmente alla compressione dei muscoli\],
            gonfiore, arrossamento, segni di disperfusione \[cianosi o
            pallore a seconda dell'edema\] unilaterale, eventuale
            turgore dei circoli collaterali \[sopratutto se
            superficiali\])
        -   Cianosi (periferica → centrale)
        -   Possibili segni di sovraccarico destro: ↑ PVG con
            dilatazione, congestione epatica ± pulsatilità, reflusso
            epatogiugulare
        -   Febbre
    -   Esami strumentali ed imaging (non AngioTC): cambiamenti
        nonspecifici, diventano tanto più specifici quanto EP è grande
        -   **ECG**: possibili segni di sovraccarico destro (p
            polmonare), possibili segni più specifici (pattern
            S1Q3/S1Q3T3), possibili altre rilevazioni nonspecifiche
            generiche[^54]
        -   **RX**: possibile atelettasia o infiltrato; raramente si
            evidenziano zone di infarto polmonare a valle del trombo
        -   **POCUS** tanto più specifica quanto EP grave: Vent dx
            dilatato (*"cuore polmonare"*) e sue pareti ipomobili;
            *segno di McConnel* (apice RV ipercontrattile ma pareti
            ipomobili); possibile evidenziare trombi a cavaliere sse
            particolarmente grandi
2.  Ddx
    -   IM (quindi faccio ECG)
    -   AHF/HF acuto su cronico
    -   Pericardite o tamponamento pericardico
    -   Polmonite
    -   Neoplasia intratoracica
    -   PNX spontaneo
    -   Frattura costale
    -   Costocondrirte
    -   Asma
    -   Dolore toracico non specifico
    -   Ansia o attacchi di panico

### Stratificazione del rischio

-   Tx: c'è quadro di grave instabilità emodinamica? Sì ⇒ alto rischio e
    poco tempo ⇒ trattare immediatamente
    1.  ACR
    2.  Shock (ostruttivo)
        -   PA~sis~ \< 90 mmHg
        -   Pressori necessari per tenere PA \> 90 mmHg nonostante
            volemia adeguata
        -   Segni di ipoperfusione periferica (AMS, cute fredda,
            oliguria, ↑ lattati
    3.  Ipotensione grave e persistente
        -   PA~sis~ \< 90 mmHg
        -   ↓ PA di ≥ 40 mmHg per 15'
-   Da @konstantinides2019ESCGuidelines2020 (LG ESC 2019)

![](data:image/png;base64,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)

-   I pz. a rischio *non alto* possono ulteriormente essere stratificati
    in sotto-classi di rischio (che correlano con mortalità e
    contribuiscono a guidare il trattamento) in funzione di
    1.  Situazione clinica grave (PESI -- Pulmonary Embolism Severity
        Index)
        -   PESI \> III, sPESI ≥ 1
    2.  Disfunzione ventricolare dx (segni all'ECO e/o AngioTC
        polmonare)
    3.  ↑ cTn

    ![](img/PE-mortality-risk.png){width="50%"}

> **PESI e sPESI score**\
> Si applicano su pz. a cui è *già stato diagnosticato PE & non sono ad
> alto rischio*: correlano la gravità della situazione clinica con 5
> classi di mortalità a medio termine
>
>   -----------------------------------------------------------------------
>   Fattore clinico                     Punteggio
>   ----------------------------------- -----------------------------------
>   Age (years)                         +1 punto per aa
>
>   Male sex                            +10
>
>   Cancer (previous or active)         +30
>
>   Heart failure                       +10
>
>   Chronic lung disease                +10
>
>   Pulse ≥ 110 min^−1^                 +20
>
>   SIS \< 100 mmHg                     +30
>
>   RR ≥ 30 min−1                       +20
>
>   Temperature \< 36°C                 +20
>
>   Altered mental status               +60
>   (disorientation, lethargy, stupor   
>   or coma)                            
>
>   SpO~2~ \< 90% (with or without the  +20
>   administration of supplemental      
>   oxygen)                             
>   -----------------------------------------------------------------------
>
>   -----------------------------------------------------------------------
>   Risk class        Points            30 day mortality  30 day mortality
>                                       risk              
>                                       stratification    
>   ----------------- ----------------- ----------------- -----------------
>   Class I           ≤ 65              Very low risk     0--1.6%
>
>   Class II          66--85            Low risk          1.7--3.5%
>
>   Class III         86--105           Intermediate risk 3.2--7.1%
>
>   Class IV          106--125          High risk         4.0--11.4%
>
>   Class V           \> 125            Very high risk    10--24.5
>   -----------------------------------------------------------------------

### Trattamento

-   L'aggressività del trattamento dipende dalla stratificazione del
    rischio, ma tutti i pz. vanno scoagulati (con varia aggressività)

    ![](img/pe-management-flowchart-esc2019.png){width="50%"}

-   Tx ha 3 (+1) cardini in funzione del rischio

    1.  Eparinizzazione (ogni classe di rischio, iniziare senza indugio
        in pz. high risk)
        -   `UFH`[^55] \> `LMWH` (bolo in funzione del peso, non
            ritardare se alto rischio)
    2.  Trombolisi se non controindicazione (High risk)
        -   **Trombolisi sistemica (farmacologica)**
            -   ⭐️ `tPA` ricombinante (*100 mg/2h EVc*)
            -   `streptokinasi`
        -   Trombectomia chirurgica sse trombolisi sistemica non
            indicata
        -   Cateterizzazione vasale percutanea per embolisi[^56] sse
            trombectomia impossibile per mancanza di cardioch
    3.  Socagulazione (Intermediate/Low risk)
        -   NAO sono prima scelta
        -   Altri agenti anticoagulanti a seconda dell'opportunità
            clinica
    4.  Supporto (secondo necessità)
        -   Supporto emodinamico di varia intensità in funzione della
            condizione clinica
        -   ECMO + embolectomia\|embolisi può essere considerato in pz.
            con PE che porta ad ACR refrattario o collasso emodinamico

> **Controindicazioni *assolute* alla trombolisi**
>
> -   Storia di stroke emorragico o di origine sconosciuta
> -   Stroke ischemico \< 6 mesi
> -   Neoplasia SNC
> -   Trauma/chirurgia/contusione testa \< 3 settimane
> -   Diatesi emorragica
> -   Sanguinamento attivo

-   Dimissione: tp. anticoagulante per almeno 3m, con f/u per decidere
    se sospendere
    -   Se eziologia tromboembolismo è risolta, o la causa era
        transitoria (eg: intervento, rottura di arto...) allora ok
        sospensione
    -   Se fattori di rischio permangono valutare opportunità di
        continuare tp.

# Ipertensione polmonare

> **Come misurare l'emodinamica del circolo polmonare; ovvero: PAP, mPAP
> e PAWP**
>
>   Parametro emodinamico   Range accettabile
>   ----------------------- -------------------
>   PAPS                    22 ± 11
>   PAPD                    10 ± 5
>   mPAP                    14 ± 6
>   PAWP                    9 ± 3
>
> TL;DR: <https://youtu.be/IRNJfqkQbVA>
>
> La misurazione *precisa* dei valori dell'emodinamica polmonare è
> un'operazione cruenta, poiché prevede il cateterismo del cuore destro
> partendo da una vena di grosso calibro (succlavia, giugulare interna o
> femorale).\
> Una *stima* di mPAP può essere ottenuta mediante valutazione
> ecografica, misurando la velocità del rigurgito parafisiologico della
> valvola tricuspide (che è direttamente proporzionale alla pressione
> del circolo polmonare).
>
> Per stimare i valori in modo preciso si cateterizza, con un catetere
> apposito ([Catetere di Swan--Ganz]()) prima un grosso vaso venoso →
> atrio dx → ventricolo dx → arteria polmonare → diramazioni del primo
> ordine.
>
> Il catetere di SG è sostanzialmente un trasduttore per la PA cruenta
> opportunamente modificato: tipicamente è a 4 lumi (porta per PA, porta
> per pressione ventricolare, per infusione e per gonfiaggio del
> palloncino) e con aggiunte necessarie per specifiche ragioni
> (monitoraggio dell'output cardiaco mediante termodiluizione).
> L'apertura del catetere per il monitoraggio è posizionata in punta,
> subito distalmente al palloncino -- che quindi si trova di qualche
> millimetro più prossimale rispetto all'apertura del lume che verrà
> collegato al trasduttore per la PA cruenta.
>
> Questo consente di misurare la pressione arteriosa in 2 situazioni
>
> -   **A palloncino sgonfio** → si misurerà la pressione dell'arteria
>     polmonare con le variazioni dovute al ciclo cardiaco (PAPS e
>     PAPD). Da qui si ricaverà la **mPAP** con un calcolo analogo alla
>     MAP sistemica:
>
>     $$ mPAP = PAPD + \frac{1}{3}(PAPS-PAPD)$$
>
> -   **A palloncino gonfio** → si interrompe il flusso (e la sua
>     variazione dovuta all'attività vent dx) ⇒ grazie alla grande
>     complianza dei vasi polmonari la pressione distale al palloncino
>     si metterà in equilibrio fino all'atrio sx. Questa pressione viene
>     detta PAWP (*"Pulmonary Artery Wedge Pressure"* o *pressione di
>     incuneamento polmonare"*). NB: PAWP correla di fatto con il volume
>     telediastolico

-   ***Ipertensione polmonare*** (PH) --- stato patofisiologico in cui
    la pressione polmonare media (mPAP) è \> 25 mmHg (mPAP fisiologica ≌
    15 mmHg)
    1.  Ipertensione da danno alla circolazione polmonare ---
        *ipertensione **pre**capillare* (↑ mPAP, PAWP ok)
    2.  Ipertensione da insufficienza sinistra --- *ipertensione
        **post**capillare* (↑ mPAP, ↑ PAWP)
-   L'ipertensione polmonare è una condizione che si riscontra in \> 50
    patologie, divisibili in gruppi (frequenza ↓)
    1.  Ipertensione polmonare da patologie del cuore sinistro[^57]
    2.  Ipertensione polmonare da patologie respiratorie (LD) e/o
        ipossia[^58]
    3.  Ipertensione polmonare propriamente detta[^59]
    4.  Ipertensione Polmonare da TromboEmbolismo Cronico o altre
        occlusioni (CTEPH)
    5.  Ipertensione polmonare multifattoriale o da eziologia non
        mista[^60]
-   Per dx: LG [@galie2015ESCERS2016] delineano algoritmi diagnostici
    che, con test strumentali, cercano di obiettivare la causa (dalle
    pat più frequenti verso quelle più rare)
-   La prognosi, in quanto a gestione e sopravvivenza, è differente a
    seconda del tipo di PH
    -   Sopravvivenza migliore → cuore polmonare cronico tromboembolico
        (possono essere operati e la situazione viene definitivamente
        risolta)
    -   Sopravvivenza intermedia → PH secondaria a LHD, PH propriamente
        detta (ci sono farmaci che, in approcci onnicomprensivi,
        permettono un controllo accettabile del letto vascolare
        polmonare, dilatandolo abbastanza efficacemente)
    -   Sopravvivenza peggiore → PH secondaria a lung disease (non c'è
        nulla se non il trapianto che risolva, e la prognosi dei
        trapianti di polmone è comunque grama)

```{=html}
<!-- gio 18 mar 2021, 16:13:45, CET -->
```
# Scompenso cardiaco cronico (CHF)

-   Lo ***scompenso cardiaco*** (HF, Hearth Failure) è una sindrome
    clinica complessa (cronica, acuta, acuta su cronica), causata
    dall'inadeguatezza del cuore a pompare sangue nell'organismo in una
    quota adeguata alle necessità fisiologiche dell'organismo
    1.  Definizione *clinica* --- sindrome caratterizzata da SeS tipici,
        indicativi di inadeguata perfusione. La severità *dei sintomi di
        CHF* è classificata secondo la classificazione NYHA

          -----------------------------------------------------------------------
          Classe                              
          ----------------------------------- -----------------------------------
          I                                   Nessuna limitazione dell'attività
                                              fisica. L'attività fisica
                                              **ordinaria** on causa dispnea,
                                              fatica, palpitazione

          II                                  Leggera limitazione dell'attività
                                              fisica. Asintomatico a riposo, ma
                                              attività fisica **ordinaria**
                                              produce dispnea, fatica,
                                              palpitazione

          III                                 Marcata limitazione dell'attività
                                              fisica

          IV                                  Impossibilitato a fare attività
                                              fisica di qualsiasi intensità senza
                                              che si presentino sintomi, i quali
                                              possono esserci anche a riposo. Se
                                              si produce attività fisica, il
                                              discomfort aumenta
          -----------------------------------------------------------------------

    2.  Definizione [*patofisiologica*](#scompensopatofisio) --- stato
        nel quale il cuore è incapace di fornire una perfusione
        sufficiente alle necessità momentanee dell'organismo senza fare
        uso estensivamente del meccanismo di Frank--Starling.[^61]
        Alternativamente, situazione in cui il cuore è incapace di
        mantenere un output adeguato a soddisfare le esigenze
        metaboliche momentanee e garantire un adeguato ritorno venoso

    3.  Definizione *emodinamica* --- stato in cui si verifica una o più
        alterazioni di parametri emodinamici o cardiaci

        -   *Indice cardiaco* \< 2.5 lt/min/m^2^ [^62]
        -   RAP[^63] \> 8 mmHg
        -   PAWP (\~ Left Atrial Pressure) ≥ 15 mmHg

## Epidemiologia

-   La prevalenza dipende dalla definizione, ma mediamente
    -   1--2% popolazione adulta
    -   ≥ 10% popolazione \> 70aa

## Patofisiologia dello scompenso cardiaco {#scompensopatofisio}

-   L'attività cardiovascolare è caratterizzata da un doppio aspetto:
    l'aspetto ventricolare e l'aspetto vascolare

    1.  Funzione ventricolare (mantenere precarico, contrattilità e
        vincere il postcarico)[^64]
        -   Precarico (volume telediastolico)
        -   Contrattilità miocardica (rapporto
            $\frac{P_{sist}}{\text{volume telesistolico}}$)
        -   Postcarico (impedenza arteriosa[^65] oppure massima tensione
            della parete miocardica, o ancora elastanza arteriosa[^66]
    2.  Funzione vascolare (vincere il postcarico[^67] e garantire MAP
        sufficiente per perfondere)
        -   Resistenza dei vasi
        -   Compliance dei vasi

-   Si determina scompenso in tutte le situazioni che concorrono a
    determinare una portata insufficiente per la domanda

    -   ↓ precarico
    -   ↓ contrattilità
    -   ↑ postcarico
    -   ↑ resistenza vasale (↓ compliance)

-   Le conseguenze che questo comporta sono 3 (tutte ben esemplificabili
    nello studio della curva pressione--volume del miocardio)

    ![](img/conseguenze-scompenso.png)

    -   Scompenso sistolico (anche HFrEF, HF con EF ridotta)
        1.  ↓ contrattilità
    -   Scompenso diastolico (anche HFpEF, HF con EF preservata)
        1.  ↑ carico (sovraccarico di volume o sovraccarico pressorio)
        2.  ↓ riempimento ventricolare

### Tipologie di scompenso cardiaco

![(1) circolo normale; (2) HF sx; (3) HF biventricolare; (4) HF
dx](img/scompenso-cardiaco-fisiopatologia.png)

-   A seconda della porzione cardiaca insufficiente si distingue
    -   Scompenso cardiaco dx (2)
    -   Scompenso cardiaco sx (3)
    -   ⭐️ Scompenso cardiaco dovuto a disfunzione di entrambi i
        ventricoli (4)

### Eziologie di scompenso cardiaco

-   Le eziologie sono svariate: HF è condizione terminale di moltissime
    patologie -- dovunque, insomma, si determini una situazione di
    insufficienza di pompa rispetto alla domanda
    1.  Patologie che danneggiano la funzionalità del miocardio, ↓
        capacità contrattile
        -   Ischemie
        -   Danno tossico
        -   Patologie autoimmuni
        -   Infiltrazioni neoplastiche
        -   Alterazioni metaboliche o ormonali
    2.  Aumento del carico
        -   Ipertensione
        -   Difetti valvolari (acquisiti o congeniti)
        -   Patologie del pericardio o dell'endocardio
        -   Stati ad alta portata cardiaca
        -   Sovraccarico di volume
    3.  Aritmie
        -   Tachiaritmie (↓ CO)
        -   Bradiaritmie (↑ volume)

### Meccanismi di compenso

-   In un quadro di IC l'organismo attua 3 tipologie di compenso,
    tentando così di mantenere un'adeguata perfusione tissutale[^68]
    1.  Compenso (adattamento) tramite rimodellamento strutturale
        (tipico se ↑ carico)
    2.  Compenso (adattamento) tramite meccanismi neuro--ormonali
        (tipico se ↓ gittata)
    3.  Compenso (adattamento) emodinamico
-   Con il progredire del tempo, gli adattamenti diventano essi stessi
    una causa che sostiene lo scompenso iniziale

#### Compenso tramite rimodellamento strutturale

![](img/hf-compenso-rimodellamento-strutturale.png){width="60%"}

#### Compenso tramite meccanismi neuro--ormonali o emodinamici

-   ↓ gittata cardiaca ⇒ ↓ pressione di perfusione. Quindi si attiva il
    compenso di sistemi di ritenzione idrica per tentare di ↑ pressione
    di perfusione (MAP)

  -----------------------------------------------------------------------
  Meccanismo                          Effetti
  ----------------------------------- -----------------------------------
  SN simpatico                        ↑ inotropismo, cronotropismo (↑
                                      richiesta metabolica)

  Sistema                             Antidiuresi, ↑ resistenze
  renina--angiotensina--aldosterone   periferiche

  Endotelina                          Vasocostrizione

  Sistema arginina--vasopressina      vasocostrizione, ↑ assorbimento
                                      renale di acqua

  Peptidi natriuretici (BNP)          ↓ riassorbimento di acqua
  -----------------------------------------------------------------------

## Clinica

-   SeS
    -   Dispnea a riposo o da sforzo (*spesso ortopnea*, spesso dispnea
        parossistica notturna)
    -   Astenia, stanchezza
    -   Segni di ritenzione idrica (es: congestione polmonare, edemi
        declivi, epatomegalia[^69]...)
    -   Possibile cardiopalmo
    -   Possibile dolore toracico
-   All'EOC
    -   ↑ pressione venosa giugulare[^70]
    -   Edemi declivi bilaterali
    -   Reperti obiettivi di megalia del cuore (itto spostato o
        ingrandito, \> area di ottusità alla percussione)
    -   reflusso epatogiugulare
    -   Rantoli
-   All'RX torace
    -   Evidenziazione di un quadro di congestione venosa polmonare[^71]
    -   Edema polmonare (opacità "ad ali di pipistrello" + rantoli a
        piccole bolle + dispnea soggettiva/oggettiva)
        -   Opacità più o meno diffusa all'RX a seconda dell'estensione
            dell'edema
        -   Addensamenti caratteristici (disordinata, localizzata in
            alveoli) alla TAC
        -   Circolo pormonale più radiopaco (anche agli apici[^72]) in
            quanto congesto
        -   ± cardiomegalia
    -   Idrotorace/versamento pleurico
-   Alla TC
    -   Edema interstiziale[^73]
    -   Edema polmonare (ovviamente si vede, ma non ha senso, la
        diagnosi è clinica!)

> **Comorbidità**
>
> Andare a capire quali siano obesità e quali siano con-cause non è
> assolutamente facile in certe situazioni
>
> -   Angina
> -   Patologie coronariche
> -   Cachessia, sarcopenia
> -   Neoplasia
> -   Patologie SNC
> -   Diabesità
> -   Artrite
> -   Gotta
> -   IpoK/IperK (diuretici)
> -   Ipertensione
> -   Sideremia
> -   IRA/IRC
> -   BPCO
> -   Disordini respiratori del sonno
> -   Patologie valvolari cardiache

## Diagnosi {#chfdiag}

![](data:image/png;base64,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)

## Trattamento

1.  Miglioro i sintomi momentanei
    -   Diuretici, diuretici e diuretici! (a meno di EPA non esagerare o
        si potrebbe avere ipotensione)
    -   O~2~ tp. al bisogno
2.  Guadagno il controllo della situazione di scompenso
    -   Diuretici diuretici e ancora diuretici
    -   Se FE ridotta (≤ 35%) obiettivo è ↑
        -   Contrasto degli adattamenti anti-neuro-ormonali
            (`ace-inibitori`, `β-bloccanti`)
        -   Se i sintomi permangono
            -   Ipotizzo agonisti dell'aldosterone se i sintomi
                permangono
            -   Alternative farmacologiche avanzate (`ARNI`[^74])
        -   Ho sintomi particolari?
            -   QRS ≥ 130 ms/evidenze di aritmia? ⇒ Cardiac
                Resynchronization Therapy
                ([CRT](https://en.wikipedia.org/wiki/Cardiac_resynchronization_therapy))
            -   HR \> 70 bpm nonostante β-bloccato? ⇒ `ivabradina`
        -   Ho rischio di morte improvvisa? (LVEF ≤ 35%, storia di
            VT/VF) ⇒ valutare IDD
        -   I sintomi resistono? Valutare aiuti
            meccanici/trapianto/misure di comfort
            -   MCS, come LVAD
    -   Se FE conservata
        -   Ho poche armi terapeutiche
        -   Bisogna trattare **la causa di base** (ipertensione mal
            controllata? Cardiomiopatia?)
3.  Ipotizzo cambiamenti a lungo termine per prevenire
    peggioramenti/riacutizzazioni
    -   Aggiustare dose terapeutica
    -   Valuto cambiamenti più a lungo termine (anche interventi non
        farmacologici)

# Scompenso cardiaco acuto (AHF)

-   ***AHF*** --- quadro patologico caratterizzato da **un'insorgenza
    acuta di scompenso cardiaco o da un peggioramento repentino di un
    quadro di scompenso preesistente**
-   Scompenso costituisce punto finale di degenerazione di
    sostanzialmente tutte le cardiopatie
    -   Ischemia/SCA
    -   Aritmie
    -   Crisi ipertensive
    -   Disfunzioni valvolari
    -   Patologie endo/mio/pericardio
    -   Embolia polmonare
    -   Dissezione aortica
    -   Tamponamento cardiaco
    -   Condizioni che alterano acutamente pre/postcarico (es: risposta
        immunitaria in infezioni, periodo gravidanza/periparto,
        tireotossicosi, anemia severa, shunt)
-   AHF monta su CHF quando ci sono fattori che precipitano il labile
    compenso in cui il pz. si trova
    -   Sovraccarico idrico
    -   Infezioni
    -   Patologie neurovascolari
    -   Disfunzioni renali
    -   BPCO
    -   Stress (traumi, chirurgia)
    -   Farmaci/sostanze (eg alcool, che deprime contrattilità)
-   Pilastri del trattamento
    -   PA normale o alta → vasodilatatori per ↓ postcarico
    -   PA bassa e/o segni di congestione → inotropi ± sostegni
        meccanici al circolo
    -   NIV

## Tipologie di AHF

1.  **AHF su CHF** per fattore scatenante
2.  **AHF ipertensivo (o vascolare) o de novo AHF**
3.  **AHF in ACS**
    -   STEMI \> NSTEMI ⇒ ↓ contrattilità ⇒ AHF
        -   ⇐ ipo/acinesia di parete
        -   ⇐ insufficienze valvolari acute
        -   ⇐ ↑ afterload del ventricolo sx (per reazioni simpatiche di
            vasocostrizione=
4.  Scompensi "monolaterali"
    -   **HF sx** → Edema polmonare
    -   **HF dx**
        -   ⇐ Embolia polmonare acuta (ipertensione polmonare molto
            rapida e ↑ postcarico solo dx)
        -   ⇐ IMA dx
5.  **AHF ipotensivo ↔ shock cardiogeno**

![](img/ahf-caratteristiche.png)

## Fisiopatologia

![](img/fisiopatologia-ahf.png) 

-   Nello scompenso il rene e il cuore si combattono
    -   I sistemi neuro--ormonali attraverso il rene tendono a
        trattenere liquidi (per basso output cardiaco ⇒ bassa perfusione
        renale)
    -   Trattenere liquidi però peggiora lo stato congestizio

## Clinica

![](img/tipologie-di-hf.png) 

-   Fare sempre dosaggio di BNP e proBNP ([vedi CHF](#chfdiag))

### Prognosi

-   Elementi prognostici negativi
    -   Età
    -   Sesso M
    -   Riospedalizzazione
    -   Ipotensione/shock (aumento notevole di mortalità intra e
        postdimissione in sg. ipo/**normo**tesi)
    -   Comorbidità (diabete, KI, insufficienza epatica, anemia, BPCO,
        cachessia, QRS largo)
    -   Iponatremia per ritenzione idrica (segni di congestione)
    -   Bassa EF
    -   Severe insufficienze valvolari
    -   Segni di ↑ riempimento del ventricolo
    -   Capacità funzionale ridotta
-   Elementi prognostici positivi
    -   Ipertensione[^75]

## Terapia

### Obiettivi terapeutici

-   Immediati (PS, ICU, CCU)
    -   Alleviare i sintomi
    -   **Controllare l'emodinamica centrale** per ripristinare la
        perfusione periferica
    -   Controllare ipossiemia
    -   Evitare danni organici vitali
    -   Limitare la degenza in ICU/CCU
-   Intermedi (ricovero in corsia)
    -   Stabilizzazione clinica e ottimizzazione della terapia
    -   Iniziare terapia orale cronica (`ace-inibitori`, `βb`,
        antagonisti dell'aldosterone)
    -   Valutare se necessari dispositivi di assistenza (pacemaker[^76],
        terapia di resincronizzazione elettrica cardiaca[^77]...)
-   A lungo termine (pre-dimissione e dimissione)
    -   Ottimizzare terapia orale cronica
    -   Educare il pz. a non aumentare il carico idrico
    -   Educare a stile di vita sano (esercizio fisico apposito per
        riabilitazione cardiaca, alimentazione, fattori di rischio)
    -   Seguire pz. dal punto di vista psicosociale e familiare

### Farmacologia

-   **Vasodilatatori** (↓ postcarico alleggerendo il lavoro miocarico e,
    permettendo un miglior svuotamento ventricolare, migliorano la
    portata e riducendo la congestione a monte \[top nell'EP\].
    Naturalmente vanno evitati se SBP non permette, in quel caso si va
    di inotropi)
    -   `nitroglicerina`, `isosorbide`, `nitroprussiato`...
-   **Diuretici** (attenzione a combinarli, a volte hanno effetto
    eccessivo)
    -   Dell'ansa (`furosemide`, `torasemide`, `betanide`)
    -   Tiazidici
-   **Inotropi e pressori** (Se SBP non permette di vasodilatare.
    Attenzione, all'inizio funzionano ma a lungo andare stancano il
    cuore ancora di più, peggiorando il quadro a lungo termine)
    -   β-agonisti → `dobutamina`, `dopamina`
    -   PDE-inibitori → `milrinone`... (che ↑ Ca^++^[^78])
    -   Sensibilizzanti al calcio → `levosimendan`
    -   Pressori → `adrenalina`, `noradrenalina`
-   **Oppioidi** e/v (ridurre il drive adrenergico)

### Trattamento dello scompenso ad alta portata (PAS \> 140)

![](img/hf-alta-portata.png)

> NB: in questo caso si ha anche la NIV (la PEEP riduce il precarico e
> favorisce lo svuotamento ventricolare) come arma terapeutica!

### Trattamento dello scompenso acuto con portata normale (PAS 140--90)

![](img/hf-normoteso.png)

### Trattamento dello scompenso acuto a bassa portata (PAS \< 90)

![](img/trattamento-ahf-bassa-portata.png)

> NB: dove possibile vasocostrittori preferibili agli inotropi (tranne
> ca-sensibilizzanti per weaning dagli eventuali supporti meccanici
> (contropulsatori/impella/emofiltrazione \[questa per risolvere il
> sovraccarico idrico in pz congesto)

# Shock

-   ***Shock*** --- sindrome clinica caratterizzata da un'insufficienza
    acuta e severa del sistema cardiocircolatorio tale per cui non è
    garantita una corretta perfusione d'organo
-   Distinguiamo 4 gruppi di shock
    -   Shock ipovolemico
    -   Shock cardiogeno
    -   Shock distributivo
    -   Shock ostruttivo
-   Segni clinici
    -   Oligo/anuria (\<20--30 ml/h)
    -   Cute fredda, cianotica, sudata, marezzata
    -   Alterazioni neurologiche e della coscienza
-   Segni emodinamici
    -   PAS \< 90mmHg
    -   CI[^79] \< 2.5 l/min/m^2^
    -   PAWP ↓
-   Pilastri terapeutici
    -   Monitoraggio intensivo
        -   ECG continuo
        -   Via centrale (se non altro per pressori)
        -   Swan--ganz (pressione atriale dx, PAP, PAWP, CO
            \[termodiulizione\])
        -   PA cruenta
        -   Catetere vescicale
    -   Farmaci per sostenere l'emodinamica
        -   Pressori (`noradrenalina`, `dopamina`\[dosaggi pressori\])
        -   Inotropi (`dobutamina`, `adrenalina`)

## Shock cardiogeno

-   Per gestione: vedi LG
    [@chioncelEpidemiologyPathophysiologyContemporary2020]

-   Con il progressivo deterioramento (progressiva ipoperfusione ⇒
    progressvo danno organico ⇒ ↑ mortalità) si individuano diverse
    situazioni cliniche (2 sistemi classificativi)

    ![](img/evoluzione-clinica-shock-cardiogeno.png)

### Fisiopatologia

![Tendenza da parte del sistema nervoso simpatico, in caso di
ipoperfusione, ad innescare una vasocostrizione nei tessuti periferici
con l'obiettivo di recuperare una pressione sufficiente. Questo tipo di
reazione può aumentare la pressione dei vasi più grandi ma non permette
più la perfusione del microcircolo distale che viene danneggiato. Il
danno andrà a richiamare cellule infiammatorie che danneggiano
ulteriormente il microcircolo](img/shock-fisiopatologia-lesioni.png)

### Trattamento

![The algorithm for pre- and in-hospital management of patients with
cardiogenic shock (CS). The level of decision by multidisciplinary heart
team is presented in red rectangles. AMI, acute myocardial infarction;
CA, cardiac arrest; CABG, coronary artery bypass graft; Dob, dobutamine;
ECG, electrocardiogram; ECMO, extracorporeal membrane oxygenation; GDMT,
guideline-directed medical therapy; HFrEF, heart failure with reduced
ejection fraction; IABP, intra-aortic balloon pump; ICCU, intensive
cardiac care unit; ICU, intensive care unit; IMV, invasive mechanical
ventilation; LVAD, left ventricular assist device; MCS, mechanical
circulatory support; MI, myocardial infarction; MR, mitral
regurgitation; MV, mitral valve; NE, noradrenaline; NV, native valve;
PCI, percutaneous coronary intervention; PCS, post-cardiac surgery; PV,
prosthetic valve; RV, right ventricle; SBP, systolic blood pressure;
VSR, ventricular septal rupture.
[@chioncelEpidemiologyPathophysiologyContemporary2020]](img/shock-gestione.png)

### Supporti meccanici alla circolazione (MCS systems)

-   **Contropulsatore aortico** (IABP --- Intra-Aortic Balloon Pump)
    -   Sistema costituito da palloncino intraortico che si gonfia in
        diastole e sgonfia in sistole
    -   Inserzione facile e comoda: cateterismo dell'aorta da aa
        femorale ⇒ frequente uso clinico
-   **Sistema Impella**
    -   Sistema per produrre un *flusso continuo* (max 5 lt/min) dal
        ventricolo sx all'aorta ascendente
        -   Il flusso viene prodotto tramite una turbina che aspira il
            sangue dal VS e lo porta in aorta
    -   È tendenzialmente una soluzione *a breve termine* (in urgenza)
        -   Flusso continuo ⇒ ↑ pressione aortica ⇒ danneggiamento della
            valvola aortica (non adeguato se preesistente insufficienza
            aortica preesistente, perché si antagonizza eccessivamente
            l'azione della pompa)
        -   Turbina ⇒ ↑ emolisi (ma rischio \> beneficio)
    -   Accesso: femorale, ascellare dx
-   **ECMO** (Extra-Corporeal Membrane Oxygenation
    -   Sistema per aspirare il sangue venoso, ossigenarlo e
        re-iniettarlo in circolo ⇒ assistenza *circolatoria e
        ventilatoria*
    -   Accesso:
        -   Solitamente cannulazione periferica (a/v o v/v a seconda
            dell'opportunità)
            -   Se insufficienza cardiaca e respiratoria: incannulamento
                artero-venoso (tipicamente arteria e vena femorale)
            -   Se solo insufficienza respiratoria: incannulamento
                veno-venoso (tipicamente vena femorale e v. giugulare
                interna)
        -   Possibile cannulazione centrale, opportuna in alcuni quadri
-   **LVAD** (Left Ventricular Assist Device, "cuore artificiale")
    -   Può essere sia bridge therapy (di solito) ma anche tp.
        definitiva in certi casi

# Cardiomiopatie

-   ***cardiomiopatia*** --- alterazione del miocardio, che è
    funzionalmente e/o strutturalmente anormale, in assenza di altri
    elementi che giustifichino tale anormalit-

-   5 forme

    ![](img/cardiomiopatie-class.png)

    1.  HCM --- Cardiomiopatia ipertrofica → ispessimento della parete
        ventricolare, con conseguente difficoltà di riempimento e
        dilatazione atriale a monte
    2.  DCM --- Cardiomiopatia dilatativa → dilatazione del ventricolo,
        che diventa ipocontrattile e quindi deve accomodare un volume
        maggiore di sangue che non riesce ad eiettare
    3.  ARVC --- Cardiomiopatia Aritmogena del Ventricolo destro →
        sostituzione del miocardio con cellule fibroadipose, le quali
        non essendo conduttive facilitano l'instaurazione di circuiti
        aritmici
    4.  RCM --- Cardiomiopatia restrittiva → ventricolo rigido e non
        compliante (es amiloidosi) con conseguente dilatazione a monte
        dell'atrio
    5.  Altro

## Cardiomiopatia ipertrofica

-   Spessore parete ventricolare sx ≥ 1.5 cm
-   Prevalenza: 1/500 (frequente)
-   La distribuzione dell'ipertrofia non è diffusa, ma focale
    -   Settale (ostruttiva)
    -   medio-ventricolare (ostruttiva)
    -   Apicale (raramente ostruttiva)
-   Patofisiologia: 4 aspetti
    -   **Disfuzione diastolica** per diminuito volume della camera
    -   **Ischemia** per ipertrofia *non* accompaganata da adeguato
        sviluppo del circolo
    -   **Ostruzione all'efflusso** in modo variabile in funzione di
        quale porzione ipertrofizza in modo prevalente
    -   ± **Disfunzione valvolare** perché l'aumentato flusso in uscita,
        per effetto venturi, richiama verso il setto il lembo mitralico
-   Clinica
    -   SeS cardio aspecifici (astenia, presincope, sincope, dolore
        toracico, dispnea)
    -   Possibili soffi da eiezione
    -   Possibile S3 (protosistolico)
    -   Anomalie ECG
        -   Ipertrofia ventricolare (criteri su ampiezza QRS)
        -   Anomalie della ripolarizzazione (giant T-wave; T inversion)
        -   Possibili onde Q di **pseudo**necrosi
    -   **Anomalie all'ECO**
-   Prognosi peggiore in
    -   pz. giovani
    -   Forma maligna familiare
    -   Pregresso ACR
    -   Ipotensione da sforzo
    -   Evidenza di ostruzione
    -   FA (fa perdere contributo atriale al riempimento del ventricolo)
        ⇒ ↑ classe funzionale NYHA
-   Trattamento: soltanto se ci sono sintomi reali
    -   Determinare eziologia. C'è ostruzione?
        -   Sì → evitare vasodilatatori e diuretici ad alte dosi
            (incrementano il gradiente di efflusso)
            -   βb, ca-ant sse c'è concomitante HF/angina
            -   Considerare farmaci di prima linea appositi
                (`mavacamten`) che inibiscono la miosina cardiaca, ↓
                capacità contrattile del miocardio in eccesso
            -   Rivalutare 1aa se non sintomi
            -   Considerare tp. chirurgiche
                -   Miectomia del setto interventricolare
                -   Alcolizzazione del setto interventricolare (alcool
                    induce fibrosi)
        -   No → trattare sse sintomi (HF/angina) -- e, nel caso, in
            funzione di EF
            -   EF conservata → βb, ca-ant, diruetici, ACE-ini
            -   EF ridotta → trattare HF, è quello il problema
                principale
    -   Rivalutare *minimo* annualmente

## Cardiomiopatia dilatativa

-   ***DCM*** --- dilatazione ventricolo sx + disfunzione sistolica
-   Patofisiologia
    1.  Allargamento del ventricolo
    2.  Assottigliamento della parete
    3.  **↓ contrattilità e ↓ CO**
-   Ez.ologie . Forme familiari
    -   Miocarditi
    -   Diminuito svuotamento ventricolare
-   SeS
    -   SeS cardiaci aspecifici ma suggestivi di bassa portata (dispnea
        riposo/sforzo/notturna/posizionale, congestione sistemica ed
        astenia)
    -   Aritmie (per danneggiamento architettura del miocardio (tipico.
        BB (sx\>dx) ipertrofia ventricolare, anomalie di
        ripolarizzazione9
    -   raro ECG ndr
-   Tp.: gestire il corrispondente grado di scompenso (HFrEF)

## Cardiomiopatia aritmogena del ventricolo destro

-   Aritmogena: FV/TV (male!)
-   Fisiopatologiea
    -   Sostituzione fibroadiposa del miocardio (tanto che in rep.
        autoptici si vede una parete molto ben trans--illuminabile)
-   Clinica
    -   Scompenso destro e contrattilità scoordinata (ventricolo
        dilatato per tessuto fibroadiposo)
    -   ECG: precordiali atipiche (onde ε, BBdx)
-   trattamento
    -   Scompenso dx, capitan ovvio
    -   Prevenzione aritmie (ICD)

## Cardiomiopatia restrittiva

-   Fisiopatologia
    -   Ventricolo ristretto, rigido e poco compliante (⇐ amiloidosi,
        difetti congenici, patologie acquisite...)
    -   Deficit di riempimento (riempimento solo nella primissima fase
        della diastole, poi il cuore non si riempie più)
-   Clinica
    -   scompenso dx (perché ho deficit di riempimento, quindi tutto si
        ripercuote a monte)
    -   ECO: riduzione del riempimento delle camere + aumento
        *simmetrico* dello spessore di parete (differenza con HCM in cui
        l'ispessimento è focale!)
    -   ECG: tendenzialmente bassi potenziali
-   Terapia
    -   di supporto
    -   sse eziologia è amiloidosi: `patisiran` (inibisce la produzione
        di transtiretina (proteina amiloidogena) quindi incoraggia lo
        smantellamento e evita accumulo). Efficacia dopo \> 1aa di tp.

# Patologie aortiche

## Introduzione

![](img/segmenti-aorta.png) 

## Acute Aortic Syndrome

-   La sintomatologia è simile per tutta la patologia aortica
    -   Dolore toracico (spesso iperacuto, spesso irradiato,
        caratteristicamente *migrante* verso il basso mano a mano che
        patologia prosegue)
    -   SeS orientativi di shock o AHF
-   Imaging è *chiave* nella patologia aortica
    -   Eco trans--toracico (TTE) bedside: top come primo livello
    -   Eco trans--esofageo (TOE)
    -   ⭐️ TC/**AngioTC** con mdc (attenzione all'opportunità del mdc)
    -   MRI (se AngioTC impraticabile)
    -   Metodiche cruente (poco usate, primariamente) come angiografia

> Chiediamoci: quali sono i grandi big miss che non vuoi mancare se non
> vuoi che il tuo paziente finisca al camposanto? Facile:
>
> -   Embolia polmonare
> -   Infarto
> -   Patologie aortiche

-   3 sindromi aortiche acute, che sono l'una l'evoluzione dell'altra
    1.  Ematoma intramurale
    2.  Dissezione della tonaca media
    3.  Ulcerazione della parete dissecata *oppure* della placca
        aterosclerotica che si approfonda fino a rottura

### Intramural Aortic Haematoma (IAH)

-   ***Ematoma intramurale*** --- ematoma secondario a emorragia nella
    parete aortica *senza* rottura dell'intima; dovuto a stravaso dei
    vasa vasorum
-   Raro (\~10--20% delle sindromi aortiche)
-   La diagnosi deve essere di esclusione: bisogna sicuramente escludere
    la dissezione con angioTC con mdc (nella quale l'ematoma si
    evidenzia bene[^80]
-   Terapia: osservazionale e di supporto
    -   Obiettivo: ↓ PA per permettere una scomparsa + riassorbimento
        dell'ematoma (`vasodilatatori`)
    -   Gestione dei sintomi (dolore, funzione renale, funzione
        respiratoria, neurologica...)
-   Possibile evoluzione in dissezione o rottura transmurale!!
    -   Se rottura è vicino a spazio pleurico: generalmente non
        catastrofica, ma si perdono fino a 2 lt per emotorace
    -   Se rottura è in pericardio: merda merda (tamponamento → morte
        improvvisa)

### Penetrating Atherosclerosis Ulcer (PAU)

![](img/pau.png)

-   Dx: angioTC mdc
-   Gestione: come IAH, solo successivamente se permane sospetto di
    rottura si ricorre ad approccio intravascolare

### Acute Aortic Dissection (AD)

-   Epidemiologia: 2.9/100k/anno
    -   Area metropolitana bolognese: \~10
    -   Frequente in 6/a e 7/ma decade
-   Mortalità alta: +1%/h pre-diagnosi/trattamento ⇒ bisogna
    riconoscerla precocemente!
-   Fattori di rischio
    -   Valcola aortica bicuspide (presente in 5--7% delle dissezioni)
    -   Ipertensione
    -   Ipercolesterolemia (ateroma → ulcera → dissezione)
    -   Cocaina
    -   Traumatismi toracici
    -   Coartazione aortica[^81]
    -   Gravidanza (rarissimo[^82])
    -   Patologie
        -   ⭐️ ***medionecrosi cistica***[^83]
        -   Patologie del connettivo (marfan, Turner, arteriti...)
        -   ***Feocromocitoma***

#### Classificazione

-   Secondo il tipo di dissezione

    ![](img/classificazione-dissezione-aortica.png)

-   Secondo il tempo di insorgenza

    -   Acuta (\< 2 settimane). Abbondante maggioranza
    -   Cronica (\> 2 settimane). Mortalità molto alta (75--80%)

#### Clinica

-   SeS
    -   Dolore iperacuto migrante (96%) e a volte irradiato (descritto
        come "lacerante", "a lama di coltello", "acuto")
        -   Raramente il dolore di presentazione è pleuritico; se questo
            è il caso pensare a pericardite acuta da irritazione per
            sangue nello spazio pericardico. Rischio di tamponamento
            dietro l'angolo
        -   Non presente in forme croniche
        -   La migrazione rispecchia il proseguire della patologia
    -   Possibili segni da conseguenze della dissezione
        -   Eventi neurologici (sincope, neuropatie, paraplegie...) da
            ostruzione di arterie
        -   CHF (7%) da insufficienza valvolare aortica
        -   Tamponamento cardiaco ± ACR
        -   Ischemie dei distretti serviti dai vasi ostruiti (miocardio
            se coronarie, renale se aa renali, mesenterica, aa inf)
    -   Anisosfigmia dei polsi (PA va misurata in polso con intensità
        maggiore, altrimenti si registra una pseudoipotensione dovuta ad
        ostruzione prossimale). presenza del segno incostante
    -   Ipertensione
    -   Ipotensione
    -   Soffi da insufficienza valvolare (\~ 30%)
    -   Masse pulsanti
    -   Versamenti pleurici monolaterali a sx
    -   Segni di compressione di strutture del mediastino (ostruzioni
        respiratorie, cambiamenti in tono della voce, raucedine,
        disfagia)
-   ECG: da ndr a STE
-   Imaging (**richiederla sempre**)
    -   RX: segni di dilatazione del bulbo aortico (solitamente tipico
        di dissezione cronica, la dilatazione in fase acuta potrebbe non
        avere tempo di avvenire)
    -   **ECO** (specialmente TE): si riesce a vedere vero lume da falso
        lume, specialmente visualizzando il flusso con effetto Doppler
    -   ⭐️ AngioTC mdc: si vede bene il flap intimale, di solito
    -   Aortografia (cateterizzazione dell'aorta) evidenzia una zona di
        restrizione da mdc

> **Angiotac è TOP: permette di fare il ROUT/RIN (sebbene con diversa
> sp/sn) di SCA, EP, dissezione aortica. Ecco perché l'imaging in questi
> contesti, spesso incerti, è fondamentale**

#### DDx

-   Dolore toracico
    -   **IMA**
    -   **EP**
    -   **PNX**
    -   Rottura esofagea
-   Dolore addominale
    -   Colica renale
    -   Ostruzione intestinale
    -   Ischemia mesenterica
-   Dolore schiena
    -   Colica renale
    -   Problemi msk (erniazione disco intervertebrale, dolore msk
        generico)
-   Deficit di polso
    -   Ostruzioni non da dissezione
    -   Fenomeni embolici
-   Deficit neuro focali
    -   CVA
    -   Cauda equina

#### Terapia

-   Imperativo Capire se la dissezione è di tipo A o B, per capire come
    conviene procedere

    ![](img/mortalita-management-ad.png)[^84]

    -   **Trattamento medico** (particolarmente se non ci sono SeS
        orientativi di rottura)
        -   **Vasodilatatori** → ↓ PA e ridurre lo stress sul vaso
    -   **Trattamento chirurgico** (particolarmente se ci sono SeS
        orientativi di rottura o di non sufficiente efficacia del
        trattamento conservativo)
        -   Sostituzione del segmento di aorta con ch vascolare (con
            tanto, se necessario, di reimpianto dei vasi
            epiaortici/strutture valvolari sulla protesi)
        -   NB: diversa invasività spiega anche differente mortalità
            -   Tipo B → endovascolare
            -   Tipo A → toracotomia

-   Mantenere situazione continuamente monitorata per valutare se ha
    senso passare all'altro approccio di trattamento

# Miocarditi

-   ***Miocardite*** --- infiammazione del miocardio
-   3 Eziologie principali 1.Infettiva - Virali (Coxackie, virus
    influenzali, RSV, CMV, EBV, ZVZ, HCV, Dengue, adenovirus) - Da altri
    morg -- batteriche, fungine, protozoarie, parassitarie (molto,
    molto, mooooolto rare \~ 1%)
    -   Non infettiva

    2.  Da tossici (chemioterapici, metalli pesanti, radiazioni, ormoni)
    3.  Immunomediata
        -   Vs allergeni
        -   vs alloantrapianti
        -   vs autoantigeni
-   Patogenesi
    -   Fase acuta
        0.  Danneggiamento del miocardio per varia eziologia
        1.  Esposizione di antigeni dei miocardiociti, precedentemente
            nascosti
        2.  Attivazione di una risposta adattativa (T + B)
            -   Vs agente/morg eziologico (che risolve)
            -   Vs self esposto a causa dei danni ai miocardiociti
    -   Fase cronica
        3.  Risposta immunitaria perdura e cronicizza
        4.  Mentre eziologia viene eliminata, permangono i danni e la
            risposta vs self
-   Clinica *molto eterogenea*[^85]
    -   Dolore acuto precordiale di tipo pericarditico (e non
        francamente cardiaco)
    -   SeS cardiaci aspecifici (dispnea, astenia, segni di HF di
        gravità variabile lieve/grave)
    -   ± aritmie, ± cardiopalmo
-   Diagnosi
    -   ECG (bassi potenziali, tachiaritmie, alterazioni ST
        *diffuse*[^86] possono indicare interessamento del pericardio)
    -   cTn (↑)
    -   Imaging con eco (ipocinesia di parete, camere di dimensione
        conservata) e **RM** (mette in evidenza aree di edema
        infiammatorio in solo alcune porzioni del tessuto miocardico)
    -   **Biopsia endomiocardica** transcatetere (dimostrazione)
        -   Presenza di infiltrato infiammatorio, con leucocitosi \>
            14/mm^2^ (criterio istochimico)
        -   Evidenza istologica di danno *non ischemico* dei miociti
            (criterio istologico)
-   Stratificazione del rischio dei pz. con dx
    -   Rischio basso → EF preservata
    -   Rischio intermedio → ↓ EF + sintomi lievi/moderati di HF
    -   Rischio alto → ↓↓ EF ± aritmie ± segni di grave HF
-   Tp.
    -   Rischio basso--intermedio
        -   Tp. convenzionale per gestire HF, che è problema principale
    -   Rischio alto
        -   Gestione aggressiva dello scompenso
        -   Tp. immunosoppressiva (`prednisone` ad alte dosi +
            `azatiopina`)

# Endocarditi infettive

-   ***Endocardite*** --- infiammazione dell'endocardio, cioè dello
    strato più interno al cuore. Eziologia microbiologica (a prevalenza
    fungina/batterica a seconda della popolazione e dei fattori di
    rischio)

## Patogenesi

0.  Batteriemia asintomatica, e solitamente inosservata
1.  I morg si stabiliscono su minuscole **formazioni microtrombotiche**
    (tipicamente a livello dell'endocardio vascolare)
    -   Essenziale che ci siano le condizioni per formazioni
        microtrombotiche
        -   Turbolenza di flusso (⇐ difetti valvolari, stenosi vasi...)
        -   Danno endoteliale
        -   Danno endocardico/valvolare (⇐ cardiopatia, difetti cardiaci
            congeniti)
2.  I morg si replicano producendo strutture più organizzate
    ("**vegetazioni**")

## Eziologie

-   A seconda di zona di provenienza (comunità vs ospedale), rischi
    (tossicodipendente, immunodepresso...), stato valvolare (valvole
    proprie, valvole prostetiche)

1.  Streptococco (56%)
2.  Stafilococco (25%)
3.  Gram^-^ (6%)
4.  Funghi (1%)
5.  Colture negative (10%)

## Clinica

-   Molto eterogenea, ma tipicamente perdura (non rapida risoluzione)
    -   Febbre (90%)
    -   Soffi cardiaci (85%)
    -   Eventi embolici (20%)
        -   Tia
        -   Emboli settici (es: polmonite)
    -   Segni classici (oggi rari, diagnosi precoce)
        -   Emorragie subungueali o nelle dita
        -   Macchie nel fundus oculi
        -   Glomerulonefrite
-   Lab
    -   ↑ indici infiammatori (PCR, VES, leucocitosi)
    -   ± anemia, ematuria

## Diagnosi {#diagnosi-1}

-   3 pilastri diagnostici per diagnosticare endocardite

    1.  Alterazioni eco (testimoniano alterazioni EOCV)
    2.  Febbre
    3.  Emocolture positive

-   Per oggettivare la diagnosi, dopo che SeS suggeriscono endocardite:
    **criteri di Duke**

      Criteri positivi                            Conclusione
      ------------------------------------------- -------------
      2 maggiori, 1 maggiore 3 minori, 5 minori   Diagnosi
      1 maggiore e 1 minore, 3 minori             Possibilità
      Diagnosi alternativa che spiega quadro      Esclusione

    -   Criteri maggiori
        -   Emocolture positive per batteri associati ad endocardite (≥
            2 su 3, OPPURE 1 su 3 *e* IgG contro morg colturato)
        -   Emocolture permangono positive nonostante abx per morg
            tipici dell'endocardite
        -   All'eco/PET/CT: vegetazioni intracardiache o altre lesioni
            suggestive
    -   Criteri minori
        -   Predisposizione all'endcardite
            -   Pz. con materiale protesico all'interno del cuore
                (valvola artificiale, patch per chiudere difetti di
                parete, presenza di condotti o cavi)
            -   Pz. che hanno già avuto endocardite
            -   Pz. con cardiopatie congenite (sopratutto se cianogene)
        -   Febbre \> 38
        -   Fenomeni embolici
        -   Fenomeni immunologici (glomerulonefrite, fenomeni
            vasculitici)
        -   1/3 emocolture + (e non IgG)

-   Se diagnosi è possibile oppure esclusa ma il sospetto non fuagato
    del tutto si prosegue con imaging di secondo livello

    -   Ripetere eco o eco TE
    -   TC torace (ascessi si vedono meglio
    -   PET

-   Eventualità possibile: riscontro di vegetazioni durante cardioch per
    altra natura (criterio "anatomopatologico")

## Trattamento

-   Due strategie terapeutiche, non mutualmente esclusive (spesso abx →
    ch, oppure solo una delle due in funzione di gravità + r/b)
    1.  Abx e/v (basato su colture + antibiogramma)
    2.  Ch
        -   Da preferire in
            -   Scompenso non controllabile (sopratutto se insufficienza
                valvolare acuta) -- se è controllabile allora rimandiamo
                un filo l'intervento (ma poco) giusto il tempo di
                prolungare la abxtp qb per ridurre/eliminare carica morg
            -   Infezione non controllata (ascessi, falsi aneurismi,
                fistole) in quanto si creano colonie in cui la MIC non è
                raggiungibile
            -   Se c'è un concreto rischio di emboli settici
                (vegetazioni molto grandi \[\> 1.5cm\] o grandi \[1cm\]
                con difetti valvolari o con già episodio embolico)
-   Essenziale profilassi in dose singola[^87] in tutti i pz. a rischio
    (che hanno predisposizione all'endocardite (vedi criteri diagnostici
    minori) in particolari situazioni di rischio
    -   Durante procedure odontostomatolotiche (IIA, C)
    -   Igiene dentale
    -   A seguito di ferite che vanno disinfettate
    -   In caso di infezioni croniche cutanee
    -   Piercing o tatuaggi sono scoraggiati
-   Se emocoltura neg (e si ha alto sospetto/certezza che sia
    endocardite \[pes per vegetazioni all'eco\]) si usano tp. ad ampio
    spettro in funzione dello stato valvolare (naturale
    \[`vancomicina` + `gentamicina` + `ciprofloxacina`\] vs protesico
    \[abxx aggressivi\])

```{=html}
<!-- Docente: Stefano Nava -->
```
```{=html}
<!--
risorse consigliate da Nava

- Da leggere
    Atul Gawande
        Better
        The Checklist
        Being Mortal
        Complications
    Jerome Groopman
        How doctors think
    Samuel Shem
        La casa di Dio
    - Codice di deontologia medica (ITA)
    - Ethics, attitude & practice in endo of life care decision: an EU perspective (Nava)
    - Compliance, Adesione, Aderenza (G Majani)

- Da vedere
    - Un uomo, Un medico
    - Patch Adams

- Da cercare
    - Come disporre anticipatamente della volontà sui trattamenti e il fine vita? Quadro medico-legale ita

-->
```
# Come mai ci ammaliamo?

-   Fattori di rischio per patologie respiratorie -- e trasversali
    -   Fumo di sigaretta
    -   e-cigarettes (particolarmente nei giovani!)
    -   Inquinamento ambientale (aria + acqua + suolo)[^88] e [materia
        particolata](https://it.wikipedia.org/wiki/Particolato). Studi
        dimostrano che insorgenza di patologie respiratorie sono legate
        con vicinanza a strade a grande traffico
        -   Particolato
            -   PM~10~ → sedimenta tratto respiratorio superiore ⇒
                infiammazione delle vie di conduzione
            -   PM~2.5~ → penetra profondamente fino agli alveoli
            -   PM~0.1~ → ↑ cancro e patologie cardiache
        -   Produzione di inquinanti specifici a seconda delle attività
            -   NO~2~, Biossido di azoto (motori a combustione e
                traffico veiolare) --- bronchite, tracheite, asma +
                cronicizzazione
            -   SO~2~, Biossido di zolfo --- principalmente
                manifestazione croniche
            -   CO
    -   Inquinamento domestico[^89]
    -   Rischio lavorativo
        -   Esposizione all'amianto
        -   Esposizioni a fumi derivanti da errato (o doloso)
            smaltimento di sostanze
        -   Esposizione a sostanze tossiche senza appropriati DPI
    -   Obesità
        -   ↑ resistenze polmonari
        -   ↑ lavoro respiratorio
        -   OSAS (⇒ ↓ pO2)
        -   Scambi alterati cronicamente ⇒ alterazione V/Q
        -   ↑ rischio CV
    -   Infezioni
        -   TBC come "capitano tra le cause di morte"
            -   Ceppi multiresistenti presenti in 63 paesi
            -   1/3 della popolazione mondiale è infetto
    -   Tenore sociale
        -   ↓ tenore sociale ⇔ ↑ mortalità in malattie non comunicabili
    -   Predisposizione genetica

```{=html}
<!-- ven 5 mar 2021, 14:19:49, CET -->
```
# Asma

-   ***Asma*** --- patologia infiammatoria cronica delle vie aeree in
    cui si ha una ostruzione **reversibile** delle stesse
    -   Abbondante ruolo della componente cellulare
    -   Se individuo è *suscettibile*: infiammazione ⇒ broncospasmo,
        tosse e dispnea (\> notte e prima mattina)
    -   Infiammazione cronica può causare ↑ reattività bronchiale in
        risposta a stimoli esterni (fisici e chimici)
-   Asma è patologia molto eterogenea e multifattoriale[^90]
-   Prevalenza stimata: 5--10% della popolazione mondiale (\~ 300M
    persone)
    -   \> prevalenza in popolazione migrante (per nuova esposizione ad
        allergeni locali) e spesso + grave e mal controllato
        (tendenzialmente \> difficoltà di accesso alle cure e \< livello
        socioeconomico)
    -   Impatto su QoL: dipende
        -   Se ben curata: non invalidante
        -   Se non ben gestita: una buona % di pz. la ritiene una
            patologia che, in qualche aspetto di vita, ha impatto

## Presentazione clinica

-   Presentazione tipica:
    -   1 sintomo tra sibilo, dispnea, tosse, senso di costrizione
        > toracica

    -   Sintomi esacerbati notte/mattino
-   Intensità dei sintomi variabile nel tempo
-   Possibili fattori scatenanti
    -   ⭐️ Allergeni (sopratutto domestici[^91] ma non sottovalutare
        anche quelli ambientali[^92])
    -   Infezioni virali
    -   Inquinanti (ambientali, *professionali*[^93], fumo[^94]
    -   Sforzo
    -   Aria fredda
    -   Risata
    -   Esposizione ad irritanti (vapori, fumi, odori forti)
    -   Alcuni tipi di alimentazione comune in occidente
    -   Glutammato
    -   Allergeni

> **Sintomi che ↓ probabilità di dx di asma**
>
> -   Tosse cronica
> -   Espettorazione cronica
> -   Dolore toracico (massimo oppressione)
> -   Stridio inspiratorio (più indicativo di ostruzione)

### Fattori di rischio {#fattori-di-rischio}

-   Maggiori
    -   Predisposizione genetica
        -   Alterazione in geni per presentazione dell'antigene
        -   Alterazione in geni coinvolti in processi di flogosi
            bronchiale
        -   Alterazioni in geni per risposta ai farmaci
        -   Positional cloning
    -   Iperreattività ambientale
    -   Atopia[^95]
    -   Fattori ambientali
        -   Allergeni
        -   Sensibilizzanti professionali
        -   Fumo
        -   Inquinamento atmosferico
        -   Pregresse infezioni delle vie respiratorie (particolarmente
            nei primi anni di vita): rinovirus e virus respiratorio
            sinciziale
-   Minori
    -   Sesso, etnia, obesità
    -   Stress e fattori psicosociali (ansia, depressione)
    -   Ambiente correlato con peggiore stato di salute (fattori
        socioeconomici, dimensione nucleo familiare, abitudine
        alimentare, stile di vita, istruzione)
    -   Antibiotici ed antipiretici in età infantile
    -   Tp. ormonale sostitutiva
    -   Infezioni virali in primissima infanzia

## Fisiopatologia

-   Nella fisiopatologia dell'asma ci sono 3 attori principali
    1.  Infiammazione
    2.  Risposta del muscolo liscio all'infiammazione
    3.  Rimodellamento strutturale delle vie aeree e interazione delle
        vie aeree con il parenchima
-   **L'eziologia di base è, essenzialmente, infiammatoria**
    0.  Bronchi che dimostrano *instabilità* nella regolazione del tono
        motorio
    1.  Infiammazione delle vie aeree
    2.  Iper-reattivitò bronchiale (esagerata risposta broncocostrittiva
        a stimoli infiammatori)

## Classificazione dei vari tipi di asma

1.  Asma con risposta di tipo 2 (mediata dalla risposta di
    ipersensibilità di tipo 1 " = allergico")
    -   Early onset (atopico)
    -   Late onset (eosinofilo)
    -   Da esercizio fisico (EIA)
    -   Da insorgenze particolari
        -   Da `ASA`
        -   Perimestruale
2.  Asma con risposta di tipo non-2 (mediata da meccanismi non
    particolarmente noti)
    -   A principale componente neutrofilica
    -   A principale componente ??
    -   A componente mista

![](img/classificazione-asma.png) 

### Asma di tipo 2

-   **Risposta mediata da una risposta di ipersensibilità di tipo 1**
    -   TH~2~
    -   Eosinofili
-   Per la sua fisiopatologia spesso è associato ad eventi allergici o
    ad agenti stimolanti esterni

#### Early onset (atopico)

-   Storia con esordio precoce
    -   Esordio precoce (pz. ped o giovane)
    -   Storia di sintomi atopici o di familiarità per atopia
-   Clinica
    -   Sintomatologie da lieve a severa
    -   Allergeni che stimolano sintomi asmatici
    -   Associato a dermatite atopica, congiuntivite allergica
-   Biomarcatori
    -   ↑ IgE totali + per allergeni stimolanti
    -   Marcatori di infezione T~2~
-   Controllabile con steroidi

#### Late onset (eosinofilo)

-   Storia
    -   Esordio in età adulta (anche molto severo)
    -   Quasi mai sintomi atopici
    -   Storia di poliposi nasale, sinusite cronica
    -   Scarsa familiarità per asma o atopia
-   Clinica
    -   Spesso severo
    -   Esordio improvviso
-   Non controllabile con steroidi a dosaggi consueti, eosinofilia
    rimane; necessari dosaggi elevati o addirittura è non responder

#### Da esercizio fisico

-   Storia
    -   Possibile atopia
    -   Insorgenza chiaramente riferita ad un evento in cui pz. si è
        sforzato
-   Clinica
    -   Spesso compresenza di asma lieve/moderato
-   Biomarcatori
    -   Non disponibili
-   Risposta
    -   Buona risposta a `β2-agonisti` e `anti-leucotrienici`

#### Asma con insorgenza particolari

##### Asma da aspirina

-   Storia
    -   Allergia all'`asa`
-   Clinica
    -   Esordio molto acuto
    -   Grave peggioramento se assunta ASA
-   Risposta
    -   Scarsa a steroidi inalatori
    -   Necessari steroidi ad alte dosi o addirittura adrenalina

##### Asma perimestruale o da gravidanza

-   Donna asmatica *può riferire* peggioramento in
    -   Periodi premestruali
    -   Gravidanza

##### Asma da esposizione professionali

-   2 forme
    -   Con latenza → necessario periodo di esposizione ad agente
        causale per produrre sintomi
    -   Senza latenza → i sintomi compaiono immediatamente con
        l'esposizione all'agente causale (ggeneralmente grandi
        irritanti/tossici diretti dell'epitelio)
-   Più a rischio
    -   Panettieri
    -   parrucchieri
    -   Addetti alle pulizie
    -   Veterinari, allevatori
    -   Lavoratori del settore secondario

### Asma di tipo non-2

-   **Risposta mediata da meccanismi non legati ad allergeni specifici**
    -   Mediata da neutrofili ("meccanismo neutrofilico")
    -   Mediata da broncoreattività senza segni clinici ("meccanismo
        pauciranulocitario")
    -   Mediata da meccanismi misti tra le due situazioni
-   Caratteristico esordio in età adulta
-   Correlato maggiormente con obesità

#### Asma da obesità

-   Storia
    -   F \> M
    -   Esordio in età adulta
-   Clinica
    -   Spesso obesità
    -   Minima atopia
    -   Molto sintomatici
-   Biomarcatori
    -   Non chiaro

## Diagnosi {#diagnosi-2}

![](data:image/png;base64,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)

### Test di broncostimolazione

-   Ok sse VEMS ≥ 80% (altrimenti chiudo bronchi già ostruiti e lo mando
    al camposanto)
-   Quantificazione dell'asma: valuto quanta `metacolina` (agente
    irritante) è necessaria a ridurre del 20% il VEMS (PD~20~)

  PD~20~          Classificazione
  --------------- -----------------
  \< 100 ug       Grave
  100÷400 ug      Moderata
  400 ÷ 1600 ug   Lieve
  \> 1600 ug      Normale

-   Diagnostico se alta prob pretest: è test positivo anche in pz. con
    CHF che hanno bronchi infarciti di liquido (e per questo iperattivi)

### Test di broncodilatazione

-   Naturalmente se spirometria evidenzia ostruzione non posso fare un
    test che potrebbe chiudere i bronchi, o ammazzo il paziente ⇒ test
    di broncodilatazione (con `salbutamolo`, β2-agonista
    broncodilatatore)
-   Se ho broncodilatazione marcata (miglioramento dei flussi \[↑ VEMS
    e/o FVC ≥ 12%\] e della geometria della curva dopo 15' da
    salbutamolo) mi posso aspettare anche una bronco-costrizione marcata
    ⇒ asma (se pretest prob era alta)

### Valutazione dei fattori di rischio

-   Valutare rischio allergologico
    -   **Prick test** per identificare allergie (I livello)
    -   Dosare le IgE (II livello, molto costoso!) per avere
        quantificazione
        -   Sierologia delle IgE totali (test PRIST)
        -   Sierologia delle IgE specifiche (test RAST)
-   Rinite o rinosinusite? (↑)
-   GERD? (↑)
-   Intolleranze a farmaci o alimenti?
-   Esposizione ambientale?

## Terapia

![](img/asma-terapia-linee-guida.png) 

-   La terapia generale per l'asma si fonda su 3 pilastri
    1.  `β2-agonisti` (broncodilatatori)
        -   Long acting (`laba`) --- \~ 12h
        -   Short acting (`saba`) --- \~ 4--6h
    2.  Steroidi **inalatori** (immunomodulanti)
        -   Terapia con aerosol è il top
            -   concentrazioni locali

            -   ↓ farmaco in circolo ⇒ \< effetti collaterali

            -   Non effetto epatico

            -   Non problemi di assorbimento
        -   Spiegare bene la tecnica di inalazione!
    3.  Eventualmente anti--colinergici
        -   Long acting (`lama`)
        -   Short acting (`sama`)
-   Per scegliere la terapia: 3 fasi
    1.  `saba` al bisogno
    2.  Definire la gravità! 5 step (valutare, secondo linee guida:
        sintomatologia + attacchi notturni + ↓ FEV~1~)
        1.  Asma intermittente
        2.  Asma lieve persistente
        3.  Asma moderato persistente
        4.  Asma grave persistente
        5.  Asma molto grave
    3.  Valutare una terapia anti-infiammatoria a seconda dello step di
        gravità per prevenire eventi acuti gravi
        -   Se lieve/intermittente → tentativo di tp. al bisogno
            (`β2-agonisti`, non per forza laba + `steroidi` inalatori)
            -   Valutare allergie! Ha senso tp. antistaminica? Magari
                stagionale?
        -   Se persistente → tp. cronica (`laba` + `steroidi` inalatori
            a dosi basse)
        -   Se grave → tp. cronica con dose medio/alta + considerare
            anticolinergici
        -   Se asma totalmente refrattario a tp. convenzionale →
            considerare farmaci biologici (Ab monoclonali anti IgE)
-   Considerare rapidamente cambiamenti additivi se riacutizzazione
    -   Distinguere una riacutizzazione da un asma che viene male
        controllato
        -   Il pz. è compliante alla tp.? Se sì sospettiamo
            riacutizzazione
        -   Ci sono state esposizioni a fattori che possono produrre
            riacutizzazzioni?
    -   Se riacutizzazione lieve/moderata spesso si può controllare con
        aumento della dose
    -   Ospedalizzazione se *riacutizzazione grave*
        -   Monitoraggio sopratutto nelle prime fasi

### Terapia per asma grave refrattario

-   `omalizumab` (ab. anti IgE)
-   `mepolizumab` (ab. anti IL5 ⇒ spegne eosinofili)

# Polmoniti

-   ***Polmonite*** --- processo infiammatorio a carico del parenchima
    polmonare, solitamente sostenuto da batteri, virus, funghi o
    protozoi
-   Alcune criticità nella gestione
    -   Diffusa
    -   Fatale in popolazioni a rischio (non in fascia 5 ÷ 70aa)
    -   Non facile classificazione eziologica, e problema delle
        resistenze
    -   Difficile staging gravità
    -   (Facile diagnosi)
-   Linee guida: @waterer_management_2011

### Classificazione

-   Clinica
    -   (\>) Acquisita in comunità (CAP)
    -   Acquisita in ospedale (HAP) --- dopo \> 48h da ricovero e non
        presente all'ingresso
        -   Associata a lungodegenza (HCAP[^96])
        -   Associata a ventilazione (VAP)
-   Anatomo--patologica
    -   Lobare
    -   Broncopolmonite
        -   Interessamento **albero bronchiale + parenchima**
        -   Tipica sg. defedati o con \< competenza immunitaria
        -   Sostenuta da batteri
            -   Gram + : Stafilococco, Streptococco, Legionella
            -   Gram - : Haemophilus, Pseudomonas, E coli, Klebsiella
            -   Anaerobi
    -   Interstiziale
        -   Interessamento principalmente dell'interstizio (interstizio
            alveolare, connettivo attorno all'albero bronchiale, pareti
            alveolari)
        -   Sostenuta da
            -   Batteri: Micoplasma pneumonie, Clamidia, Legionella,
                Coxiella burneti
            -   Funghi
            -   Virus: Sars-CoV-2

#### CAP

-   2 forme
    -   Tipica → lobare
        -   *Streptococcus pneumoniae* (35%)
        -   *Haemophilus influenzae*
        -   *Moraxella catharralis*
        -   *Micoplasma pneumoniae*
        -   *Chalmidia pneumoniae*
        -   *Legionella pneumofila*
        -   *Pneumocystis carinii*
    -   Atipica → interstiziale \> lobare
        -   Neisseria meningitidis
        -   Klebsiella pneumonae
        -   Staph aureus
        -   H1N1
        -   Adenovirus
        -   VRS
        -   SarsCov2

                    CAP tipica              CAP atipica
  ----------------- ----------------------- -------------------------
  Anamnesi          Esordio brusco          Esordio lento
  Rx                Alveolare/lobare        Interstiziale
  EO                Addensamento            Sfumati o assenti
  Età               Tutte                   Prevalentemente giovani
  Dolore pleurico   Spesso                  Raro
  Leucociti         \> 10K--12K             Normale
  Espettorato       Purulento o rugginoso   Mucoide

#### HAP

-   Insorgenza early onset vs late onset
    -   Precoce (\< 4gg da ricovero): maggiore probabilità di patogeni
        sensibili
    -   Tardiva (\> 5 gg da ricovero): maggiore probabilità di multi
        drug resistance
-   Principali agenti che sostengono le HAP
    -   Pseudomonas aeruginosa
    -   Klebsiella pneumoniae
    -   Enterobacter
    -   Serratia
    -   Acinetobacter
    -   Stenotrophomonas maltophilia
    -   MRSA (sopratutto USA)
    -   Streptococcus penumoniae (ma molto più tipico di CAP)
    -   Hemophilius influenzae
    -   Legionella pneumophilia
    -   Funghi e virus

#### HCAP

-   Polmoniti in pz.:
    -   con ricovero \< 2gg nei 3 mesi antecedenti
    -   degente in casa di cura
    -   in pz con abx e/v, chemiotp, medicazione in 30gg antecedenti
    -   pz. che frequenta H
    -   emodialisi
-   Eziologie principali
    -   Polmoniti da aspirazione (!!) e ab ingestis
    -   Strepto pneumoniae

## Clinica

-   **Sintomi tipici**
    -   Polmonari --- dispnea, tachipnea, tachicardia, ridotta
        espansibilità, ↑ FVT, ottusità plessica, soffio bronchiale,
        crepitii, sibili, sfregamenti pleurici
    -   Altro --- febbre ± brivido, tachicardia, shock. Nell'anziano:
        stato mentale alterato
-   **Sintomi atipici** (aspecifici) --- cefalea, nausea, vomito,
    diarrea, mialgie, atralgie, astenia, herpes labialis (segno di
    immunodepressione)

### Diagnosi {#diagnosi-3}

-   Esami del sangue
    -   Leucocitosi o lecuopenia (a seconda dell'ezioologia
    -   Iperglicemia, iponatremia, ipofosfatemia
    -   ↑ indici di flogosi (PCR e VES) e anche indici di danno GOT,
        GPT, CK, LDH
-   EGA
    -   Ipossiemia e/o insufficienza respiratoria (tipo 1 e/o 2)
    -   Attenzione: possibile alcalosi respiratoria se pz compensa con ↑
        FR (mascherando falsamente i valori!)
-   ⭐️ **Imaging Rx (CXR)**
    -   Non si può (statisticamente) fare diagnosi solo con EO
-   Metodiche diagnostiche per capire agente patogeno (nel 60% dei casi
    l'eziologia rimane sconosciuta)
    -   Non invasive (da preferire assolutamente se sospetto polmonite!)
        -   Esame espettorato con coltura
            -   1--2 ml di escreato emesso spontaneamente
            -   Al mattino a digiuno, con bocca sciacquata con
                cloroxidina per evitare contaminazioni
            -   Consegna entro 2h, conservato a 4°C
            -   Molto face rischio di contaminazione
            -   Segue esame colturale (indicazione pereliminare a 1gg,
                negatività a 2 gg, positività a 3 gg (tardissimo! tp. va
                cominciata in poche *ore*!)
        -   Emocoltura
            -   Non ha molto senso (non è significativo) in sg. con
                febbre bassa (\< 38°C) o senza sintomatologia importante
            -   Se si fa, se ne fanno almeno 3 seriate a distanza di
                15--30 min
            -   Spesso ci sono interferenze
                -   Stafilococcus epidermidis o contaminazione da flora
                    batterica cutanea
                -   Antibiotico terapia (emocoltura *prima*)
        -   Sierologia
        -   Ricerca *degli antigeni* nelle urine
            -   Esame di 1/o livello, molto affidabile e provante
            -   Di fatto ha senso sempre, anche se si ricerca solo per
                staph e legionella
                -   Staphilococcus pneumoniae (*ottimo* in CAP/polmoniti
                    lobari)
                -   Legionella (rara, ma se c'è è grave e bisogna
                    riconoscerla in tempo!)
            -   Preferibilmente primo mitto
            -   Può essere conservato per 48h a temperatura ambiente
    -   Invasive
        -   Broncoaspirato/BAL con coltura
            -   1 ml di materiale recuperato da aspirazione tracheale

            -   Consegna entro 2h

            -   Sempre possibili (anche se molto meno di esame
                dell'escreato) contaminazioni e/o falsi negativi da tp.
                antibiotica

#### Trattamento

-   Abx appropriato se eziologia batterica, antifungino se eziologia
    fungina, di supporto sintomatico (± tp. antivirale) se ez virale
-   **Abx entro prime ore da dx riduce sensibilmente la mortalità!**
    Iniziare senza indugio abxtp empirica (anche perché resa diagnostica
    dei vari test non sempre è ottimale)
-   Ogni addensamento polmonare può nascondere altre patologie (es
    tumore), quindi followup dove appropriato
-   Diagnostica eziologica non invasiva eseguita sempre, anche se \> 50%
    non sarà conclusiva

##### Staging della gravità

-   È complicato valutare la gravità e stabilire la prognosi

-   Ci sono alcuni indici per lo staging e stratificare la prognosi
    (PSI, CURB65, CRB65)

      Symptom                             Points
      ----------------------------------- --------
      **C**onfusion                       1
      B**U**N\>7 mmol/L (19 mg/dL)[^97]   1
      **R**espiratory rate≥30             1
      **B**P: S\<90mmHg, D≤60mmHg         1
      Age≥**65**                          1

-   Per decidere cosa fare ha più senso una valutazione clinica

    -   Criteri minori (almeno ammissione)
        -   Tachipnea (spesso compensatoria!)
        -   PaO~2~ \< 60 mmHg o SpO~2~ \< 92%
        -   Focolai multipli
        -   Disorientamento
        -   Leucopenia
        -   Trombocitopenia
        -   Urea \> 20 mg/dl
        -   Ipotermia (abbiamo infezione, ci dovrebbe essere febbre!)
        -   Ipotensione che necessita fluidi
    -   Criteri maggiori (ricovero in TI)
        -   Shock settico
        -   Ventilazione meccanica

# BPCO

> **Quantificare consumo di sigarette**
>
> **Anni pacchetto** =
> $\frac{\text{sigarette al giorno}}{\text{sigarette in un pacchetto (=20)}} \cdot \text{anni di fumo attivo}$
>
> Intuitivamente: 1 anno--pacchetto identifica la quantità fumata da un
> fumatore che, per un anno, fuma un pacchetto al giorno ⇒ indice mi
> dice quanti anni di fumo ha fatto un fumatore se, data la sua quantità
> di sigarette giornaliere, fumasse un pacchetto al giorno

-   ***BPCO*** (BroncoPneumopatia Cronica Ostruttiva, anche COPD[^98])
    --- patologia cronica, a progressione tendenzialmente lenta, che
    provoca **ostruzione al flusso aereo** per un coinvolgimento
    **irreversibile e progressivo del parenchima e/o delle vie aeree**
    -   **Ostruzione del flusso ⇒ ↓ Tiffenau**

        $$ Tiffenau = \frac{FEV_1}{FVC}$$
-   Fattori di rischio
    -   Legati al sg.
        -   Genetici (α1-antitripsina)
        -   iperreattività bronchiale
        -   Patologie polmonari della periparto/primissima/prima
            infanzia
    -   Legati all'ambiente
        -   Fumo
        -   Rischio professionale
        -   Inquinamento
        -   Infezioni
        -   Stato socioeconomico

## Epidemiologia

## Fisiopatologia

![](img/fisiopat-bpco.png)

![](img/fisiopatbpco2.png)

-   Raramente BPCO si presenta da sola. Spiegazione: infiammazione è
    trigger per altre patologie (in 1/4 BPCO sono presenti ≥ 4
    comorbidità)

### Fenotipi anatomopatologici di pz. BPCO

-   A seconda del *prevalente* interessamento (vie aeree o parenchima)
    individuiamo due fenotipi di BPCO
    1.  Fenotipo bronchitico, anche "blue bloater" (bronchiolite cronica
        fibrosante → bronchite cronica
    2.  Fenotipo enfisematoso, anche "pink puffer"
        a.  Enfisematoso puro (enfisema **pan**lobulare)
        b.  Bronchitico + enfisematoso (bronchiolite cronica fibrosante
            → bronchite cronica → enfisema **centro**lobulare)

#### Fenotipo bronchitico

0.  Situazione predisponente: interessamento infiammatorio delle *vie* e
    non del parenchima
    -   Bronchiolite cronica → bronchite cronica
        -   **Bronchiol**ite cronica --- tosse produttiva per \> 3 mesi
            per almeno 2 anni consecutivi in assenza di altra causa.
            Interessa le vie \< 3mm
        -   **Bronch**ite cronica --- interessamento delle vie \> 3mm
    -   Tono broncomotore spiccto
    -   Depositi di muco intraluminali (bronchiolite/bronchite)
1.  Diminuzione del lume delle piccole vie aeree
2.  Distribuzione non omogenea dell'inspirato, che segue le vie a minor
    resistenza
3.  Alterato rapporto V/Q

#### Fenotipo enfisematoso puro (enfisema panlobulare)

0.  Situazione predisponente: interessamento principale del *parenchima*
    e non delle vie, spesso presente concomitante deficit di
    α1-antitripsina[^99]
1.  Distruzione generalizzata del parenchima elastico (setti alveolari e
    strutture di ancoraggio che distendono le vie aeree)
2.  Scompaginamento dell'architettura del parenchima
    -   Prima distorsione, poi progressivo collabimento delle vie aeree
    -   Allargamento degli spazi aerei nel parenchima respiratorio
        dovute alla rottura dei setti e alla confluenza di alveoli
    -   Alterazione delle arteriole polmonari
    -   Riduzione del network capillare

#### Fenotipo enfisematoso e bronchitico (enfisema centrolobulare)

-   Situazione mista
    -   Si ha interessamento delle vie aeree, come nel processo
        bronchiolitco/bronchitico
    -   Si ha interessamento del parenchima, come nel processo
        enfisematoso, con un primo coinvolgimento della porzione
        circostante le vie aeree e una successiva espansione verso la
        periferia del lobulo
-   Generalmente minor riduzione del ritorno elastico, quindi prognosi
    migliore

## Clinica

-   Pz. tipico \> 40aa

-   Triade tipica

    -   Tosse (intermittente o persistente)

    -   Dispnea ingravescente (valutata con MRC Breathlesness Scale o
        mMRC \[modified MRC\])

          mMRC   
          ------ -------------------------------------------------------------------
          0      Manca fiato solo sotto sforzo intenso
          1      Manca fiato quando cammino veloce in pianura o normale in salita
          2      Cammino più piano dei coetanei o mi devo fermare
          3      Mi devo fermare dopo 100 metri/pochi minuti a riprendere il fiato
          4      Non riesco ad uscire di casa o manca respiro per atti quotidiani

    -   Espettorazione cronica

-   Obiettività

    ![](img/bbpf-clinica.jpg)

> **Iperinflazione dinamica**
>
> BPCO (bronchitico o enfisematoso che sia) ha problemi in *espirio*,
> non in inspirio
>
> -   In inspirio in torace c'è pressione negativa ⇒ anche se le vie
>     aeree sono ostruite la presione transtoracica incoraggia
>     l'ingresso
> -   In espirio in torace c'è pressione positiva ⇒ vie aeree già
>     ostruite tendono a chiudersi per pressione transtoracica
>
> Questo produce il fenomeno dell'**iperinflazione**: il BPCO prende
> aria, ma non la riesce a buttare fuori.\
> L'iperinflazione è tipica dell'enfisematoso (dove l'aumento del volume
> residuo è *molto* marcata per perdita dell'interstizio che tende ad
> espandere le vie aeree), ma non risparmia il bronchitico

## Diagnosi {#diagnosi-4}

-   **La diagnosi di BPCO è spirometrica**: si osserva

    ![](img/bpco-spirometria.png)

    -   VEMS ↓
    -   ↓ Tiffenau
    -   "Scucchiaiamento" della curva

-   Medesimo percorso asma ma ostruzione è irreversibile, quindi

    -   Spirometria indica ostruzione
    -   Spirometria *post* broncodilatazione porta a miglioramento \<
        12% del predetto

-   Stadiazione della BPCO: in funzione della VEMS (FEV1)
    **post-broncodilatatore**

  Stadio                   VEMS
  ------------------------ ------------------
  GOLD 1 --- Lieve         ≥ 80% teorico
  GOLD 2 --- Moderata      50 ÷ 80% teorico
  GOLD 2 --- Grave         30 ÷ 50% teorico
  GOLD 4 --- Molto grave   \< 30% teorico

-   Ruolo della diagnostica per img: utile per ddx (r/out di altre
    patologie)
    -   Reperti rx *compatibili* con BPCO (ma assolutamente *non*
        diagnostici);
        -   Polmone iperinflato (VR elevato) e/o radiolucente
        -   Diaframma piatto
        -   Allargamento degli spazi intercostali
        -   Irrorazione vascolare distorta e scarsa
    -   Reperti HRCT: utili per approfondire quello che *alla
        spirometria* appare come ostruzione bronchiale

## Prognosi

-   Predittore di mortalità a 5aa: indice BODE (correla *direttamente*
    con mortalità)

                                               0       1        2        3
      ---------------------------------------- ------- -------- -------- -------
      **B**MI                                  \> 21   \< 21             
      **O**bstruction: FEV1                    ≥ 65    \> 50    \> 35    \< 35
      **D**yspnea (mMRC)                       0--1    2        3        4
      **E**xsercise capacity (metri al 6MWT)   ≥ 350   \> 250   \> 150   \<150

-   I 3 fenotipi di BPCO hanno comunque intrinsecamente una prognosi
    differente

    -   Bronchitico → FEV *tendenzialmente* mantenuta
    -   Bronchitico con enfisema centrolobulare → FEV in lento declino
    -   Enfisematoso panlobulare → FEV in rapido declino (circa ↓ 100
        ml/anno)

## Trattamento

1.  Ridurre i fattori scatenanti, principalmente **smettere di fumare**

    ![](img/fumobpco.png)

2.  Esercizio fisico quotidiano (studi dimostrano ↑ sopravvivenza e PFR
    migliori per attività fisica alta--moderata)

3.  Tp. farmacologica (aderenza è essenziale: anche se nessuna tp.
    migliora sopravvivenza a lungo termine, )

    -   2 pilastri farmacologici: **broncodilatazione** + contrasto
        dell'infiammazione
        -   ⭐️ Broncodilatazione
            -   `LABA`
            -   `LAMA`
        -   Controllo dell'infiammazione
            -   `CSI`(corticosteroidi inalatori)
    -   Strategia, da LG:
        a.  Se FEV1 \< 80%: partire con broncodilatatore **a lunga
            durata** (SABA/SAMA non hanno nessun senso clinico, servono
            per tp. al bisogno dell'asma)
        b.  Se non successo: ↑ dose, OPPURE usare un altro meccanismo
            d'azione
        c.  CSI, sopratutto se riacutizzazioni frequenti

4.  Vaccinazioni

5.  Tenere controllata la spirometria

## Riacutizzazione

-   ***Riacutizzazione di BPCO*** --- evento clinico importante, che si
    verifica nel corso della storia naturale della malattia,
    caratterizzato da un **peggioramento rispetto al basale di tosse,
    dispnea e/o espettorato**, che eccede la variabilità quotidiana e
    **richiede modifiche del trattamento**
    -   Possibile, in aggiunta: febbre, variazione dell'obiettività
        polmonare, edemi declivi
-   Riacutizzazione dovuta a infiammazione, ma non per forza ha
    eziologia infettiva: (prevalenza calante)
    1.  Riacutizzazioni ad impronta *eosinofila* (con meccanismo simile
        all'asma)
    2.  Riacutizzazione ad impronta *batterica*
    3.  Riacutizzazione ad impronta *virale* (50% delle riacutizzazioni
        *gravi* sono virali)
    4.  Riacutizzazione ad impronta paucinfiammatoria
-   Più la condizione di base è severa (GOLD) più le riacutizzazioni e
    le ospedalizzazioni sono frequenti
-   Riacutizzazione è correlata con mortalità
    -   16% dei pz. che riacutizzano muore durante esacerbazione
    -   Dopo una riacutizzazione mortalità a 5aa è 50% (25% nel primo
        anno)
-   Trattamento della riacutizzazione:
    1.  **Corticosteroidi a basse dosi PO**[^100], per avere effetti
        sistemici
    2.  **Abx in pz. ad alto rischio** (da LG)
        -   Riacutizzazione severa
        -   Riacutizzazione con ↑ purulenza dell'espettorato + 1 altro
            sintomo chiaro tra i 3 caratteristici della riacutizzazione

        > Considerare abx anche in virosi: studi dimostrano che, in pz
        > BPCO che fanno virosi, le sovrainfezioni sono molto probabili
        > (questo non è vero per pz. generico)
-   Ospedalizzare riacutizzazione *senza indugio* se
    -   Sintomatologia importante
    -   Riacutizzazione in BPCO GOLD 3/4
    -   Obiettività preoccupante (cianosi, edemi, dispnea)
    -   Non risposta al trattamento
    -   Comorbidità importanti
    -   Aritmie di nuova insorgenza
    -   Dubbio diagnostico
    -   Età avanzata
    -   Nuovi disturbi del sensorio
    -   Logistica sfavorevole
        -   Non autosufficienza
        -   Non caregiver
        -   Impossibilità di rivalutazione

# Diffuse Lung Disease

-   ***DLD*** (o Interstitial Lung Desease) --- gruppo *eterogeneo* di
    patologie nelle quali un processo infiammatorio interessa **la
    parete alveolare, che regredisce o viene soppiantata da connettivo**
    (alterando quindi l'architettura e la funzionalità del parenchima
-   Un numero enorme ed eterogeneo di patologie produce un quadro di
    DLD/ILD
    1.  [Da causa nota, anche **interstiziopatie
        secondarie**](#dldsecondarie)
        -   Autoimmune (**vasculiti**)
        -   Connettivopatie
        -   **Esposizione professionale** (pneumoconiosi \[polveri
            inorganiche\] o polmoniti da ipersensibilità \[polveri
            organiche\])
        -   **Farmaci**
        -   [**Polmonite eosinofila**](#dldeosinofila)
    2.  Idiopatica (IIP -- Idiopatic Interstitial Pneumonia)
        -   [**IPF**, Idiopatic pulmonary fibrosis)](#ipf)
            -   UIP, Usual Interstitial Pneumonitis (\> 50% delle IIP)
        -   [**NSIP**, Non-Specific Interstitial Pneumonia](#nsip) (\>
            25% delle IIP)
        -   Desquamative interstitial pneumonia
        -   Respiratory bronchiolitis
        -   Cryptogenic organising pneumonia
        -   AIP (Acute interstitial Pneumonia
    3.  ILD granulomatose
        -   [**Sarcoidosi**](#dldsarcoidosi)
        -   Da ipersensibilità
            -   Graft vs host
        -   Infezioni
    4.  Altre forme
        -   Proteinosi alveolari
        -   Lymphangioleiomiomatosis
        -   Istiocitosi polmonare a cellule di Lanherans
        -   Da cause cardiache e renali

## Epidemiologia

-   DLD sono causa del 15% pz. ambulatoriali che chiedono consulenza per
    patologia respiratoria
    -   Prevalenza: M \> F (81% maschi vs 67% femmine)
    -   Incidenza: ↑ per età \> 55aa (Marcato aumento oltre settima
        decade)
        -   Possibile inizio subdolo e misconosciuto con ritardo della
            diagnosi
-   Quadri di gravità varabiabile
    -   IPF è la più severa
    -   sarcoidosi è quella generalmente con prognosi più favorevole
    -   Forte correlazione con altre patologie autoimmuni (vasculite,
        artrite, sclerodermia)

## Meccanismo patogenetico comune

![](data:image/png;base64,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)

## Diagnostica

### Indagini di primo livello

-   **6MWT** o equivalenti (sit--stand test) per misurare riserva e
    capacità di diffusione
    -   Riserva = volumi polmonari
    -   Capacità di diffusione sotto sforzo (surrogato per stimare DLCO)
-   **Spirometria** per valutare se esiste un quadro di restrizione o se
    c'è altro
    -   **FVC** --- principale indice per vedere se restrizione
    -   **FEV1** --- ridotto consensualmente a FVC se restrizione, da
        solo se c'è ostrizione
        -   **Tiffenau** --- principale indice per vedere se c'è
            ostruzione (in DLD mi aspetto ndr \[perché calano i volumi e
            i flussi consensualmente\] o addirittura ↑ \[calano i volumi
            ma sg. fit riesce a fare comunque buoni flussi\])
    -   Volumi polmonari singoli (ridotti in DLD)
-   RX: ok, ma non esclude nulla, al limite incoraggia ad altri
    approfondimenti
-   ⭐️ **HRTC** (ad alta risoluzione, altrimenti difficile distinguere
    se opacità è davvero *honeycombing*, segno più patognomonico di
    fibrosi)
    -   Indicazioni tecniche
        -   Essenziale chiedere che siano sezioni sottili
        -   Senza contrasto
        -   Prono e supino
        -   Inspiratoria ed espiratoria
    -   Pattern da ricercare per porre diagnosi
        -   Bronchiectasie da trazione
        -   Favo d'ape, o *honeycombing*, indicativo di ***IPF***
            (Fibrosi Polmonare Idiopatica)
        -   Opacità ground glass (patognomonico di ***NSIP***
            (Non-Specific Interstitial Pneumonia))

### Indagini di secondo livello

-   **BAL** (caratterizzare meglio il processo infiammatorio
    dell'alveolo)
    -   Cellularità normale: 10^6^ (macrofagi \> linfociti \>
        neutrofili/eosinofili/mastcellule), con opportuno rapporto tra
        le popolazioni linfocitarie (CD3 più rappresentate)
    -   A seconda del citotipo prevalente al citogramma
        -   Alveolite linfocitaria (linf \> 15%)
        -   Alveolite neutrofila (neu \> 4%)
        -   Alveolite eosinofila (eos \> 2%)
        -   Alveolite globale (\> linf, neu ed eos)
        -   Alveolite macrofagica
        -   Alveolite gigantocellulare (riscontro di elementi cellulari
            multinucleari)
-   Biopsia transbronchiale (risulta essenziale in \< 15% dei casi,
    negli altri gli esami precedenti sono efficaci)

## Focus su forme più rappresentative

### Fibrosi Polmonare Idiopatica (IPF) {#ipf}

-   ***Fibrosi polmonare idiopatica*** --- DLD idiopatica in cui si ha
    l'accumulo di materiale fibrotico nell'interstizio del parenchima
    polmonare a causa sconosciuta
-   Esordio tipicamente acuto
-   UIP (Usual Interstitial Pneumonia) rappresenta l'entità clinica di
    IPF più rappresentata (\> 55%)

> **Ipossia da sforzo, P(A-a) e fibrosi polmonare**\
> In IPF ipossia compare prima sotto sforzo perché si ha riduzione della
> diffusione alveolo → capillare per un interstizio fibrotico (all'EGA
> vedrei ↑ P(A-a), se facessi DLCO lo vedrei alterato).
>
> Questo però accade solamente quando il metabolismo dei tessuti chiama
> ossigeno, quindi non in situazioni normali dove c'è ancora una minima
> capacità di diffusione. In queste situazioni spesso si osserva
> ipocapnia, perché il sg. tende a iperventilare inutilmente per
> migliorare lo scambio di O~2~, ma la CO~2~ ha una capacità di
> diffusione maggiore rispetto all'ossigeno, e riesce comunque a
> diffondere attraverso interstizio fibrotico molto meglio di quanto
> faccia l'ossigeno.
>
> Con l'aggravamento della situazione, l'ipossia si può avere anche a
> riposo.

#### Presentazione clinica

-   Patologie tipicamente *correlate* con FP (si co-presentano)
    -   MRGE
    -   Disfagia
    -   Fenomeno di Reynaud
    -   Secchezza cute
-   SeS
    -   Tosse secca
    -   Dispnea da sforzo
    -   ipossia da sforzo
    -   Crackles inspiratori non modificabili con tosse
    -   Clubbing digitale
    -   Ipertensione polmonare
    -   (Insufficienza ventricolare dx)
-   Diagnostica
    -   Spirometria: quadro restrittivo
    -   HRTC: Honeycombing

#### Fattori di rischio {#fattori-di-rischio-1}

-   Genere (M\>F)
-   Esposizione al fumo (\> 20 pacchetti--anno è fortemente correlato
    con FPI)
-   Inalazione di polveri fini (es: di legno)
-   MRGE (\> 70% di chi ha FP ha MRGE; probabilmente per
    micro--inalazioni)
-   infezioni virali
-   Fattori genetici (\< 55 IPF ha genesi genetica)

#### Terapia

-   Non esistono farmaci che permettono di abbassare la mortalità, ma
    aumentano la qualità di vita (↓ riacutizzazioni, ↓ riduzione della
    CVF)
    -   `nintedanib` --- inibisce GF di crescita per fibroblasti,
        piastrine e inibisce i VEGFr
    -   `pirfenidone` --- inibisce la proliferazione di fibroblasti e la
        produzione di collagene stimolata da TGFβ + in vitro riduce la
        produzione di mediatori di fibrogenesi/infiammazione

### NSIP

-   ***NSIP*** (Non Specific Interstitial Pneumonia) --- DLD idiopatica
    caratterizzata da un quadro di polmonite interstiziale
-   Epidemiologia
    -   F \> M
    -   Pz tipico è giovane e non fumatore
-   Esordio meno acuto (sintomi misconosciuti anche per mesi/anni)
-   Clinica
    -   SeS
        -   Tosse cronica
        -   Dispnea ingravescente
-   Diagnosi
    -   HRTC: pattern ground glass è patognomonico di NSIP
    -   Bisogna però *escludere attivamente* altre patologie che possono
        provocare NSIP, prima di concludere che è idiopatica
-   Tp.: buona risposta a tp. antinifiammatoria (visto che genesi della
    NSIP *idiopatica* è infiammatoria
    -   Steroidi
    -   Altri immunisiooressori se necessario (`azatiopina`,
        `ciclofosfamide`)
-   Prognosi: dipende
    -   Se NSIP classica, buona progonsi a 10aa
    -   Se NSIP però esita in forma fibrosante la prognosi diventa più
        grave

### Interstiziopatie polmonari secondarie {#dldsecondarie}

-   DLD secondarie a causa nota
    1.  Pneumoconiosi da inalazione di polveri (tipico setting è
        esposizione professionale)
        -   Silicosi
        -   Asbestosi
            -   Versamento pleurico + ispessimento pleurico. Mesotelioma
                maligno è virtualmente sempre da asbestosi
            -   Diagnosi: HRTC + BAL per dimostrazione definitiva della
                presenza di amianto
        -   Da altri silicati (eg talco)
        -   Da polveri minerali inerti (ie ferro, stagno, bario,
            berillio)
    2.  Da droghe voluttuarie
        -   Cannabis
            -   Problema non è cannabis, ma *paraquat* (agente usato per
                essicazione) che produce stress ossidativo, danno
                cellulare ⇒ ↑ fibroblasti
        -   Cocaina (Crack Lung Syndrome)
            -   Enfisema bolloso
            -   Polmonite da ipersensibilità
            -   Edema polmonare
            -   Broncospasm
            -   Alveoliti e fibrosi interstiziale
        -   Eroina
            -   Granulomatosi da talco usato per tagliarla che si
                deposita nei polmoni
    3.  Polmoniti eosinofile (ipereosinofilie polmonari)
        -   Polmoniti da infiltrati eosinofili nel parenchima polmonare
        -   Riscontro di ipereosinofilia *sempre* nel BAL, *a volte*
            anche nel sangue periferico
        -   Ha principalmente 2 andamenti
            -   Acuto (anche fatale se non diagnosticata per IR grave)
            -   Cronico (esordio subdolo e spesso confuso con asma
                refrattario a terapia)
    4.  Aspergillosi broncopolmonare allergica
        -   DLD da colonizzazione delle vie aeree da parte di
            *Aspergillus fumigatus* (fungo) e conseguente processo
            infiammatorio che si organizza nei polmoni
        -   Ha un doppio andamento
            1.  Stadio acuto (spesso confuso con asma[^101])
                -   Asma, ↑ IgE
                -   Immediata reazione cutanea ad ag di Aspergillo
            2.  Stadio cronico
                -   Prosegue il danno infiammatorio fino a fibrosi
        -   Diagnosi: tecnicamente facile, il difficile è far venire il
            sospetto clinico e non trattarla come asma
            -   CXR con infiltrati parenchimali + bronchiecatsie
                centrali
            -   ↑ IgE, alla tipizzazione si vede che non è aumento
                aspecifico ma contro Ag di aspergillo
    5.  Da patologie collageno--vascolari reumatiche/autoimmuni[^102]
        -   ***granulomatosi di Wegener*** --- vasculite ANCA-associata
            necrotizzante su base autoimmune dei piccoli e medi vasi che
            interessa il sistema respiratorio e frequentemente i reni
        -   ***sindrome di churg--strauss*** --- vasculite autoimmune
            sistemica dei piccoli vasi sanguigni, sia arterie (arterite
            delle arteriole) che vene
            -   Spesso misconosciuta
            -   Triade sintomatica: asma + ipereosinofilia + vasculite
                necrotizzante ≥ 2 organi
    6.  Da ipersensibilità ad un antigene
        -   DLD dovuta a continua esposizione ad antigene verso cui si è
            sensibili (\> 300 cause!! Anamnesi accurata è essenziale!)
        -   Patogenesi: ipersensibilità → infiltrato (prima
            neutrofilico, poi linfocitico/macrofagico) → granuloma →
            risoluzione (se trattamento) o fibrosi (se granuloma si
            organizza)
        -   Esempio tipico: polmonite del contadino, polmonite
            dell'allevatore
        -   SeS
            -   Esordio con sintomi aspecifici: astenia, mialgie,
                perdita di peso
            -   Progressivo interessamento polmonare
    7.  Conseguente a ***sarcoidosi***[^103]
        -   Spesso prognosi fausta
        -   10--15% evolve verso fibrosi polmonare (anche se
            coinvolgimento del polmone c'è virtualmente sempre). 60%
            guarisce spontaneamente
        -   Scoperta dei noduli polmonari granulomatosi a CXR è spesso
            incidentale per altri motivi
        -   Mortalità. 6% (più che il coinvolgimento polmonare, è il
            coinvolgimento cardiaco che risulta fatale, in quanto i
            granulomi danneggiano il sistema di conduzione favorendo
            aritmi
        -   Dx: di esclusione (problema!)
            -   Si nota coinvolgimento polmonare
            -   SI hanno SeS tipici (es: coinvolgimento della cute con
                eritema nodoso o uveite)
            -   Si escludono *attivamente* ddx che assomigliano
                (linfomi/malattie ematologiche)
        -   Stadiazione dell'interessamento polmonare
            0.  Non adenopatie nè infiltrati polmonari
            1.  Solo adenopatie ileomediastiniche
            2.  Aenopatie ileomediastiniche + infiltrati polmonari
            3.  Solo infiltrati polmonari
            4.  Fibrosi polmonare
        -   Trattamento efficace solo stadio 2÷4 e sensato (r/b) sse FVC
            \< 70% predetto

    -   Da farmaci
        -   `amiodarone` --- ILD lenta e insidiosa
        -   `metotrexato` --- ILD acuta (se presa per tempo è
            reversibile)
        -   `bleomicina` --- ILD cronica
        -   `nitrofurantoina` --- ILD acuta
        -   Inibitori della `tirosin--kinasi` --- ILD acuta o cronica

```{=html}
<!-- ven 19 mar 2021, 14:18:05, CET -->
```
# Versamento pleurico

-   ***Versamento pleurico*** --- accumulo anormale di liquido nello
    spazio pleurico di unoo di entrambi dei polmoni (fisiologicamente
    5--15ml in spazio pleurico)

## Eziologie principali

-   **Versamento da trasudato** --- spesso bilaterale, conseguente a ↑
    gradienti pressori o del fluido interstiziale

    $$\begin{align*} &K[\text{Filtrazione} - \text{Riassorbimento}]=\\ &K[(P_{vasi} + \pi_{interstizio}) - (P_{interstizio} + \pi_{vasi})] \end{align*}$$

    -   **CHF**[^104]
    -   **Epatopatie**[^105] (cirrosi)
    -   **Problemi renali**: sindromi nefrotiche, glomerulonefriti...
    -   **Dialisi peritoneale**
    -   Ostruzione della vena cava superiore (sindromi da occupazione
        mediastinica)
    -   Ipoalbuminemia
    -   Diminuzione del ritorno linfativo
    -   ...

-   **Versamento da essudato** (spesso monolaterale, conseguente a
    infiammazione)

    -   **Patologie infettive** a carico del parenchima polmonare
        (polmoniti a varia eziologia, TBc, infezioni fungine, virali,
        parassitiche)
    -   **Neoplasie dei polmoni**[^106] (mesotelioma, adenok, k
        squamoso, k anaplastico grandi/piccole cellule)
    -   Traumi ⇒ alterazioni della permeabilità
    -   Secondari a problemi gastroenterici
    -   Secondari a problemi ginecologici (es: postpartum)
    -   Patologie del collagene e vasculiti
    -   Da farmaci (`amiodarone`, `dantrolene`[^107], `metotrexato`)
    -   Post ch/post trapianto
    -   Asbestosi
    -   Annegamento
    -   Emotorace (versamento su)
    -   Chilotorace (versamento su)
    -   Embolia polmonare

> **Eziologie prevalenti** ---
>
> Se ci dobbiamo ricordare proprio le 3 cause più frequenti di
> versamento (essudatizio E trasudatizio):
>
> -   Scompenso cardiaco congestizio (trasudato)
> -   Polmonite (essudato)
> -   Neoplasia (essudato)

## Diagnosi {#diagnosi-5}

1.  Sospetto clinico (APR, APP, SeS, EO)
    -   Ispezione: riduzione della motilità nell'emitorace sede del
        versamento
    -   Palpazione: FVT ridotto
    -   Percussione: ipofonesi/abolizione del SCP a seconda della
        disposizione del liquido e del decubito del pz
    -   Auscultazione: MV ridotto/abolito, ± egofonia (sopratutto
        margine superiore del versamento), ± broncofonia
2.  ⭐️ RX torace (segno: obliterazione seno costofrenico)
    -   Se visibile in proiezione std: \> 200 ml
    -   Proiezione laterale visualizza versamenti \> 50 ml
3.  Toracentesi ecoguidata + analisi campione (50--100ml)
    -   Analisi: batteriologico + citologico (a volte utile fare
        direttamente EGA su drenato)
    -   Per capire il meccanismo scatenante
    -   Per migliorare meccanica respiratoria
    -   Seguire procedura appropriata (vedi video)
    -   Non drenare \> 1--1.5 lt (possibile ***edema da riespansione***)
        e fermarsi comunque quando insorge tosse
    -   Complicanze
        -   Immediate: PNX, sanguinamento (safe spot per evitare il
            bundle vascolonervoso: **margine superiore della
            costa**[^108])
        -   A lungo termine: infezioni secondarie (sterilità!!!),
            emorragie non riconosciute/prevenute (APR, APP, APF!!!)
4.  Eco se quadro "difficile" (versamento piccolo, per guidare
    toracentesi, per valutare versamenti saccati[^109]...)

> **Imaging del torace nel versamento** --- Tac torace non è mai misura
> di prima linea! Utile per valutare empiemi, ascessi, neoplasie, o se
> versamento recidiva o per valutare eventuali evoluzioni... Di fatto è
> una cosa che si usa per *seguire* il versamento, non per
> diagnosticarlo.
>
> Una TAC equivale 300÷500 Rx!

### Analisi del liquido della toracentesi

-   Capire se si tratta di essudato e trasudato (\> 1 dei **criteri di
    Light** \[sp 98%, sn 99%\]):

  Criteri                                       Trasudato   Essudato
  --------------------------------------------- ----------- ----------
  Proteine liquido pleurico/proteine sieriche   ≤ 0.5       \> 0.5
  LDH liquido pleurico/LDH sierico              ≤ 0.6       \> 0.6
  LDH liquido pleurico                          ≤ 200       \> 200

> NB: durante diuresi (specie se aggressiva) o dopo ripetute
> toracentesi, rimuovendo quota liquida le caratteristiche di un
> trasudato possono spostarsi verso quelle di un essudato

-   Se essudato: valuto glucosio, pH, WBC e torbidezza del liquido (ci
    sono cellule, magari batteriche?)
    -   Se glucosio \< 60 mg/dl (poco) e pH acido ⇒ è legittimo supporre
        una eziologia infiammatoria, tipicamente infettiva. Eziologie
        tipiche sono 4:
        -   ***TBC***
        -   Versamento neoplastico
        -   Artrite reumatoide
        -   Versamento che si è complicato[^110] verso l'empiema (pH \<
            7.2 indicativo di colonizzazione batterica[^111], pH ≤ 7 di
            empiema franco)
    -   Se glucosio normale/alto ⇒ ci si orienta su altre eziologie
        (vedi sopra)

## Complicanze

-   Versamento semplice (solo liquido) → versamento complicato (con
    microorganismi) → empiema (con germi e pus (PMN morti)) → empiema
    saccato/organizzato (empiema stabilmente incapsulato da tessuto
    fibrinoso)

### Empiema pleurico

-   Fattori favorenti/di rischio
    -   Età \> 65aa
    -   Diabete
    -   Abuso di alcool e droghe
    -   Scarsa igiene mentale (in anziani è problema che non va
        sottovalutato)
-   Eziologia
    -   → **Infezione polmonare** (55%, *Strepto* \[famiglia\] ma anche
        *Staph aureus* \[che ha prognosi peggiore, se poi è MRSA non ne
        parliamo\]. Batteriologia è complicata, dipende da setting di
        vita/dove è stato preso/fascia d'età/stato immunitario)
        -   Versamento complicato/empiema parapneumonico → insorgenza
            sincrona a focolaio
        -   Versamento complicato/empiema metaoneumonico → insorgenza a
            distanza da focolaio
    -   Complicanza chirurgica (21%)
    -   Trauma (6%)
    -   Perforazione esofagea
    -   PNX spontaneo
    -   Complicanza post toracentesi
    -   Infezione sottodiaframmatica
    -   Setticemia
    -   Altre
-   Formazione in 4 stadi (versamento complicato/empiema da fase 3/4)
    1.  Fase prodromica alla fase essudatizia
    2.  Fase essudativa (pH \> 7.3, \[Glucosio\] \> 60 mg/dL)
    3.  Fase fibrino--purulenta, anche (pH \< 7.2, \[Glucosio\] \< 60
        mg/dL)
    4.  Fase organizzata (pH \< 7, \[Glucosio\] \< 40 mg/dL, tanto LDH,
        tanti leucociti)
-   Trattamento:
    -   **Evacuazione**, se possibile (*Ubi pus, ibi evacua*)
        -   Toracentesi \> Drenaggio fisso \> VATS (a seconda
            dell'opportunità, della fattibilità e del singolo caso)
            -   Chirurgia va considerata se sepsi è persistente
        -   Indicazioni al drenaggio (linee guida BTS)
            -   Coltura/colorazione di gram + che indicano infezione
                pleurica certa
            -   pH \< 7.2
            -   Versamento multiloculato
            -   Assenza di miglioramento delle condizioni cliniche
                nonostante abx
        -   Ritardo in evacuazione ⇒ ↑ tempo di degenza, ↑ mortalità, ↑
            necessità di terapie invasive, quindi: gestione aggressiva e
            proattiva del peggioramento
    -   Ab a tronchi e osservazione

# Bronchiectasia

-   ***Bronchiectasia*** --- dilatazione irreversibile delle vie aeree

## Epidemiologia

-   F \> M
-   Età media alla diagnosi: 70aa (ma spesso dx tardiva)
-   Nei 50% dei casi sono idiopatiche

## Fisiopatologia

![](img/bronchiectasie-fisiopat.png)

## Classificazione

-   Classificazione anatomopatologica ("di Reid")
    1.  Bronchiectasie cilindriche → bronchi con contorni regolari e non
        molto aumentati in diametro. Terminazione dei bronchi è
        improvvisa
    2.  Bronchiectasie varicoidi → dilatazione del lume maggiore, con
        restringimenti locali che creano profilo irregolare.
        Terminazione dei bronchi è caratteristica, detta "a bulbi di
        tulipano"
    3.  Bronchiectasie cistiche → dilatazione bronchiale crescente verso
        la periferia. Terminazione dei bronchi "a palla"
-   Classificazione eziopatogenetica
    -   Idiopatiche
    -   Secondarie (← flogosi \[cicatrici parenchimali stirano le vie
        aeree\], ostruzione delle vie prossimali, retrazione del
        parenchima, anomalie congenite, aspirazione)

## Fattori di rischio e correlazioni cliniche

-   Infezioni (anche dell'infanzia
-   Aspirazione/inalazione di materiali
-   Anomalie delle ciglia
-   Ostruzione delle vie aeree
-   Patologie specifiche in cui si ritrova bronchiectasia
    -   ***Sindrome di Hermansky--Pudlak*** \[pat autosomica recessiva
        che provoca albinismo oculocutaneo + diatesi emorragica lieve +
        colite granulomatosa ± fibrosi polmonare → bronchiectasia\])
    -   Ciliopatie (***Sindrome di Kartagener***, discinesia ciliare)
-   Deficit di α1-antitripsina (flogosi è fibrosante e si distrugge
    l'architettura elastica a favore di cicatrici che stirano le vie9
-   AIDS

## Diagnosi {#diagnosi-6}

-   Anamnesi
-   SeS
    -   Tosse cronica con espettorato muco--purulento (sopratutto la
        mattina)
        -   Francamente purulento nelle riacutizzazioni
    -   Emottisi/emoftoe[^112] (50--70% dei casi)
    -   Malessere
    -   febbre remittente--intermittente solo durante riacutizzazioni
        \[continua se si sovrappongono focolai\]
    -   dispnea senso di ripienezza catarrale e congestione
-   EO (attenzione, molto sfumato in periodi di benessere asintomatico)
    -   Ottusità marcata e FVT aumentato nelle zone di ristagno di
        secreto (che aumenta vibrazione indotta)
    -   MV abolito/assente nelle aree ectasiche
    -   Ronchi e rantoli in corrispondenza della lesione e anche
        bilaterali
-   Imaging
    -   RX torace *assolutamente aspecifico, dice veramente poco*
        -   In fasi di riacutizzazione\_ speso riscontro di
            addensamenti/opacità generici, facilmente
            identificati/confusi come focolai broncopneumonici
        -   ± aumento della trama vascolare
        -   ± definizione del disegno bronchiale
        -   ± riconoscimento di bronchi affastellati per perdita di
            volume aereo
    -   ⭐️ **HRTC**
-   Indagini strumentali
    -   Coltura espettorato
    -   Fibrobroncoscopia se espettorato non conclusivo OPPURE con
        intento terapeutico
        -   Esame espettorato non ci dice qual è causa scatenante per
            fare prelievo in sito
        -   Rimuovere bronchi congestionati

> **Principale ddx prima di HRTC con bronchiectasia è polmonite**
> (presentazione *simile*). Difficilmente però una polmonite bilaterale
> (bronchiectasie danno sintomatologia bilaterale) ha febbre remittente
> e buona saturazione... Una polmonite bilaterale darebbe un quadro
> molto più critico e in peggioramento

## Terapia

-   Obiettivo: detergere le vie aeree rimuovendo secrezioni
    -   Fisiochinesioterapia
        -   Esercizi fisioterapeutici per drenaggi posturali
        -   Tosse assistita
    -   Cicli molto prolungati (12 mesi) di ab. a dosi subterapeutiche
        di `azitromicina`[^113] ⇒ ↓ riacutizzazioni
    -   Mucolitici: non supportati da EBM (a meno che sg. non sia
        fumatore)

### Prognosi

-   Normale/accettabile se
    -   Diagnosi precoce
    -   Buona gestione
    -   Bronchiectasia altera poco la qualità di vita

# Fibrosi cistica

-   Patologia autosomica recessiva dovuta a mutazione del gene CFTR
    (7q31.2) caratterizzata dalla **produzione di secrezioni esocrine
    molto dense**
    -   1/2.5K nati vivi (1/30 è portatore della mutazione)
-   Secrezioni dense di svariati distretti
    -   polmoni
    -   intestino
    -   pancreas e vie biliari
    -   ghiandole sudoripare (segno del "sudore salato")
    -   apparato genitourinario

## Fisiopatologia

-   CFTR codifica per un canale per il cloro, che non è funzionante nei
    sg. con FC
-   La FC è sostenuta da 2 meccanismi fisiopatologici
    -   Ispessimento dei secreti per mancata diluizione degli stessi
        (canale non funzionante ⇒ non escrezione di Cl^-^ ⇒ non
        idratazione dei secreti)

## Clinica

-   Apparato respiratorio (100% pz.)
    -   Bronchiolite nel 1/o anno di vita (sibili, tosse secca
        simil--pertosse poi progressivamente produttiva e mucopurulenta,
        rantoli fini, iperfonesi generalizzata, iperinflazione torace
        \[EO ed RX\])
    -   Sindrome bronchiectasica ricorrente (dilatazione per (1)
        continue infezioni; (2) accumulo di secrezioni favorito)
    -   Crescita batterica ⇒ polmoniti recidivanti (*Staph aureus,
        Pseudomonas aeruginosa, Burkholderia cepacia*)
    -   Sindrome ostruttiva progressiva
-   Apparato g/i (90% pz.)
    -   Insufficienza pancreatica ⇒ malassorbimento
    -   Ileo da meconio (15%)
    -   Cirrosi biliare focale (20% pz., solo 5% sintomatico)
-   Apparato genitale (97% pz.)
    -   Infertilità

## Diagnosi {#diagnosi-7}

-   In primis sospetto clinico
-   Conferma con
    -   ⭐️ test del sudore (\[Cl\] \> 60 mEq/l nel sudore)
    -   PCR per amplificazione e valutazione delle mutazioni (specifico
        ma non grandissima sensibilità, per numerosità mutazioni
        mutazioni di CFTR)

## Prognosi e terapia

-   Profilassi ab. per riacutizzazioni (ma dipende un sacco da età, non
    si può cominciare profilassi ab. ad 1 anno)
-   Rimuovere muco!
    -   Fluidificare muco! ⇒ bere molto + aerosol--tp.
    -   Macchina della tosse
        -   Device che produce pressione positiva di insufflazione +
            pressione negativa rapida per generare un flusso espulsivo
            repentino che simula il colpo di tosse
    -   Coppettazioni, PEEP-bottiglia[^114]
-   Studi ongoing su farmaci
-   Trapianto bipolmonare aumenta aspettativa, che però ad oggi rimane
    \~ 30aa

# Cenni di O~2~tp

## O~2~ tp. in acuto

-   O~2~ tp. spesso abusata
-   In pz. non ipercapnici: SpO~2~ target deve essere 92--96%: lavoro di
    [@girardisEffectConservativeVs2016] dimostra che o2tp conservativa
    (paO~2~ 70 ÷ 100 mmHg) in pz. ICU porta a outcome migliori
-   O~2~ ha tossicità intrinseca (per ↑ stress ossidativo)
    -   Tossicità cerebrale documentata
    -   O~2~ $\propto$ ROS ⇒ danno cellulare e infiammazione
    -   Danno polmonare diretto (alti flussi + ossidazione diretta)
    -   ↑ O~2~ ⇒ vasocostrizione[^115] (coronarica, arteriolare e delle
        arterie cerebrali)

> **O2 a bassi flussi va somministrato non umidificato**\
> L'ossigeno non umidificato è più benefico dell'ossigeno umidificato
> (nell'erogazione a bassi flussi con maschere oro-nasali e occhialini).
> Quest'ultimo peggiora la situazione, perché l'acqua non è riscaldata,
> è acqua fredda che quindi non genera umidità, irritando ancora di più
> le vie aeree del paziente

### Raccomandazioni per pz. acuti non ipercapnici

![](img/o2tp.png)

-   Da [@siemieniukOxygenTherapyAcutely2018]
    -   SpO~2~ target: \< 96%
    -   Mai SpO~2~ \> 93% in pz. acuti (STEMI o stroke nello studio)
    -   90--92% tp. è ancora accettabile, valutare bene se
        incominciarla, raccomandazione *debole* ad essere attendisti

### Raccomandazioni per pz. ipercapnici

-   I pz. BPCO trattati con alti flussi durante riacutizzazioni hanno
    prognosi peggiore [@austinEffectHighFlow2010], verosimilmente perché
    in quei pz. è esseniale il controllo del drive basato sulla paO2 e
    si rischia di indurre un calo del drive respiratorio
-   O2tp conservativa in pz. BPCO riacutizzato ↓ rischio di mortalità
    del 78%

## Long Term O~2~ therapy (LTOT)

-   EBM indica che LTOT è indicata solo in BPCO con insufficienza
    respiratoria cronica. Possibile uso off-label (cure palliative,
    fibrosi polmonari, disordini neuromuscolari)
    -   Riduce l'alto ematocrito
    -   Migliora la tolleranza all'esercizio
    -   Riduce dispnea
    -   Riduce numero di riacutizzazioni/ricoveri
    -   Migliora la funzione neuro--psicologica
-   Bisogna che ci sia ipossia ben documentata e in stabilità clinica
    -   **Stabile** nelle ultime settimane
    -   Documentata con **EGA multipli** (\> 3 a riposo) che evidenzino
        una tra 2 situazioni
        1.  PaO~2~ \< 55 mmHg 2.PaO~2~ 55÷60 mmHg con ≥ 1 tra 5
            condizioni aggiuntive
            -   Ematocrito \> 55%
            -   Cuore polmonare cronico
            -   Ipertensione polmonare
            -   Cardiopatia ischemica
            -   Aritmia severa a rischio (CHF, cardiopatia
                ipertrofica...)
-   LTOT deve essere fatta almeno per 15 h/die, altrimenti non si ha
    miglioramento statistico di mortalità e morbilità
-   Ocio ai rischi, spiegarli a pz.

## O~2~ tp. in voli aerei per pz. ipercapnici

-   "Salve dottore, sono BPCO e devo andare in aereo. Che faccio?"
    -   In aereo la cabina è pressurizzata come se si fosse a 2400 mt ⇒
        ↓ pO~2~
-   A spanne:
    -   SpO~2~ a livello del mare \> 95%: no O~2~ tp. per viaggio
    -   SpO~2~ a livello del mare \< 92%: sì O~2~ tp. per viaggio
    -   Se 92--95: parliamone

```{=tex}
\clearpage
\part{Fisiopatologia respiratoria}
```
# Introduzione

-   ```{=tex}
    \todo{i primi 10 minuti}
    ```

## La respirazione

-   Respirazione = processo di scambio di O~2~ e CO~2~ con l'obiettivo
    di, in ultima analisi, permettere la catena di ossidazioni a livello
    dei citocromi mitocondriali e produrre ATP (*respirazione
    cellulare*)
-   **La respirazione**, in un organismo complesso, **è un insieme di 3
    fasi** distinte, che richiedono una collaborazione di diversi
    sistemi
    1.  Scambio respiratorio (apparato respiratorio)
        -   Ventilazione (sistema nervoso e apparato muscoloscheletrco)
        -   Scambio gassoso alveolo ↔ capillare (diffusione semplice)
    2.  Trasporto (apparato cardiovascolare)
    3.  Scambio cellulare (diffusione semplice)

### Cenni di anatomia funzionale dell'apparato respiratorio

-   L'apparato respiratorio è grossolanamente composto da 3 grandi
    elementi
    1.  Vie aeree superiori (di conduzione)
    2.  Vie aeree inferiori (albero tracheobronchiale)
        -   Zona di conduzione (prime 16 biforcazioni)
            -   ```{=tex}
                \a{bronchi}
                ```

            -   ```{=tex}
                \a{bronchioli}
                ```

            -   ```{=tex}
                \a{bronchioli terminali}
                ```
        -   Zona di transizione e ventilazione (biforcazioni dalla 16
            alla 23)
            -   ```{=tex}
                \a{bronchioli respiratori}
                ```

            -   ```{=tex}
                \a{dotti alveolari}
                ```

            -   `\a{sacchi alveolari}`{=tex}
                `\marginnote{3--5 sacchi alveolari riuniti daranno gli \a{acini}, e un gruppo di circa 15 acini costituisce il \a{lobulo polmonare secondario} (la struttura che, alla TAC ad alta risoluzione, è la più elementare porzione di parenchima individuabile). Il lobulo secondario è  a forma piramidale, ed è organizzato attorno ad un bronchiolo lobulare e ad un'arteriola, mentre è percorso dalla periferia al centro da venule e vasi linfatici}`{=tex}
    3.  Parenchima polmonare (`\a{alveoli}`{=tex})
-   La ventilazione (= espansione e contrazione del parenchima polmonare
    per mantenere costante il gradiente che permette la diffusione
    alveolo ↔ capillare) è permessa dai muscoli respiratori
    -   Principali
        -   ```{=tex}
            \goldstandard \mus{diaframma}
            ```

        -   ```{=tex}
            \mus{intercostali esterni}
            ```
    -   Accessori
        `\marginnote{Il loro uso intensivo è indice di una condizione patologica di \emph{grave} difficoltà ventilatoria}`{=tex}
        -   ```{=tex}
            \mus{sternocleidomastoideo}
            ```

        -   ```{=tex}
            \mus{scaleni}
            ```

        -   ```{=tex}
            \mus{mm. addominali}
            ```

        -   ```{=tex}
            \mus{mm. intercostali interni}
            ```

### Controllo del respiro

-   Il controllo del respiro (*drive respiratorio*) è effettuato dal SNA
    (`\a{centri respiratori}`{=tex} del `\ner{bulbo}`{=tex}), tramite un
    feedback -- costante, rapido e preciso -- delle informazioni
    recepite dai distretti periferici
    -   pCO~2~
    -   pH
    -   pO~2~
-   Obiettivo: garantire una regolazione del respiro (ventilazione +
    scambio + trasporto + scambio) adeguato alle necessità istantanee
    dell'organismo

![](data:image/png;base64,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)

### Fase dello scambio respiratorio

#### Ventilazione

-   ```{=tex}
    \todo{roba}
    ```

-   La capacità ventilatoria è quantificabile con le PFR (prove di
    funzionalità respiratoria)
    -   `\goldstandard `{=tex}Spirometria (o curva flusso/volume)
    -   Studio dei volumi polmonari
    -   Studio dell'efficienza dei muscoli respiratori

##### PFR

-   Indicazioni
    -   Se devo inquadrare sg. con sintomi respiratori (per capire se
        l'origine è ventilatoria)
    -   Se devo capire se c'è un deficit ventilatorio (asma, BPCO...)
    -   Per la valutazione preoperatoria (particolarmente per pz.
        pneumopatici o per procedure chirurgiche che implicano resezione
        del parenchima polmonare)
    -   Per attività sportiva
    -   Per valutare l'esposizione occupazionale
-   Controindicazioni
    -   ```{=tex}
        \todo{}
        ```

##### Incapacità ventilatoria

-   L'incapacità a ventilare si divide in 2 gruppi, a seconda della
    causa
    -   Incapacità ventilatoria ostruttiva
    -   Incapacità ventilatoria restrittiva
-   Le cause di una potenziale incapacità ventilatoria sono
    essenzialmente 3
    `\asidefigure{img/deficit-ventilatorio-cause.png}{}`{=tex}
    1.  Endobronchiali (secrezioni, muco, corpi estranei)
    2.  Della parete del bronco (spasmo muscolare, ipertrofia muscolare,
        infiltrazione flogistica, edema di parete)
    3.  Peribronchiali (distruzione delle fibre elastiche interstiziali
        che mantengono pervie le vie aeree nonostante le variazioni di
        pressione transtoracica, fibrosi peribronchiale da flogosi,
        compressione del parenchima, distruzione della parete
        alveolare...)

#### Scambio gassoso

-   Passaggio di gas tra alveolo e capillare
-   Quantificato dal **rapporto ventilazione/perfusione**, che
    identifica quanto è efficace l'accoppiamento tra l'atto ventilatorio
    e l'atto perfusionale
    `\marginnote{Sostanzialmente mi dice quanto efficacemente ho alveoli \textbf{ben ventilati e ben perfusi!}}`{=tex}
    -   A riposo: \~ 0.8 lt/min
    -   Sotto sforzo: $\leadsto$ 1
-   La qualità dello scambio gassoso è monitorabile principalmente con 2
    metodiche laboratoriali
    -   DLCO
    -   `\goldstandard `{=tex}EGA

### Muscoli principali

-   L'azione *ventilatoria* è permessa da 2 gruppi di muscoli
    -   Principali
        -   ```{=tex}
            \goldstandard \mus{diaframma}
            ```

        -   ```{=tex}
            \mus{intercostali esterni}
            ```
    -   Accessori
        -   ```{=tex}
            \mus{sternocleidomastoideo}
            ```

        -   ```{=tex}
            \mus{scaleni}
            ```

        -   ```{=tex}
            \mus{mm. addominali}
            ```

        -   ```{=tex}
            \mus{mm. intercostali interni}
            ```

### Capacità e volumi polmonari

-   ```{=tex}
    \todo{tutto}
    ```

![](img/capacita-volumi-polmonari.png) 

### Flussi polmonari

-   ```{=tex}
    \todo{tutto - FEV~1~ - Indice di Tiffenau}
    ```

```{=html}
<!-- mer 10 mar 2021, 16:17:54, CET -->
```
# Argomento sconosciuto `\todo{Forse insufficienza respiratoria?}`{=tex}

-   Cause di IRC
    -   Cause polmonari
        -   Alterato controllo ventilatorio
            -   Funzionali
            -   Strutturali
            -   Idiopatiche
        -   ↓ compliance polmonare
    -   Cause extrapolmonari
        -   Ostruzione delle vie aeree
        -   Alterazioni anatomiche della gabbia toracica e della pleura
        -   Patologie neuromuscolari
            -   Neuropatia SNC che diminuiscono il *drive ventilatorio*
            -   Neuropatie periferiche che impediscono la propagazione
                degli impulsi
            -   Patologie dei muscoli che ne riducono la funzionalità

## Rapporto P/F

-   ```{=tex}
    \todo{}
    ```

## IRA

-   `\pat{ira}`{=tex} --- `\pat{ir}`{=tex} che si instaura in condizioni
    acute

## Evoluzione clinica

1.  Stadio 1 --- Ipoventilazione con o senza dispnea
    -   Tachicardia, ipertensione, diaforesi molto abbondante
    -   Ipersecrezione bronchiale
    -   Iniziale deterioramento neurologico
2.  Stadio 2 --- Ipoventilazione evidente con cianosi calda
3.  Stadio 3 --- Fasping
4.  Stadio 4 --- Arresto respiratorio → ACR

## Terapia dell'IR

-   ```{=tex}
    \todo{}
    ```

-   Obiettivo primario se IRA: correggere l'ipossiemia! Altrimenti ci
    lasciamo il paziente
    1.  Correggo ipossiemia
    2.  Penso a ipercapnia

### Ossigenoterapia

-   Per valutare l'entità dello scambio gassoso: rapporto P/F
    $$P/F=\frac{\text{PaO}_2}{\text{FiO}_2}$$

  P/F      Qualità dello scambio gassoso
  -------- -------------------------------
  \> 400   Normale
  \> 300   Alterato
  \> 200   Molto alterata
  \< 200   Gravemente alterata!

-   Erogabile principalmente con 3 modalità (scegliere modalità a
    seconda di stile di vita)
    1.  Bombole a gas pressurizzato
    2.  Bombole a gas liquefatto
    3.  Concentratori di O~2~ a batteria
-   Interfacce ossigeno--pz.:
    -   Interfacce comuni
        -   Occhialini nasali (FiO~2~ = 20 + (4 $\times$ flusso O~2~
            erogati), evitare flussi \> 6 lt per disconfort e FiO~2~
            sempre meno controllabile)
        -   `\goldstandard `{=tex}Ventimask (FiO~2~ a seconda della
            valvola)
        -   Reservoir (FiO~2~ \~ 80% se non rebreather e flussi \>
            10--12lt/min)
    -   Interfacce per gli alti flussi (fino a 60 lt/min)
        -   Sia come occhialino che come mask (con lacci per fissaggio)
        -   O~2~ va *riscaldato e umidificato* (circuito + macchina
            dedicato)
        -   FiO~2~ $\propto$ flusso a muro (\~ 95% con tutto maxato)
            -   Alti flussi permettono di regolare molto precisamente la
                FiO~2~ che raggiunge il pz.
                `\marginnote{Il paziente contamina molto meno l'aria in ingresso con CO~2~ espirato (la contaminazione c'è comunque perché il pz. deve pur espirare, ma per via dell'alto flusso è molto meno rilevante rispetto)}`{=tex}

#### Ossigenoterapia in acuto

-   Obiettivo della supplementazione: correggere al volo una ipossiemia
    arteriosa aumentando la FiO~2~, favorendo quindi la diffusione
    alveolo--capillare
    `\marginnote{Di fatto, devo allontanare il mio paziente dalla soglia del burrone. Ho necessità di mettere al sicuro il soggetto per allontanarlo dai valori di cut-off. Se non faccio questo, il paziente rischia di peggiorare irrimediabilmente}`{=tex}
-   Indicazioni **in acuto**
    -   **PaO~2~ \< 60 mmHg ⇔ SaO~2~ \< 90%**
    -   Se AR/ACR
    -   Se severo broncospasmo, insufficienza cardiaca o altra patologia
        cardiopolmonare instabile clinicamente
    -   Bassa portata cardiaca

#### Ossigenoterapia cronica

-   Obiettivo: prevenire o rallentare la progressione di complicanze che
    l'ipossiemia cronica porta sul cuore dx
-   Deve essere **continua, più è meglio è** (comunque \> 18h/die,
    altrimenti *nessun* beneficio)
-   Indicazioni
    -   PaO~2~ \< 55 mmHg e/o SaO~2~ \< 88%
    -   PaO~2~ \< 60 mmHg o SaO~2~ \< 89% con almeno una condizione
        aggravante
        -   Scompenso dx recidivante

        -   Sottostante cardiopatia ischemica

        -   ```{=tex}
            \pat{cuore polmonare}
            ```

        -   Ematocrito elevato (\> 56%)

#### Ossigenoterapia da sforzo

-   Indicazione controversa e non chiara
    -   Valutare bene costo/beneficio (spesa, compliance vs qualità di
        vita)
    -   Da valutare bene se SaO~2~ \< 90% durante **6-min walking test**
-   Se già in O~2~-tp. valutare un aumento di flusso sotto sforzo

#### Rischi dell'ossigenoterapia

-   **Do il minimo ossigeno necessario per avere una saturazione
    accettabile!**
-   Iperossiemia può portare a calo del *drive respiratorio*
-   Rischi principali
    -   ↓ del drive respiratorio ⇒ arresto respiratorio
    -   Mancato riconoscimento precoce di ipercapnia
    -   Irritazione da agenti ossidanti
    -   O~2~ è comburente! Attenzione a tp. domiciliare

### Ventilazione meccanica

-   3 obiettivi principali
    -   Supportare (parzialmente o totalmente) il paziente
        ipo`\emph{ventilante}`{=tex} (**↓ PaCO~2~** e ↑ PaO~2~)
    -   Migliorare il pattern respiratorio
    -   Ridurre il lavoro dei muscoli respiratori ⇒ defaticare i
        `\ner{centri del respiro}`{=tex}
-   Ventilazione meccanica può essere sia invasiva che non invasiva
    -   Ventilazione non invasiva (NIV) --- *assistenza* della funzione
        respiraoria
        -   CPAP con Boussignac[^116]
        -   Maschera facciale totale
        -   Casco
        -   Maschere solo nasali o solo boccali
    -   Ventilazione invasiva --- *vicarianza* della funzione
        respiratoria
        -   Intubazione o/t o n/t

------------------------------------------------------------------------

# Bibliografia {#bibliografia .unnumbered}

[^1]: neg per pressione intratoracica in espansione

[^2]: Il ventricolo non si dilata, perché di fatto la mitrale stenosata
    riduce il flusso verso il ventricolo proteggendolo dall'aumentato
    volume. Viceversa, l'atrio agirà da "camera di raccolta" del volume
    ematico che non defluisce verso il ventricolo e quindi si dilaterà.
    Ecco perché le aritmie da alterata conduzione sono atriali, nella
    stenosi mitralica

[^3]: Rullio dovuto al fatto che il ventricolo è molto pieno + soffio
    presistolico in corrispondenza della contrazione atriale attraverso
    una valvola stenosata. I suoni sono in diastole perché è in diastole
    che si ha flusso attraverso le valvole AV -- che sono continenti, ma
    stenosate. NB: in insufficienza il flusso è a valvola chiusa, quindi
    in sistole

[^4]: più lo schiocco è vicino a S2 più la situazione è grave, poiché
    indica che ci sono subito grandi pressioni (da volume) sufficienti
    per aprire la valvola dopo poco

[^5]: Un palloncino viene gonfiato nell'orifizio mitralico per
    allargarlo. Fattibile solo se non grandi calcificazioni

[^6]: "per motivi anatomici", qualsiasi cosa voglia dire

[^7]: Se non misurazione diretta, si può sempre usare la [Formula di
    Gorling](https://it.wikipedia.org/wiki/Calcolo_dell%27area_valvolare_aortica)

[^8]: Prognosi operati vs non operati è drammaticamente a sfavore dei
    non operati

[^9]: Produce generalmente bradicardie sinusali

[^10]: Infarto del miocardio dovuto a una ostruzione dell'arteria
    coronaria dx, che porta alla necrosi di una porzione inferiore della
    parete cardiaca. Questo mima gli effetti di un'aumentato tono
    vagale, aumentando i tempi necessari per propagare il potenziale
    d'azione -- diminuendo, di fatto, l'automatismo -- e portando a cali
    di frequenza

[^11]: Inibisce tono vagale (antagonista competitivo
    dell'acetilcolina sui recettori muscarinici) ⇒ ↓ tono vagale ⇒ ↑ FC

[^12]: Preferire posizionamento delle piastre anteroposteriore! Questo è
    perché è necessario stimolare i ventricoli. Necessario sedare il pz.
    perché è doloroso, anche se pacer cattura

[^13]: Produce generalmente tachicardie sinusali

[^14]: Da anemia, pneumopatie, embolia polmonare...

[^15]: Produce tachicardie ventricolari polmorfiche a QT lungo, chiamate
    dagli amici ***torsioni di punta***. Vtach polimorfa non bella.

[^16]: Produce tachicardie ventricolari monomorfiche a QT normale,
    ovvero tachicardia focale e tach multifocale

[^17]: Vit K Antagonist, eg `warfarin`

[^18]: Ma questo ha efficacia limitata, spesso FA è parossistica e
    ritorna. Cardioversione a RS spontanea in 50% pz.

[^19]: Tecnicamente nelle linee

[^20]: Transient Loss Of Conscience

[^21]: Perdita del tono muscolare

[^22]: Parkinson, atrofie sitemiche multiple, DM, amiloidosi, anemia,
    CKI, lesioni mieliche

[^23]: Valutare quantomeno ad EO lo stato dei tronchi sovraortici, non
    vogliamo far venire un ictus al pz. per vedere se forse questo
    potrebbe avere nei nostri sogni un problema di iperriflessia
    autonomica

[^24]: Il tipo di rimodellamento lo si distingue facendo
    cateterizzazione coronarica + eco intravascolare e vedendo il
    rapporto tra lume e distanza tra tonaca intima e tonaca avventizia
    (fisiologicamente devono essere aderenti)

[^25]: altrimenti sarebbe IMA...

[^26]: ECG a riposo in angina stabile sono fondamentalmente sempre non
    diangostici -- e grazie, aggiungerei, in quel momento la fisiologia
    coronarica è a posto. Le modifiche ECG sono la foto momentanea del
    miocardio, per cui registrano solo sofferenze ischemiche che si
    stanno verificando in quel momento: per questo nelle angine stabili
    sono modifiche che si scatenano con sforzo.

[^27]: Verosimilmente dovuto a vasospasmo coronarico (***angina di
    Prinzmetal***) o a disfuzione del microcircolo (per deficit
    funzionale o rarefazione del circolo rispetto alla massa miocardica
    \[***sindrome X cardiaca***\])

[^28]: Idealmente ECG \< 10' da primo contatto sanitario

[^29]: Apertura del vaso epicardico e suo stenting ha successo, ma
    questo non porta a ripristino del flusso

[^30]: Bypass aortocoronarico, angioplastica coronarica...

[^31]: Meglio considerare TP come punto di riferimento, isoelettrica è
    seconda scelta

[^32]: Ma non valid se in aVR, V1 o se isolata in III

[^33]: bastano nstemi che coinvolgono \<1g di tessuto per fare rialzare
    cTn \> 99mo perc

[^34]: ST Elevation, o ST sopraslivellato

[^35]: nb: Q patologiche invece sono segno di *necrosi irreversibile*

[^36]: ST Depression/Deviation, o ST sottoslivellato

[^37]: Regola d'oro del PS: ogni dolore dalla punta del naso
    all'ombelico è cardiogeno fino a prova contraria

[^38]: ll ponte miocardico è una condizione congenita caratterizzata
    dalla presenza di fibre muscolari che passano al di sopra di un
    tratto di coronaria. Nella stragrande totalità dei casi, è
    l'interventricolare anteriore (la più importante)

[^39]: DES, Drug--Eluting Stent. L'agente citostatico è molto efficace
    nel prevenire la complicanza della ristenosi o della stenosi "a
    caramella" (stenosi a monte + a valle dello stent) che si aveva con
    gli stent non medicati (BMS, Bare Metal Stent). Tuttavia, per il
    fatto che la maglia metallica rimane esposta visto che il vaso non
    si riepitelizza, è **essenziale** tp. anti**aggregante** (il
    problema sono le piastrine che si depositano nello stent e lo
    trombano (😏)). Solitamente: **doppia** antiaggregazione con
    `clopidogrel`+ `aspirina`

[^40]: L'attività di pompa viene meno perché si perde la rigidità di
    parete necessaria per pompare (visto che il tessuto fibroso è molto
    compliante e le pressioni cardiache sono elevate). Si dice che il
    cuore "pompa nella sacca". In più, essendo il tessuto fibroso non
    contrattile, si aumenta di molto il rischio di aritmie da conduzione
    anomala. Per di più l'inerzia della parete favorisce la formazione
    di trombi organizzati sulla parete stessa, aumentando il rischio di
    ictus (se a sx) o di embolia polmonare (se a dx)

[^41]: **Pseudoaneurisma** --- raccolta di sangue che si forma tra i due
    strati esterni di una arteria, la tonaca muscolare e la tonaca
    avventizia. Di solito è causato da una lesione al vaso. Può essere
    pulsante e assomigliare ad un vero aneurisma, tuttavia quest'ultimo
    coinvolge tutti e tre gli strati del vaso sanguigno. In questo caso
    è una dilatazione sacciforme del sacco pericardico (localizzata)
    dovuta ad una piccola rottura di parete ischemica

[^42]: Cumulativamente: morte, nuovo MI, rivascolarizzazione urgente

[^43]: Tecnicamente: apical balooining

[^44]: [ECO apical
    balooning](https://www.youtube.com/watch?v=n9HS_Mm5OOA&ab_channel=LearnTheHeart)

[^45]: Per esposizione, durante infarto, di antigeni precedentemente
    nascosti verso i quali non si era costruita tolleranza

[^46]: Ma questi si sentono solo quando il versamento pericardico sta
    montando, se diventa abbondante non si sentono più. Potrebbero in
    questo caso risultare attenuati i toni cardiaci

[^47]: Patofisiologia: il versamento, quando abbondante, comprime il
    ventricolo sx. In inspirio la pressione negativa richiama sangue in
    vent dx, che contribuisce a comprimere vent sx diminuendo la gittata
    nel grande circolo e quindi il polso scompare ("paradosso" perché
    normalmente in inspirio il polso effettivamente diminuisce in
    intensità per questo meccanismo, ma non deve scomparire)

[^48]: Questo potrebbe ingannare, aumentando la percezione di STE

[^49]: Se ECO non disponibile e siamo nella caccona c'è anche una
    tecnica alla cieca, che prevede l'uso di un ago attaccato a
    derivazione precordiale con morsetto a coccodrillo: se si dovesse
    toccare epicardio ad ECG si vede improvviso STE o PVC

[^50]: Anche in aereo (rischio di TVP proporzionale a lunghezza del
    volo) e in lunghi viaggi in macchina

[^51]: Se ci sono emboli piccoli che si alloggiano nel letto arterioso
    polmonare in maniera lenta e progressiva

[^52]: **Cuore polmonare** --- ingrandimento del ventricolo destro (⇒
    alterazioni in struttura e funzione), causato da una qualche
    malattia polmonare (solitamente ipertensione polmonare), che porta
    ad una risposta cardiaca errata. Raramente si è dimostrato anche
    l'interessamento del lato sinistro del cuore

[^53]: Tachipnea e tachicardia sono sintomi che aiutano a monitorare
    l'andamento: se peggiora il quadro peggiorano questi sintomi, se la
    terapia ha successo piano piano rientrano

[^54]: BBDX di nuovo riscontro (anche incompleto9, ST rigido o STE in
    una derivazione (sopratutto inferiori)

[^55]: UFH is a heterogeneous mixture of different length strands of
    heparin. It sticks to endothelial cells, macrophages, and various
    heparin-binding proteins. This makes its pharmacokinetics
    unpredictable, requiring monitoring.
    ([emcrit.org/ibcc](https://emcrit.org/ibcc/heparin/#choice_of_agent)).

    UFH È inoltre preferibile per una migliore tutela dell'azione renale
    e nelle done in gravidanza, perché non sorpassa il circolo
    placentare\]

[^56]: Tramite cateterizzazione dei vasi si gunge all'arteria in cui c'è
    il trombo, e si tenta di frammentarlo o spingerlo in periferia

[^57]: Scompenso sinistro sistolico (a FE ridotta) o diastolico (a FE
    conservata), insufficienza mitralica

[^58]: COPD, interstiziopatie, patologie ostruttive/restrittive, apneee
    notturne, ipoventilaioni alveolari, patologie dello sviluppo

[^59]: Idiopatica, ereeditabile, da farmaci, associata ad altri
    disordini (connettivopatie, HIV, ipertensione portale, difetti
    cardiaci congenici, schistosomiasi, da patologie veno--occlusive, da
    emangiomatosi dei capillari polmonari

[^60]: Disordini ematologici, sarcoidosi, disordini metabolici, altra
    roba particolarmente strana e veramente impronunciabile, vedi LG ESC

[^61]: *Meccanismo di Frank Starling* = meccanismo per il quale aumenta
    la portata cardiaca se aumenta il precarico

[^62]: Dove l'*indice cardiaco* è il rapporto (*CO* = Cardiac Output)

    $$\frac{\text{CO [lt/min]}}{\text{superficie corporea}}$$

[^63]: Right Atrial Pressure. Misurabile sempre con catetere SG
    attaccando il trasduttore alla porta del lume che sbuca
    posteriormente rispetto alla punta del catetere, in modo che quando
    la punta sia incuneata in arteria polmonare l'apertura del lume si
    trovi nel cuore destro

[^64]: Indice che riassume la funzionalità cardiaca:
    $\frac{\text{gittata cardiaca}}{\text{pressione atriale}}$, con CO =
    5l/min

[^65]: Somma di tutte le forze che si oppongono all'eiezione del volume
    diastolico

[^66]: $\frac{\text{Max Pressure during Systole}}{Stroke Volume}$

[^67]: NB: vincere il postcarico è il punto di raccordo tra la funzione
    ventricolare e quella vascolare, perché il precarico è formalmente
    *vinto* dal ventricolo ma *originato* dalle resistenze vascolari

[^68]: Di fatto, questo è ben evidenziabile studiando i cambiamenti
    nella curva pressione--volume (vedi fisio cardiaca)

[^69]: Epatomegalia da congestione epatica (stasi venosa ⇒ ristagno nei
    vasi epatici e rigonfiamento (a volte pulsatile) del parenchima
    epatico). Oltre ad avere quindi solitamente reperti di epatomegalia
    all'esame obiettivo si può avere dolore in ipocondrio dx e altri
    segni generici (ascite, nausea, vomito...). Se cronico, si può
    accompagnare a distruzione del parenchima con franco danno epatico

[^70]: Misurabile guardando a che altezza si ha il massimo rigonfiamento
    (pulsatile) della vena giugulare esterna in pz.. posizionato supino
    sul lettino, inclinato a \~ 45° (altezza da notch sternale + 5 cm
    per tenere conto della distanza tra manubrio e atrio dx). Se la PVG
    non è visualizzabile si può porre la mano a taglio sul decorso delle
    vene, occludendole parzialmente, per facilitare nel
    l'identificazione. In caso di scompenso, siccome spesso aumenta il
    precarico, avrò una pressione venosa giugulare più alta
    (registrabile più in alto). Spesso questo è sintomo di scompenso
    destro

[^71]: Quadro tipico in cui si visualizza il reticolo venoso polmonare
    all'RX (tipicamente, per un fatto di gravità, è più visibile alle
    basi, non visibile agli apici)

[^72]: Normalmente il circolo polmonare all'RX dovrebbe essere visibile
    (quando lo è) alle basi, per l'azione della gravità (hanno \< V/Q)

[^73]: È stato più precoce dell'edema alveolare (non rantoli, non
    ronchi, possibile MV ridotto)

[^74]: Inibitori del recettore dell'angiotensina

[^75]: ipertensione non va bene, ma abbiamo più armi per trattare
    l'ipertensione che lo shock, e la bassa portata è quella che fa
    danni immediati. L'ipertensione anche, ma la statistica dice che è
    protettiva rispetto alla mortalità intraH e post

[^76]: Defibrillatori impiantabili, ICDs (Implantable Cardiac
    Defibrillators)

[^77]: Anche detta CRT. È terapia elettrica che serve a migliorare il
    coordinamento contrattile del muscolo cardiaco

[^78]: PDE3 inhibitors are a type of phosphodiesterase inhibitors.
    Inhibition of the PDE isoenzyme 3 leads to an increase of
    intracellular concentrations of the second messenger cyclic
    adenosine monophosphate (cAMP). cAMP mediates the phosphorylation of
    protein kinases, which in turn activates cardiac calcium channels.
    An increased calcium influx from the sarcoplasmic reticulum (SR)
    during phase 2 (the plateau phase) of the cardiac action potential
    leads to a positive inotropic effect of PDE3 inhibitors: they
    increase the force of cardiac contraction. Increased reflux of
    calcium into the SR following the plateau phase is responsible for
    their positive lusitropic effect: they increase relaxation speed.
    Additionally, PDE3 inhibitors act as vasodilators (especially
    effective in vasodilating pulmonary circulation.

[^79]: Cardiac Index, ovvero CO/min/metro di superficie corporea

[^80]: \[Ematoma intramurale (H)\](img/ematoma-intramurale.png

[^81]: Cardiopatia congenita con stenosi a valle dell'istmo aortico e
    succlavia sinistra

[^82]: Da circolo ipercinetico ⇒ maggiore stress sulla parete aortica

[^83]: Substrato anatomopatologico di qualsiasi cosa che indebolisce la
    media elastica: si hanno porzioni ("cistica") di tonaca media che
    vengono indebolite e distrutte ("medionecrosi")

[^84]: NB: sono sempre condizioni con mortalità che bene che vada non si
    abbassa oltre l'8--10% a 30gg, quindi comunque siamo nella caccona

[^85]: Nel senso che a seconda di quali sintomi prevalgono si hanno
    varie manifestazioni. una forma pericarditica, una forma che inizia
    con lo scompenso, una forma che inizia con scompenso *grave*, una
    forma che inizia con sole aritmie

[^86]: Non focali; la situazione ricalca quella di pericardite

[^87]: 20--30 min prima dell'evento (così eventuali batteri trovano
    livelli terapeutici di abx in circolo e non colonizzano).
    `amoxi`/`ampi` (2g PO adulti, 50 mg/kg bimbi OPPURE se allergia alla
    penicillina 600 mg po `clinda` adulti, 20 mg/kg bimbi

[^88]: Traffico + fabbriche + combustibili + trasformazione
    chimicofisica di agenti (da sole, umidità, radiazioni...) Questo
    produce inquinanti sia disciolti nell'aria, che inquinanti "pesanti"
    che si depositano nel terreno e entrano negli organismi sottoforma
    di acqua, alimenti...

[^89]: Aria viziata + vapori + fumo + esalazioni chimiche presenti
    all'interno delle case

[^90]: È molto multifattoriale! C'entrano i geni, l'ambiente, i fattori
    di rischio, la fortuna e l'esposizione...

[^91]: Cane, gatto, altri animali

[^92]: Piante erbacee (\> graminacee) arboree (oleacee, betulle) funghi,
    animali (cavallo...)

[^93]: 15% dei casi di asma è collegato a lavoro

[^94]: \> 20% asmatici fuma

[^95]: *Atopia* = predisposizione genetica a sviluppare alcune reazioni
    allergiche

[^96]: Health Care Acquired Pneumonia

[^97]: Azoto ureico, o uremia

[^98]: Cronic Obsturctive Pulmonary Disease

[^99]: è anti-elastasi e normalmente contrasta il processo di digestione
    dei tessuti inevitabile durante la risposta infiammatoria

[^100]: Corticosteroide PO ha stessa disponibilità di corticosteroide EV

[^101]: Tipicamente: confuso con asma e le riacutizzazioni idem. Questo
    però porta a una mancata eradicazione dell'infezione da aspergillo,
    con un quadro assolutamente ingravescente, non risolvendo la causa
    di base

[^102]: Spesso pat autoimmuni (artrite, sclerodermia, dermatomiosite)
    sono *correlate* con interessamento polmonare di grado variabile

[^103]: Sarcoidosi --- Patologia multisistemica con eziologia
    sconosciuta che porta alla formazione di granulomi non necrotizzanti
    nel parenchima polmonare o nel mediastino

[^104]: 75% dei casi bilaterale, quando monolaterale è più frequente nel
    lato dx. Spesso giallastro, pochi WBC. Se scompenso severo (classe
    IV) spesso è ribelle a diuretici

[^105]: Pressione pleurica negativa "risucchia" il liquido ascitico
    addominale verso il diaframma -- che spesso viene facilmente
    attraversato -- e poi verso lo spazio pleurico E POI
    ipoproteinemia/ipoalbuminemia

[^106]: Il meccanismo è principalmente infiammatorio, ma non bisogna
    dimenticarsi che masse neoplastiche possano infiltrare/ostruire le
    vie linfatiche, portando a ridotto riassorbimento

[^107]: postsynaptic muscle relaxant that lessens excitation-contraction
    coupling in muscle cells. It achieves this by inhibiting Ca2+ ions
    release from sarcoplasmic reticulum stores by antagonizing ryanodine
    receptors. It is the primary drug used for the treatment and
    prevention of malignant hyperthermia

[^108]: Anche se c'è variabile anatomica con vaso che si divide in due e
    si porta anche verso l'alto

[^109]: Versamenti che sono in sede da tempo e vengono circondati da un
    *cercine* fibrotico

[^110]: Polmonite → complciazione → infiammazione strong → versamento
    semplice (solo liquido) → versamento complicato (colonizzato ⇒ ↓ pH)
    → empiema

[^111]: Batteri fanno fermentazione lattica del glucosio

[^112]: Flogosi del parenchima ⇒ erosioni dei vasi parenchimali ⇒
    sanguinamento

[^113]: Macrolide ab. + antiinfiammatori. Attenzione: così ci si espone
    ad un'insorgenza di farmacoresistenze in \~ 20% dei casi. Valutare
    bene funzionalità epatica prima di cominciare un trattamento del
    genere

[^114]: Device (anche casalingo) per imporre peep che (1) recluta
    alveoli migliorando la ventilazione; (2) favorisce lo spostamento
    delle secrezioni dalla periferia ai bronchi centrali, dove sono più
    eliminabili; (3) essendo esercizio contro resistenza funge da
    "ginnastica respiratoria". Particolarmente comoodo il fatto che la
    PEEP è regolabile semplicemente controllando la quota d'acqua della
    bottiglia

[^115]: ↓ NO, ↑ prostacicline PC12, ↑ endoteline

[^116]: Utile per reclutare, grazie alla pressione continua positiva,
    aree di parenchima che non scambiano più
